Document:

EX-10.19

 Exhibit 10.19 

BRITANNIA SEAPORT CENTRE 

LEASE 
 This Lease (the
“Lease”), dated as of the date set forth in Section 1 of the Summary of Basic Lease Information (the “Summary”), below, is made by and between HCP LS REDWOOD CITY,
LLC, a Delaware limited liability company (“Landlord”), and BOLT BIOTHERAPEUTICS, INC., a Delaware corporation
(“Tenant”). 
 SUMMARY OF BASIC LEASE
INFORMATION 
  

							
	TERMS OF LEASE	  	DESCRIPTION
			
	1.	  	Date:	  	August 7, 2020.
			
	2.	  	 Premises
 (Article 1).
	  	
				
		  	2.1	  	Buildings:	  	That certain building containing approximately 45,690 rentable square feet of space (“RSF”), located at 800 Chesapeake Drive, Redwood City, California (the “800 Building”) and that certain building
containing approximately 46,930 RSF located at 900 Chesapeake Drive, Redwood City, California (the “900 Building”) (the 800 Building and 900 Building are collectively, the “Buildings”).
				
		  	2.2	  	Premises:	  	Approximately 71,646 RSF in the aggregate, comprised of (i) 45,690 RSF comprising the entirety of the 800 Building (the “Initial Premises”), and (ii) 25,956 RSF on the second (2nd) floor of the 900 Building
(the “Additional Premises”), as further set forth in Exhibit A to the Lease.
			
	3.	  	 Lease Term
 (Article 2)
	  	
				
		  	3.1	  	Length of Term:	  	Ten (10) years.
				
		  	3.2	  	Lease Commencement Date:	  	The later of (i) six (6) months after the date of this Lease and (ii) the date that the Premises are “Ready for Occupancy” as defined in the Tenant Work Letter attached hereto as Exhibit
B.
				
		  	3.3	  	Additional Premises Lease Commencement Date:	  	August 1, 2025 (the “Additional Premises Lease Commencement Date”)
				
		  	3.4	  	Lease Expiration Date	  	The day prior to the tenth (10th) anniversary of the Lease Commencement Date.

  

					
		 	-1-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

					
	4.	  	Base Rent (Article 3):
			
		  	4.1	  	Base Rent for Initial Premises:

  

													
	 Lease Year
	  	Annualized
Base Rent	 	  	Monthly
Installment
of Base Rent	 	  	Approximate
Monthly Base
Rent per RSF	 
	 1
	  	$	2,878,470.00	 	  	$	239,872.50	 	  	$	5.25	 
	 2
	  	$	2,979,216.45	 	  	$	248,268.04	 	  	$	5.43	 
	 3
	  	$	3,083,489.03	 	  	$	256,957.42	 	  	$	5.62	 
	 4
	  	$	3,191,411.14	 	  	$	265,950.93	 	  	$	5.82	 
	 5
	  	$	3,303,110.53	 	  	$	275,259.21	 	  	$	6.02	 
	 6
	  	$	3,418,719.40	 	  	$	284,893.28	 	  	$	6.24	 
	 7
	  	$	3,538,374.58	 	  	$	294,864.55	 	  	$	6.45	 
	 8
	  	$	3,662,217.69	 	  	$	305,184.81	 	  	$	6.68	 
	 9
	  	$	3,790,395.31	 	  	$	315,866.28	 	  	$	6.91	 
	 10
	  	$	3,923,059.14	 	  	$	326,921.60	 	  	$	7.16	 

 Address for Payment of Rent: 

If by check, remittances should be mailed to: 

HCP Life Sciences REIT 
 File
51142 
 Los Angeles, CA 90074-1142 
 If by
ACH, remit to: 
 HCP Life Sciences REIT Bank of America 

ABA: 121000358 
 Acct:
1235928034 
 If by Wire, remit to: 
 HCP Life
Sciences REIT Bank of America 
 ABA: 026009593 

Acct: 1235928034 
 If by overnight mail, remit
to: 
 Bank of America Lockbox Services 

Lockbox 51142 
 2706 Media
Center Drive 
 Los Angeles, CA 90065-1733 

  

					
		 	-2-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

	4.2	 Base Rent for Additional Premises: 

 

													
	 Lease Year
	  	Annualized
Base Rent	 	  	Monthly
Installment
of Base Rent	 	  	Approximate
Monthly Base
Rent per RSF	 
	 Additional Premises

Lease Commencement

Date – end of Lease Year

5
	  	 	N/A	 	  	$	156,371.81	 	  	$	6.02	 
	 6
	  	$	1,942,137.90	 	  	$	161,844.83	 	  	$	6.24	 
	 7
	  	$	2,010,112.73	 	  	$	167,509.39	 	  	$	6.45	 
	 8
	  	$	2,080,466.67	 	  	$	173,372.22	 	  	$	6.68	 
	 9
	  	$	2,153,283.01	 	  	$	179,440.25	 	  	$	6.91	 
	 10
	  	$	2,228,647.91	 	  	$	185,720.66	 	  	$	7.16	 

  

					
	5.	  	 Tenant Improvement Allowance
 (Exhibit
B):
	  	$85.00 per RSF of the Initial Premises (i.e., $3,883,650.00 for the 45,690 RSF of the Initial Premises), which may only be used in the Initial Premises and Alterations to the Pad.
			
	6.	  	 Tenant’s Share
 (Article 4):
	  	 Initial Premises: 100% of the 800 Building.
  

Additional Premises: 55.31% of the 900 Building.

			
	7.	  	 Permitted Use
 (Article 5):
	  	The Premises shall be used only for general office, research and development, engineering, lab scale manufacturing, QC testing, process development, analytical development, laboratory and vivarium uses, including, but not limited
to, administrative offices and other lawful uses reasonably related to or incidental to such specified uses, all (i) consistent with first class life sciences projects in Redwood City, California (“First
Class Life Sciences Projects”), and (ii) in compliance with, and subject to, applicable laws and the terms of this Lease.
			
	8.	  	 Letter of Credit
 (Article 21):
	  	$980,764.80, which amount shall be increased on the Additional Premises Lease Commencement Date to $1,537,926.78.
			
	9.	  	 Parking
 (Article 28):
	  	The right to use up to 3.0 on-site parking spaces at the Project for each 1,000 RSF of the then existing Premises, on an unreserved basis, subject to the terms of Article 28 of the
Lease.

  

					
		 	-3-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

					
	10.	  	 Address of Tenant
 (Section 29.18):
	  	 Bolt Biotherapeutics, Inc.
 900 Chesapeake
Drive
 Redwood City, CA 94063
 Attention: Chief Business
Officer
  
 and to:

 
 Wilson Sonsini Goodrich & Rosati

650 Page Mill Road
 Palo Alto, CA 94034

Attention: Real Estate Dept./SPR

			
	11.	  	 Address of Landlord
 (Section 29.18):
	  	See Section 29.18 of the Lease.
			
	12.	  	 Broker(s)
 (Section 29.24)
	  	Savills and CBRE, Inc.

  

					
		 	-4-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 1.    PREMISES, BUILDING, PROJECT, AND COMMON AREAS. 

1.1    Premises, Building, Project and Common Areas. 

1.1.1    The Premises. Landlord hereby leases to Tenant and Tenant hereby leases from Landlord the premises
set forth in Section 2.2 of the Summary (the “Premises”). Notwithstanding the foregoing, Landlord and Tenant hereby acknowledge and agree that, as of the Lease Commencement Date, the “Premises” shall consist
exclusively of the Initial Premises and, as of the Additional Premises Lease Commencement Date, the “Premises” shall consist of the Initial Premises and the Additional Premises, collectively. In connection with the foregoing, Landlord and
Tenant hereby acknowledge and agree that (i) Tenant currently occupies the Additional Premises as a subtenant of the current tenant of the Additional Premises pursuant to a sublease dated June 14, 2019 ( the “Additional Premises
Sublease”) by ARMO Biosciences (“ARMO”) to Tenant, which sublease is pursuant to an underlying lease from Landlord to ARMO dated March 16, 2018 (the “ARMO Lease”) (the terms of both
of which expire as of the date immediately preceding the Additional Premises Lease Commencement Date), (ii) Landlord shall have no obligation to “deliver” the Additional Premises to Tenant, and (iii) that a portion of the Initial
Premises consisting of 10,000 rentable square feet of space on the first (1st) floor of the 800 Building (the “Subleased Premises”) pursuant to a sublease being entered into concurrently herewith (the
“OncoMed Sublease”) between Tenant and OncoMed Pharmaceuticals, Inc. (“OncoMed”), shall be occupied by OncoMed pursuant to the terms of the OncoMed Sublease, and that accordingly
Landlord’s delivery of the Initial Premises to Tenant shall not be with the Initial Premises vacant, Tenant shall accept such delivery with OncoMed in occupancy of the Subleased Premises and the same shall be deemed Landlord’s delivery of
the Initial Premises to Tenant. The outline of the Premises (both the Initial Premises and Additional Premises) is set forth in Exhibit A attached hereto. The outline of the “Building” and the “Project,” as those terms are
defined in Section 1.1.2 below, are further depicted on the Site Plan attached hereto as Exhibit A. The parties hereto agree that the lease of the Premises is upon and subject to the terms, covenants and conditions herein set forth, and Tenant
covenants as a material part of the consideration for this Lease to keep and perform each and all of such terms, covenants and conditions by it to be kept and performed. The parties hereto hereby acknowledge that the purpose of Exhibit A is to show
the approximate location of the Premises only, and such Exhibit is not meant to constitute an agreement, representation or warranty as to the construction of the Premises, the precise area thereof or the specific location of the “Common
Areas,” as that term is defined in Section 1.1.3, below, or the elements thereof or of the accessways to the Premises or the “Project,” as that term is defined in Section 1.1.2, below, and that the square footage of the
Premises shall be as set forth in Section 2.1 of the Summary of Basic Lease Information. Except as specifically set forth in this Lease and in the Tenant Work Letter attached hereto as Exhibit B (the “Tenant Work
Letter”), Landlord shall not be obligated to provide or pay for any improvement work or services related to the improvement of the Premises. Tenant also acknowledges that neither Landlord nor any agent of Landlord has made any
representation or warranty regarding the condition of the Premises, the Building or the Project or with respect to the suitability of any of the foregoing for the conduct of Tenant’s business, except as specifically set forth in this Lease and
the Tenant Work Letter. Landlord shall deliver the Initial Premises to Tenant in good, vacant (other than with respect to OncoMed pursuant to the terms above), broom clean condition, in compliance with all laws, with the roof water-tight and shall
cause the plumbing, electrical systems, fire sprinkler system, lighting, and all other building systems serving the Premises, including the Generator, in good operating condition and repair, fully decommissioned and otherwise in substantially the
same condition that exists as of the date of this Lease on or before the Lease Commencement Date, or such earlier date as Landlord and Tenant mutually agree. Landlord will be responsible for causing the exterior of the Building, the existing
Building entrances, the base building and all exterior Common Areas (including required striping and handicapped spaces in the parking areas) to be in compliance with ADA and parking requirements, to the extent required to allow the legal occupancy
of the Premises or completion of the Tenant Improvements. Notwithstanding anything in this Lease to the contrary, in connection with the foregoing Landlord shall, at Landlord’s sole cost and expense (which shall not be deemed an “Operating
Expense,” as that term is defined in Section 4.2.4), repair or replace any failed or inoperable portion of the HVAC and other mechanical, plumbing, electrical or other building systems serving the Initial Premises during the first twelve
(12) months of the initial Lease Term (“Warranty Period”), provided that the need to repair or replace was not caused by the misuse, misconduct, damage, destruction, omissions, and/or negligence of
Tenant, its subtenants and/or assignees, if any, or any 

  

					
		 	-5-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 
company which is acquired, sold or merged with Tenant (collectively, “Tenant Damage”), or by any modifications, Alterations or improvements constructed by or on behalf of
Tenant (which shall not include the Tenant Improvements). Landlord shall coordinate such work with Tenant and shall utilize commercially reasonable efforts to perform the same in a manner designed to minimize interference with Tenant’s use of
the Premises. To the extent repairs which Landlord is required to make pursuant to this Section 1.1.1 are necessitated in part by Tenant Damage, then Tenant shall reimburse Landlord for an equitable proportion of the cost of such repair. Any
process utilities shall be provided without warranty, in their currently existing, “as-is” condition. 

1.1.2    The Building and The Project. The Premises constitutes the entirety of the 800
Building and the portion of the 900 Building set forth in Section 2.1 of the Summary. The Buildings are part of an office/laboratory project currently known as “Britannia Seaport Centre.” The term “Project,” as
used in this Lease, shall mean (i) the Buildings and the Common Areas, (ii) the land (which is improved with landscaping, parking facilities and other improvements) upon which the Buildings and the Common Areas are located, (iii) the
other office/laboratory buildings located at Britannia Seaport Centre, and the land upon which such adjacent office/laboratory buildings are located, and (iv) at Landlord’s discretion, any additional real property, areas, land, buildings
or other improvements added thereto outside of the Project (provided that any such additions do not increase Tenant’s obligations under this Lease). All references in this Lease to the Building shall mean (i) the 800 Building when
the context applies to the 800 Building or any portion of the Premises located in the 800 Building, (ii) the 900 Building when the context applies to the 900 Building or any portion of the Premises located in the 900 Building, and
(iii) both the 800 Building and the 900 Building when the context applies to both of such buildings; provided, however, prior to the Additional Premises Lease Commencement Date or Recognition Lease Period, all references to the
Building shall be to the 800 Building and Tenant shall not be responsible under this Lease for any Direct Expenses with respect to the 900 Building. 

1.1.3    Common Areas. Tenant shall have the non-exclusive right to
use in common with other tenants in the Project, and subject to the rules and regulations referred to in Article 5 of this Lease, those portions of the Project which are provided, from time to time, for use in common by Landlord, Tenant and any
other tenants of the Project, which shall include the shipping and receiving area, elevators and staircase in the 900 Building and grounds (such areas, together with such other portions of the Project designated by Landlord, in its discretion, are
collectively referred to herein as the “Common Areas”). Landlord shall maintain and operate the Common Areas, including all sprinkler and other systems serving the Common Areas, in a first class manner, and the use thereof
shall be subject to such rules, regulations and restrictions as Landlord may reasonably make from time to time. Landlord reserves the right to close temporarily, make alterations or additions to, or change the location of elements of the Project and
the Common Areas, provided that in connection therewith Landlord will use commercially reasonable efforts to minimize any interference with Tenant’s use of and access to the Premises and parking areas.
-In addition, Tenant shall have the exclusive right to use the patio/picnic table area adjacent to the Initial Premises for seating, eating and company gatherings, including the right to install seating and
other improvements, subject to Article 8 hereof. 
 1.2    Rentable Square Feet of Premises. The rentable
square footage of the Premises is hereby deemed to be as set forth in Section 2.2 of the Summary, and shall not be subject to measurement or adjustment during the Lease Term. 

1.3    Right of First Offer. 

1.3.1    Right of First Offer. Subject to the terms and conditions of this Section 1.3, Landlord hereby
grants to Tenant, commencing on the date of this Lease, an on-going right of first offer during the Lease Term with respect to any rentable space which becomes available for lease in the 900 Building and not
located in the Additional Premises (the “First Offer Space”). Notwithstanding the foregoing, such first offer right of Tenant shall commence only following the expiration or earlier termination of the existing lease of the
First Offer Space (including renewals of any such lease, irrespective of whether any such renewal is currently set forth in such lease or is subsequently granted or agreed upon, and regardless of whether such renewal is consummated pursuant to a
lease amendment or a new lease). Such 

  

					
		 	-6-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 
right of first offer shall further be subject and subordinate to any renewal of any lease of the First Offer Space entered into by Landlord with a third party after Tenant’s failure to
exercise its right of first offer as provided in this Section 1.3 (the “Intervening Leases”). All such existing tenants of the First Offer Space and tenants under Intervening Leases, are collectively referred to as the
“Superior Right Holders”. 
 1.3.2    Procedure for Lease. 

1.3.2.1    Procedure for Offer. Subject to the terms hereof, Landlord shall notify Tenant (the
“First Offer Notice”) prior to entering into any lease with a third party for the First Offer Space, which notice shall outline the base rent, allowance amounts if any, length of term, and other economic terms on which
Landlord would be willing to lease the First Offer Space (as set forth in such proposal) to Tenant (the “Fundamental Terms”). Pursuant to such First Offer Notice, Landlord shall offer to lease to Tenant the applicable First
Offer Space on the Fundamental Terms. 
 1.3.2.2    Procedure for Acceptance. If Tenant wishes to
exercise Tenant’s right of first offer with respect to the First Offer Space described in the First Offer Notice, then within ten (10) business days after delivery of the First Offer Notice to Tenant, Tenant shall deliver notice to
Landlord of Tenant’s irrevocable exercise of its right of first offer with respect to all of the First Offer Space described in the First Offer Notice on the Fundamental Terms provided for therein. If Tenant does not so notify Landlord within
such ten (10) business day period of Tenant’s exercise of its first offer right, then Landlord shall be free to negotiate and enter into a lease for the First Offer Space to anyone whom it desires on any terms that Landlord desires,
provided that, if Landlord has not entered into any such lease within one hundred eighty (180) days after the date of delivery of the First Offer Notice, then, prior to entering into any lease of such First Offer Space, Landlord shall first
again offer such space to Tenant in accordance with the terms of this Section 1.3, provided that, prior to the entering into a lease of such space on terms that are more than 5% more favorable to the tenant than those set forth in the First
Offer Notice (as determined on a net effective present value basis), Landlord shall first deliver any other First Officer Notice to Tenant offering such space to Tenant on such reduced terms. Tenant shall respond to any such “re-offer” within five (5) days after delivery of such “re-offer” notice. 

1.3.2.3    Construction In First Offer Space. Unless the Fundamental Terms provided to Tenant for
the First Offer Space otherwise specify, Tenant shall take the First Offer Space in its “as is” condition, and Landlord shall not be obligated to provide or pay for any improvement of the First Offer Space. For the avoidance of doubt, if
the Fundamental Terms include a tenant improvement allowance or a turn-key build out, Tenant shall receive the same allowance or turn-key build out, as applicable. 

1.3.2.4    Lease of First Offer Space. If Tenant timely exercises Tenant’s right of first offer
to lease First Offer Space as set forth herein, Tenant shall within fifteen (15) days after receipt of Landlord’s first draft of an amendment accurately setting forth the Fundamental Terms and not containing any new material terms, enter
an amendment to this Lease (the “First Offer Space Amendment”) for such First Offer Space pursuant to this Section 1.3. Tenant’s lease of such First Offer Space shall be upon the express terms set forth in the First
Offer Notice, but otherwise upon the same general terms and conditions set forth in this Lease and this Section 1.3. The First Offer Space Lease shall not contain the rights set forth in Section 2.2, below, unless such rights were set
forth in the First Offer Notice. The term of Tenant’s lease of the First Offer Space shall commence on the date set forth in the First Offer Notice (provided that such commencement date shall in no event be earlier than the date of
Landlord’s delivery of the applicable First Offer Space to Tenant), and shall expire on the applicable date set forth in the First Offer Notice (the “First Offer Space Expiration Date”). 

1.3.2.5    Limitation of Exercise of First Offer Right. The right to lease First Offer Space as
provided in this Section 1.3 may not be exercised if, as of the date of the attempted exercise of the expansion option by Tenant, Tenant is in default under this Lease, beyond any applicable notice and cure period. The terms of this
Section 1.3 shall be personal to the originally named Tenant hereunder (the “Original Tenant”) or a Permitted Transferee, and may not be exercised by any assignee, subtenant, or other Transferee of Original Tenant’s
interest in this Lease other than a Permitted Transferee. 

  

					
		 	-7-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 
Tenant’s right of first offer shall be continuous during the Lease Term. Tenant’s rejection of any particular offer shall not relieve Landlord of its obligation to again offer the First
Offer Space to Tenant any time the First Offer Space subsequently becomes available (provided that Tenant’s rights under this Section 1.3 shall be subject and subordinate to the renewal of any tenant under a lease entered into by Landlord
after Tenant has declined or failed to respond to a First Offer Notice). 
 1.4    Additional Premises.
Effective as of the Additional Premises Lease Commencement Date, in addition to the Initial Premises, Tenant shall lease from Landlord and Landlord shall lease to Tenant the Additional Premises. Accordingly, (i) Tenant shall commence payment of
“Base Rent,” as that term is defined in Article 3, below, and “Additional Rent,” as that term is defined in Section 4.1, below, for the Additional Premises on the Additional Premises Lease Commencement Date, and
(ii) effective upon the Additional Premises Lease Commencement Date, and notwithstanding any contrary provision of this Lease, the Premises shall include the Initial Premises and the Additional Premises. Tenant’s lease of the Additional
Premises shall terminate concurrently with Tenant’s lease of the Initial Premises on the Lease Expiration Date, unless this Lease is sooner terminated in accordance with the terms hereof. Tenant acknowledges and agrees that Tenant shall
continue to accept the Additional Premises on the Additional Premises Lease Commencement Date is its then existing, “as is” condition. Except as provided in this Section 1.2, Tenant’s lease of the Additional Premises shall be
subject to the terms and conditions set forth in this Lease. Tenant’s occupancy of the Additional Premises after the termination of the ARMO Lease shall be deemed pursuant to this Lease and not as a holdover under the ARMO Lease and ARMO shall
be deemed to have surrendered the Additional Premises in the required condition notwithstanding Tenant’s continued occupancy thereof. Landlord agrees that in the event the ARMO Lease is terminated prior to the Additional Premises Lease
Commencement Date, Tenant will automatically become a direct tenant of Landlord in the Additional Premises on all of the terms and conditions of this Lease (subject to the last sentence of this Section 1.4), Landlord will recognize Tenant on
all of the terms and conditions of the Lease, and Tenant will attorn to Landlord on all of such terms from the date of such termination through the Additional Premises Lease Commencement Date (the “Recognition Lease Period”).
The termination of the ARMO Lease, and direct lease of the Additional Premises by Tenant as set forth above, shall not modify the Additional Premises Lease Commencement Date or Lease Expiration Date under this Lease. During the Recognition Lease
Period, Tenant shall pay Base Rent and Additional Rent for the Additional Premises in accordance with the terms of Additional Premises Sublease. 

1.5    Beneficial Occupancy. Notwithstanding any provision to the contrary contained in the Lease, Tenant
shall have the right to occupy the first floor of the Initial Premises for the conduct of its business from the date of this Lease until the Lease Commencement Date (the period from the date of this Lease until the Lease Commencement Date being
referred to herein as the “Beneficial Occupancy Period”), provided that (i) Tenant has delivered to Landlord satisfactory evidence of the insurance coverage required to be carried by Tenant in accordance with Article 10
below, (ii) Tenant has delivered to Landlord the Base Rent for the first month of the Lease Term as required pursuant to Article 3, below and timely provides the L-C as required pursuant to Article 21
below, and (iii) all of the terms and conditions of the Lease shall apply as to the portion occupied by Tenant or its subtenants, other than Tenant’s obligation to pay Base Rent, as though the Lease Commencement Date had occurred (although
the Lease Commencement Date shall not actually occur until the occurrence of the same pursuant to the terms of Section 2.1) upon such occupancy of a portion of the Premises by Tenant or its subtenant. Landlord hereby agrees that Tenant may
sublease a portion of the Initial Premises during the Beneficial Occupancy Period, subject to the terms of Article 14 below (including Section 14.3, as any rent paid by any such subtenants shall be shared equally with Landlord as Tenant is not
obligated to pay Base Rent during the Beneficial Occupancy Period). 
 2.    LEASE TERM; OPTION TERM. 

2.1    Lease Term. The terms and provisions of this Lease shall be effective as of the date of this Lease.
The term of this Lease (the “Lease Term”) shall be as set forth in Section 3.1 of the Summary, shall commence on the date set forth in Section 3.2 of the Summary (the “Lease Commencement
Date”). As provided for in Section 1.4, above, the term of Tenant’s lease of the Additional Premises shall commence on the date set forth in Section 3.3 of the Summary. The term of this Lease with

  

					
		 	-8-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 
respect to the Initial Premises and the Additional Premises shall terminate on the date set forth in Section 3.4 of the Summary (the “Lease Expiration Date”) unless
this Lease is sooner terminated as hereinafter provided. For purposes of this Lease, the term “Lease Year” shall mean each consecutive twelve (12) month period during the Lease Term. At any time during the Lease Term,
Landlord may deliver to Tenant a notice in the form as set forth in Exhibit C, attached hereto, as a confirmation only of the information set forth therein, which Tenant shall execute and return to Landlord within ten (10) days of receipt
thereof. Notwithstanding the foregoing, if the Premises is not Ready for Occupancy, (1) on or before August 15, 2021, then, as Tenant’s sole remedy for such delay, the date Tenant is otherwise obligated to commence payment of rent
shall be delayed by one day for each day that the delivery date is delayed beyond such date, or (2) October 15, 2021, then, Tenant shall also have the right to terminate this Lease by written notice thereof to Landlord, whereupon any
monies previously paid by Tenant to Landlord shall be reimbursed to Tenant. The foregoing dates shall be extended to the extent of any delays in delivery of possession caused by (i) Tenant Delay, as provided in Section 1(j) of the Tenant
Work Letter, or (ii) war, terrorism, acts of God, natural disaster, civil unrest, governmental strike or area-wide or industry-wide labor disputes, inability to obtain services, labor, or materials or reasonable substitutes therefor, delays due
to utility companies that are not the result of any action or inaction of Landlord, actual or threatened public health emergency (including, without limitation, epidemic, pandemic, famine, disease, plague, quarantine, and other significant public
health risk), governmental edicts, actions, declarations or quarantines by a governmental entity or health organization (including, without limitation, any
shelter-in-place orders, stay at home orders or any restrictions on travel related thereto that preclude Tenant, its agents, contractors or its employees from accessing
the Premises, national or regional emergency), or breaches in cybersecurity (provided that any such delay in this item (ii) shall not extend any such date by more than ninety (90) days). Landlord represents that it has terminated the
existing lease(s) of the Initial Premises, which termination is effective as of the date of this Lease. 

2.2    Option Term. 

2.2.1    Option Right. Landlord hereby grants to the Original Tenant, and its “Permitted
Assignees”, as that term is defined in Section 14.8, below, one (1) option to extend the Lease Term (the “Option Right”) for a period of eight (8) years (the “Option Term”), which
option shall be irrevocably exercised only by written notice delivered by Tenant to Landlord not more than twelve (12) months nor less than nine (9) months prior to the expiration of the initial Lease Term, provided that the following
conditions (the “Option Conditions”) are satisfied: (i) as of the date of delivery of such notice, Tenant is not in default under this Lease, after the expiration of any applicable notice and cure period;
(ii) Tenant has not previously been in default under this Lease, after the expiration of any applicable notice and cure period, more than twice in the twelve (12) month period prior to the date of Tenant’s attempted exercise; and
(iii) the Lease then remains in full force and effect. Landlord may, at Landlord’s option, exercised in Landlord’s sole and absolute discretion, waive any of the Option Conditions in which case the option, if otherwise properly
exercised by Tenant, shall remain in full force and effect. Tenant shall have the right to exercise the foregoing Option Right with respect to (i) the entirety of the then-existing Premises, (ii) the Initial Premises only (in which case
the Lease Term for any portion of the Premises located in the 900 Building shall not be extended and shall terminate on the Lease Expiration Date), or (iii) if any only if Tenant leases the entirety of the rentable space in the 900 Building,
with respect to the entirety of the 900 Building only (in which case the Lease term for the Initial Premises shall not be extended and shall terminate on the Lease Expiration Date). Upon the proper exercise of such option to extend, and provided
that Tenant satisfies all of the Option Conditions (except those, if any, which are waived by Landlord), the Lease Term, as it applies to the Premises, shall be extended for a period of eight (8) years. The rights contained in this
Section 2.2 shall be personal to Original Tenant and any Permitted Assignees, and may be exercised by Original Tenant or such Permitted Assignees (and not by any other assignee, sublessee or other “Transferee,” as that term is defined
in Section 14.1 of this Lease, of Tenant’s interest in this Lease). 
 2.2.2    Option Rent.
The annual Rent payable by Tenant during the Option Term (the “Option Rent”) shall be equal to the “Fair Rental Value,” as that term is defined below, for the Premises as of the commencement date of the Option Term.
The “Fair Rental Value,” as used in this Lease, shall be equal to the annual rent per rentable square foot (including additional rent and considering any “base year” or “expense stop” applicable thereto),
including all escalations, at which tenants (pursuant to leases 

  

					
		 	-9-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 
consummated within the twelve (12) month period preceding the first day of the Option Term), are leasing non-sublease,
non-encumbered, non-equity space which is not significantly greater or smaller in size than the subject space, with a comparable level of improvements (excluding any
property that Tenant would be allowed to remove from the Premises at the termination of the Lease), for a comparable lease term, in an arm’s length transaction, which comparable space is located in the “Comparable Buildings,” as that
term is defined in this Section 2.2.2, below (transactions satisfying the foregoing criteria shall be known as the “Comparable Transactions”), taking into consideration the following concessions (the
“Concessions”): (a) rental abatement concessions, if any, being granted such tenants in connection with such comparable space; (b) tenant improvements or allowances provided or to be provided for such comparable space,
and taking into account the value, if any, of the existing improvements in the subject space, such value to be based upon the age, condition, design, quality of finishes and layout of the improvements and the extent to which the same can be utilized
by a general office/lab user other than Tenant (other than improvements installed by Tenant at Tenant’s sole cost and expense); and (c) other reasonable monetary concessions being granted such tenants in connection with such comparable
space; provided, however, that in calculating the Fair Rental Value, no consideration shall be given to the fact that Landlord is or is not required to pay a real estate brokerage commission in connection with Tenant’s exercise of its right to
extend the Lease Term, or the fact that landlords are or are not paying real estate brokerage commissions in connection with such comparable space. The Concessions shall be reflected in the effective rental rate (which effective rental rate shall
take into consideration the total dollar value of such Concessions as amortized on a straight-line basis over the applicable term of the Comparable Transaction (in which case such Concessions evidenced in the effective rental rate shall not be
granted to Tenant)) payable by Tenant. The term “Comparable Buildings” shall mean the Building and those other life sciences buildings which are comparable to the Building in terms of age (based upon the date of completion of
construction or major renovation of to the building), quality of construction, level of services and amenities, size and appearance, and are located in Redwood City, California and the surrounding commercial area. 

2.2.3    Determination of Option Rent. In the event Tenant timely and appropriately exercises an option to
extend the Lease Term, Landlord shall notify Tenant of Landlord’s determination of the Option Rent within thirty (30) days thereafter. If Tenant, on or before the date which is ten (10) days following the date upon which Tenant
receives Landlord’s determination of the Option Rent, in good faith objects to Landlord’s determination of the Option Rent, then Landlord and Tenant shall attempt to agree upon the Option Rent using their best good-faith efforts. If
Landlord and Tenant fail to reach agreement within ten (10) days following Tenant’s objection to the Option Rent (the “Outside Agreement Date”), then Tenant shall have the right to withdraw its exercise of the
option by delivering written notice thereof to Landlord within five (5) days thereafter, in which event Tenant’s right to extend the Lease pursuant to this Section 2.2 shall be of no further force or effect. If Tenant does not
withdraw its exercise of the extension option, each party shall make a separate determination of the Option Rent, as the case may be, within ten (10) days after the Outside Agreement Date, and such determinations shall be submitted to
arbitration in accordance with Sections 2.2.3.1 through 2.2.3.7, below. If Tenant fails to object to Landlord’s determination of the Option Rent within the time period set forth herein, then Tenant shall be deemed to have accepted
Landlord’s determination of Option Rent. 
 2.2.3.1    Landlord and Tenant shall each appoint one
arbitrator who shall be a real estate appraiser who shall have been active over the five (5) year period ending on the date of such appointment in the appraisal of other class A life sciences buildings located in the Redwood City market area.
The determination of the arbitrators shall be limited solely to the issue of whether Landlord’s or Tenant’s submitted Option Rent is the closest to the actual Option Rent, taking into account the requirements of Section 2.2.2 of this
Lease, as determined by the arbitrators. Each such arbitrator shall be appointed within fifteen (15) days after the Outside Agreement Date. Landlord and Tenant may consult with their selected arbitrators prior to appointment and may select an
arbitrator who is favorable to their respective positions. The arbitrators so selected by Landlord and Tenant shall be deemed “Advocate Arbitrators.” 

2.2.3.2    The two (2) Advocate Arbitrators so appointed shall be specifically required pursuant to an
engagement letter within ten (10) days of the date of the appointment of the last appointed Advocate Arbitrator to agree upon and appoint a third arbitrator (“Neutral Arbitrator”)

  

					
		 	-10-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 
who shall be qualified under the same criteria set forth hereinabove for qualification of the two Advocate Arbitrators, except that neither the Landlord or Tenant or either parties’ Advocate
Arbitrator may, directly or indirectly, consult with the Neutral Arbitrator prior or subsequent to his or her appearance. The Neutral Arbitrator shall be retained via an engagement letter jointly prepared by Landlord’s counsel and Tenant’s
counsel. 
 2.2.3.3    The three arbitrators shall, within thirty (30) days of the appointment of the
Neutral Arbitrator, reach a decision as to whether the parties shall use Landlord’s or Tenant’s submitted Option Rent, and shall notify Landlord and Tenant thereof. 

2.2.3.4    The decision of the majority of the three arbitrators shall be binding upon Landlord and Tenant. 

2.2.3.5    If either Landlord or Tenant fails to appoint an Advocate Arbitrator within fifteen (15) days
after the Outside Agreement Date, then either party may petition the presiding judge of the Superior Court of San Mateo County to appoint such Advocate Arbitrator subject to the criteria in Section 2.2.3.1 of this Lease, or if he or she refuses
to act, either party may petition any judge having jurisdiction over the parties to appoint such Advocate Arbitrator. 

2.2.3.6    If the two (2) Advocate Arbitrators fail to agree upon and appoint the Neutral Arbitrator, then
either party may petition the presiding judge of the Superior Court of San Mateo County to appoint the Neutral Arbitrator, subject to criteria in Section 2.2.3.1 of this Lease, or if he or she refuses to act, either party may petition any judge
having jurisdiction over the parties to appoint such arbitrator. 
 2.2.3.7    The cost of the arbitration shall
be paid by Landlord and Tenant equally. 
 2.2.3.8    In the event that the Option Rent shall not have been
determined pursuant to the terms hereof prior to the commencement of the Option Term, Tenant shall be required to pay the Option Rent initially provided by Landlord to Tenant, and upon the final determination of the Option Rent, the payments made by
Tenant shall be reconciled with the actual amounts of Option Rent due, and the appropriate party shall make any corresponding payment to the other party. 

3.    BASE RENT. Tenant shall pay, without prior notice or demand, to Landlord at the address set forth in
Section 4 of the Summary, or, at Landlord’s option, at such other place as Landlord may from time to time designate in writing, by a check for currency which, at the time of payment, is legal tender for private or public debts in the
United States of America, base rent (“Base Rent”) as set forth in Section 4 of the Summary, payable in equal monthly installments as set forth in Section 4 of the Summary in advance on or before the first day of
each and every calendar month during the Lease Term, without any setoff or deduction whatsoever. The Base Rent for the first full month of the Lease Term for the Initial Premises only shall be paid at the time of Tenant’s execution of this
Lease. If any Rent payment date (including the Lease Commencement Date) falls on a day of the month other than the first day of such month or if any payment of Rent is for a period which is shorter than one month, the Rent for any fractional month
shall accrue on a daily basis for the period from the date such payment is due to the end of such calendar month or to the end of the Lease Term at a rate per day which is equal to 1/365 of the applicable annual Rent. All other payments or
adjustments required to be made under the terms of this Lease that require proration on a time basis shall be prorated on the same basis. 

4.    ADDITIONAL RENT. 

4.1    General Terms. 

4.1.1    Direct Expenses; Additional Rent. In addition to paying the Base Rent specified in Article 3 of
this Lease, Tenant shall pay during the Lease Term “Tenant’s Share” of the annual 

  

					
		 	-11-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 
“Direct Expenses,” as those terms are defined in Sections 4.2.6 and 4.2.2 of this Lease, respectively, allocable to the applicable Building as described in
Section 4.3. Such payments by Tenant, together with any and all other amounts payable by Tenant to Landlord pursuant to the terms of this Lease, are hereinafter collectively referred to as the “Additional Rent”, and the
Base Rent and the Additional Rent are herein collectively referred to as “Rent.” All amounts due under this Article 4 as Additional Rent shall be payable for the same periods and in the same manner as the Base Rent. Without
limitation on other obligations of Tenant which survive the expiration of the Lease Term, the obligations of Tenant to pay the Additional Rent provided for in this Article 4 shall survive the expiration of the Lease Term. 

4.1.2    Triple Net Lease. Landlord and Tenant acknowledge that, to the extent provided in this Lease, it
is their intent and agreement that this Lease be a “TRIPLE NET” lease and that as such, the provisions contained in this Lease are intended to pass on to Tenant or reimburse Landlord for the costs and expenses reasonably
associated with this Lease, the Building and the Project, and Tenant’s operation therefrom to the extent provided in this Lease. To the extent such costs and expenses payable by Tenant cannot be charged directly to, and paid by, Tenant, such
costs and expenses shall be paid by Landlord but reimbursed by Tenant as Additional Rent. 

4.2    Definitions of Key Terms Relating to Additional Rent. As used in this Article 4, the following terms
shall have the meanings hereinafter set forth: 
 4.2.1    Intentionally Deleted. 

4.2.2    “Direct Expenses” shall mean “Operating Expenses” and
“Tax Expenses.” 
 4.2.3    “Expense Year” shall mean each
calendar year in which any portion of the Lease Term falls, through and including the calendar year in which the Lease Term expires, provided that Landlord, upon notice to Tenant, may change the Expense Year from time to time to any other twelve
(12) consecutive month period, and, in the event of any such change, Tenant’s Share of Direct Expenses shall be equitably adjusted for any Expense Year involved in any such change. 

4.2.4    “Operating Expenses” shall mean all expenses, costs and amounts of every kind and
nature which Landlord pays or accrues during any Expense Year because of or in connection with the ownership, management, maintenance, security, repair, replacement, restoration or operation of the Project, or any portion thereof. Without limiting
the generality of the foregoing, Operating Expenses shall specifically include any and all of the following: (i) the cost of supplying all utilities, the cost of operating, repairing and maintaining the utility, telephone, mechanical, sanitary,
storm drainage, and elevator systems, and the cost of maintenance and service contracts in connection therewith; (ii) the cost of licenses, certificates, permits and inspections and the cost of contesting any governmental enactments which are
reasonably likely to increase Operating Expenses during the Lease Term, and the costs incurred in connection with a governmentally mandated transportation system management program or similar program; (iii) the cost of all insurance carried by
Landlord in connection with the Project and Premises as reasonably determined by Landlord; (iv) the cost of landscaping, relamping, and all supplies, tools, equipment and materials used in the operation, repair and maintenance of the Project,
or any portion thereof; (v) the cost of parking area operation, repair, restoration, and maintenance; (vi) management and/or incentive fees, consulting fees, legal fees and accounting fees, of all contractors and consultants in connection
with the management, operation, maintenance and repair of the Project; (vii) payments under any equipment rental agreements; (viii) subject to item (f), below, wages, salaries and other compensation and benefits, including taxes levied
thereon, of all persons engaged in the operation, maintenance and security of the Project; (ix) costs under any easement pertaining to the sharing of costs by the Project; (x) operation, repair, maintenance and replacement of all systems
and equipment and components thereof of the Project; (xi) the cost of janitorial, alarm, security and other services, replacement of wall and floor coverings, ceiling tiles and fixtures in Common Areas, maintenance and replacement of curbs and
walkways, repair to roofs and re-roofing; (xii) amortization (including interest on the unamortized cost) over such period of time as Landlord shall reasonably determine, of the cost of acquiring or the
rental expense of personal property used in the maintenance, operation and repair of the Project, or any portion thereof; 

  

					
		 	-12-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 
(xiii) the cost of capital improvements or other costs incurred in connection with the Project (A) which are intended to effect economies in the operation or maintenance of the Project, or
any portion thereof, or to reduce current or future Operating Expenses or to enhance the safety or security of the Project or its occupants, (B) which are required to comply with present or anticipated conservation programs, (C) which are
replacements or modifications of nonstructural items located in the Common Areas required to keep the Common Areas in good order or condition, or (D) which are required under any governmental law or regulation; provided, however, that
any capital expenditure shall be amortized (including reasonable interest on the amortized cost) over the reasonable useful life of such capital item; and (xiv) costs, fees, charges or assessments imposed by, or resulting from any mandate
imposed on Landlord by, any federal, state or local government for fire and police protection, trash removal, community services, or other services which do not constitute “Tax Expenses” as that term is defined in Section 4.2.5,
below, and (xv) payments under any easement, license, operating agreement, declaration, restrictive covenant, or instrument pertaining to the sharing of costs by the Building, including, without limitation, any covenants, conditions and
restrictions affecting the property, and reciprocal easement agreements affecting the property, any parking licenses, and any agreements with transit agencies affecting the Property (collectively, “Underlying Documents”).
Notwithstanding the foregoing, for purposes of this Lease, Operating Expenses shall not, however, include: 

(a)    costs, including legal fees, space planners’ fees, advertising and promotional expenses (except as
otherwise set forth above), and brokerage fees incurred in connection with the original construction or development, or original or future leasing of the Project, and costs, including permit, license and inspection costs, incurred with respect to
the installation of tenant improvements made for new tenants initially occupying space in the Project after the Lease Commencement Date or incurred in renovating or otherwise improving, decorating, painting or redecorating vacant space for tenants
or other occupants of the Project (excluding, however, such costs relating to any common areas of the Project or parking facilities); 

(b)    except as set forth in items (xii), (xiii), and (xiv) above, depreciation, interest and principal
payments on mortgages and other debt costs, if any, penalties and interest; 
 (c)    costs for which the
Landlord is reimbursed by any tenant or occupant of the Project or by insurance by its carrier or any tenant’s carrier or by anyone else, electric power costs for which any tenant directly contracts with the local public service company and
costs of utilities and services provided to other tenants that are not provided to Tenant; 
 (d)    any bad debt
loss, rent loss, or reserves for bad debts or rent loss or other reserves to the extent not used in the same year; 

(e)    costs associated with the operation of the business of the partnership or entity which constitutes the
Landlord, as the same are distinguished from the costs of operation of the Project (which shall specifically include, but not be limited to, accounting costs associated with the operation of the Project). Costs associated with the operation of the
business of the partnership or entity which constitutes the Landlord include costs of partnership accounting and legal matters, costs of defending any lawsuits with any mortgagee (except as the actions of the Tenant may be in issue), costs of
selling, syndicating, financing, mortgaging or hypothecating any of the Landlord’s interest in the Project, and costs incurred in connection with any disputes between Landlord and its employees, between Landlord and Project management, or
between Landlord and other tenants or occupants; 
 (f)    the wages and benefits of any employee who does not
devote substantially all of his or her employed time to the Project unless such wages and benefits are prorated to reflect time spent on operating and managing the Project
vis-a-vis time spent on matters unrelated to operating and managing the Project; provided, that in no event shall Operating Expenses for purposes of this Lease include
wages and/or benefits attributable to personnel above the level of Project manager; 
 (g)    amount paid as
ground rental for the Project by the Landlord; 

  

					
		 	-13-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 (h)    except for a property management fee not to exceed three
percent (3%) of gross revenues, overhead and profit increment paid to the Landlord, and any amounts paid to the Landlord or to subsidiaries or affiliates of the Landlord for services in the Project to the extent the same exceeds the costs of such
services rendered by qualified, first-class unaffiliated third parties on a competitive basis; 
 (i)    any
compensation paid to clerks, attendants or other persons in commercial concessions operated by the Landlord (other than as direct reimbursement for costs which, if incurred directly by Landlord, would properly be included in Operating Expenses);

 (j)    rentals and other related expenses incurred in leasing air conditioning systems, elevators or other
equipment which if purchased the cost of which would be excluded from Operating Expenses as a capital cost, except equipment not affixed to the Project which is used in providing engineering, janitorial or similar services and, further excepting
from this exclusion such equipment rented or leased to remedy or ameliorate an emergency condition in the Project; 

(k)    all items and services for which Tenant or any other tenant in the Project reimburses Landlord or which
Landlord provides selectively to one or more tenants (other than Tenant) without reimbursement; 
 (l)    any
costs expressly excluded from Operating Expenses elsewhere in this Lease; 
 (m)    rent for the amenities center
or for any office space occupied by Project management personnel; 
 (n)    costs arising from the gross
negligence or willful misconduct of Landlord or its agents, employees or contractors in connection with this Lease; 

(o)    costs incurred to comply with laws relating to the removal or remediation of hazardous material (as defined
under applicable law), and any costs of fines or penalties relating to the presence of hazardous material, in each case to the extent not brought into the Building or Premises by Tenant or any Tenant Parties; 

(p)    costs to correct any construction defect in the Project or to remedy any violation of a covenant, condition,
restriction, underwriter’s requirement or law that exists as of the Lease Commencement Date; 

(q)    capital costs occasioned by casualties or condemnation. 

(r)    legal fees, accountants’ fees (other than normal bookkeeping expenses) and other expenses incurred in
connection with disputes of tenants or other occupants of the Project or associated with the enforcement of the terms of any leases with tenants or the defense of Landlord’s title to or interest in the Project or any part thereof; 

(s)    costs incurred due to a violation by Landlord or any other tenant of the Project of the terms and conditions
of a lease; and 
 (t)    self-insurance retentions and premiums for insurance coverage not customarily paid by
tenants of similar projects in the vicinity of the Premises. 
 4.2.5    Taxes. 

4.2.5.1    “Tax Expenses” shall mean all federal, state, county, or local governmental or
municipal taxes, fees, charges or other impositions of every kind and nature, whether general, special, ordinary or extraordinary (including, without limitation, real estate taxes, general and special assessments, transit taxes, leasehold taxes or
taxes based upon the receipt of rent, including gross 

  

					
		 	-14-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 
receipts or sales taxes applicable to the receipt of rent, unless required to be paid by Tenant, personal property taxes imposed upon the fixtures, machinery, equipment, apparatus, systems and
equipment, appurtenances, furniture and other personal property used in connection with the Project, or any portion thereof), which shall be paid or accrued during any Expense Year (without regard to any different fiscal year used by such
governmental or municipal authority) because of or in connection with the ownership, leasing and operation of the Project, or any portion thereof. 

4.2.5.2    Tax Expenses shall include, without limitation: (i) Any tax on the rent, right to rent or other
income from the Project, or any portion thereof, or as against the business of leasing the Project, or any portion thereof; (ii) Any assessment, tax, fee, levy or charge in addition to, or in substitution, partially or totally, of any
assessment, tax, fee, levy or charge previously included within the definition of real property tax; (iii) Any assessment, tax, fee, levy, or charge allocable to or measured by the area of the Premises or the Rent payable hereunder, including,
without limitation, any business or gross income tax or excise tax with respect to the receipt of such rent, or upon or with respect to the possession, leasing, operating, management, maintenance, alteration, repair, use or occupancy by Tenant of
the Premises, or any portion thereof; and (iv) Any assessment, tax, fee, levy or charge, upon this transaction or any document to which Tenant is a party, creating or transferring an interest or an estate in the Premises or the improvements
thereon. 
 4.2.5.3    Any costs and expenses (including, without limitation, reasonable attorneys’ and
consultants’ fees) incurred in attempting to protest, reduce or minimize Tax Expenses shall be included in Tax Expenses in the Expense Year such expenses are incurred. Tax refunds shall be credited against Tax Expenses and refunded to Tenant
regardless of when received, based on the Expense Year to which the refund is applicable, provided that in no event shall the amount to be refunded to Tenant for any such Expense Year exceed the total amount paid by Tenant as Additional Rent under
this Article 4 for such Expense Year. If Tax Expenses for any period during the Lease Term or any extension thereof are increased after payment thereof for any reason, including, without limitation, error or reassessment by applicable governmental
or municipal authorities, Tenant shall pay Landlord upon demand Tenant’s Share of any such increased Tax Expenses. Notwithstanding anything to the contrary contained in this Section 4.2.5, there shall be excluded from Tax Expenses
(i) all excess profits taxes, franchise taxes, gift taxes, capital stock taxes, inheritance and succession taxes, transfer taxes, estate taxes, federal and state income taxes, and other taxes to the extent applicable to Landlord’s net
income (as opposed to rents, receipts or income attributable to operations at the Project), (ii) any items included as Operating Expenses, (iii) any items paid by Tenant under Section 4.5 of this Lease, (iv) assessments in excess of
the amount which would be payable if such assessment expense were paid in installments over the longest permitted term; (v) taxes imposed on land and improvements other than the Project; and (vi) tax increases resulting from the
improvement of any of the Project for the sole use of other occupants. 

4.2.6    “Tenant’s Share” for the Initial Premises and
the Additional Premises shall mean the percentages set forth in Section 6 of the Summary. 

4.3    Allocation of Direct Expenses. The parties acknowledge that the Building is a part of a multi
building project and that the costs and expenses incurred in connection with the Project (i.e., the Direct Expenses) should be shared between the Building and the other buildings in the Project. Accordingly, as set forth in Section 4.2 above,
Direct Expenses (which consist of Operating Expenses and Tax Expenses) are determined annually for the Project as a whole, and a portion of the Direct Expenses, which portion shall be determined by Landlord on an equitable basis, shall be allocated
to the Building (as opposed to other buildings in the Project). Such portion of Direct Expenses allocated to the Building shall include all Direct Expenses attributable solely to the Building and a pro rata portion of the Direct Expenses
attributable to the Project as a whole, and shall not include Direct Expenses attributable solely to other buildings in the Project; provided, however, common amenities which can be used by tenants of the Project outside a particular
Building, shall be allocated to the Project as a whole (and not to the Building). 
 4.4    Calculation and
Payment of Additional Rent. Commencing on the Lease Commencement Date, Tenant shall pay to Landlord, in the manner set forth in Section 4.4.1, below, and as Additional Rent, Tenant’s Share of Direct Expenses for each Expense Year
during the Lease Term. 

  

					
		 	-15-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 4.4.1    Statement of Actual Direct Expenses and Payment by
Tenant. Landlord shall give to Tenant within five (5) months following the end of each Expense Year, a statement (the “Statement”) which shall state the Direct Expenses incurred or accrued for such preceding Expense
Year, and which shall indicate the amount of Tenant’s Share of Direct Expenses. Upon receipt of the Statement for each Expense Year commencing or ending during the Lease Term, Tenant shall pay, with its next installment of Base Rent due that is
at least thirty (30) days thereafter, the full amount of Tenant’s Share of Direct Expenses for such Expense Year, less the amounts, if any, paid during such Expense Year as “Estimated Direct Expenses,” as that term
is defined in Section 4.4.2, below, and if Tenant paid more as Estimated Direct Expenses than the actual Tenant’s Share of Direct Expenses, Tenant shall receive a credit in the amount of Tenant’s overpayment against Rent next due
under this Lease. The failure of Landlord to timely furnish the Statement for any Expense Year shall not prejudice Landlord or Tenant from enforcing its rights under this Article 4. Even though the Lease Term has expired and Tenant has vacated the
Premises, when the final determination is made of Tenant’s Share of Direct Expenses for the Expense Year in which this Lease terminates, Tenant shall immediately pay to Landlord such amount, and if Tenant paid more as Estimated Direct Expenses
than the actual Tenant’s Share of Direct Expenses, Landlord shall, within thirty (30) days, deliver a check payable to Tenant in the amount of the overpayment. The provisions of this Section 4.4.1 shall survive the expiration or
earlier termination of the Lease Term. Notwithstanding the immediately preceding sentence, Tenant shall not be responsible for Tenant’s Share of any Direct Expenses attributable to any Expense Year which are first billed to Tenant more than two
(2) calendar years after the earlier of the expiration of the applicable Expense Year or the Lease Expiration Date, provided that in any event Tenant shall be responsible for Tenant’s Share of Direct Expenses levied by any governmental
authority or by any public utility companies at any time following the Lease Expiration Date which are attributable to any Expense Year (provided that Landlord delivers Tenant a bill for such amounts within two (2) years following
Landlord’s receipt of the bill therefor). 
 4.4.2    Statement of Estimated Direct Expenses. In
addition, Landlord shall give Tenant a yearly expense estimate statement (the “Estimate Statement”) which shall set forth Landlord’s reasonable estimate (the “Estimate”) of what the total amount
of Direct Expenses for the then-current Expense Year shall be and the estimated Tenant’s Share of Direct Expenses (the “Estimated Direct Expenses”). The failure of Landlord to timely furnish the Estimate Statement for
any Expense Year shall not preclude Landlord from enforcing its rights to collect any Estimated Direct Expenses under this Article 4, nor shall Landlord be prohibited from revising any Estimate Statement or Estimated Direct Expenses theretofore
delivered to the extent necessary. Thereafter, Tenant shall pay, with its next installment of Base Rent due that is at least thirty (30) days thereafter, a fraction of the Estimated Direct Expenses for the then-current Expense Year (reduced by
any amounts paid pursuant to the last sentence of this Section 4.4.2). Such fraction shall have as its numerator the number of months which have elapsed in such current Expense Year, including the month of such payment, and twelve (12) as
its denominator. Until a new Estimate Statement is furnished (which Landlord shall have the right to deliver to Tenant at any time), Tenant shall pay monthly, with the monthly Base Rent installments, an amount equal to
one-twelfth (1/12) of the total Estimated Direct Expenses set forth in the previous Estimate Statement delivered by Landlord to Tenant. 

4.5    Taxes and Other Charges for Which Tenant Is Directly Responsible. Tenant shall be liable for and
shall pay ten (10) days before delinquency, taxes levied against Tenant’s equipment, furniture, fixtures and any other personal property located in or about the Premises. If any such taxes on Tenant’s equipment, furniture, fixtures
and any other personal property are levied against Landlord or Landlord’s property or if the assessed value of Landlord’s property is increased by the inclusion therein of a value placed upon such equipment, furniture, fixtures or any
other personal property and if Landlord pays the taxes based upon such increased assessment, which Landlord shall have the right to do regardless of the validity thereof but only under proper protest if requested by Tenant, Tenant shall upon demand
repay to Landlord the taxes so levied against Landlord or the proportion of such taxes resulting from such increase in the assessment, as the case may be. 

4.6    Landlord’s Books and Records. Within one hundred twenty (120) days after receipt by Tenant
of a Statement, if Tenant disputes the amount of Additional Rent set forth in the Statement, a member of Tenant’s finance department, or an independent certified public accountant (which 

  

					
		 	-16-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 
accountant is a member of a nationally recognized accounting firm and is not working on a contingency fee basis) (“Tenant’s Accountant”),
designated and paid for by Tenant, may, after reasonable notice to Landlord and at reasonable times, inspect Landlord’s records with respect to the Statement at Landlord’s offices, provided that there is no existing Event of Default and
Tenant has paid all amounts required to be paid under the applicable Estimate Statement and Statement, as the case may be. In connection with such inspection, Tenant and Tenant’s agents must agree in advance to follow Landlord’s reasonable
rules and procedures regarding inspections of Landlord’s records, and shall execute a commercially reasonable confidentiality agreement regarding such inspection. Tenant’s failure to dispute the amount of Additional Rent set forth in any
Statement within one hundred twenty (120) days of Tenant’s receipt of such Statement shall be deemed to be Tenant’s approval of such Statement and Tenant, thereafter, waives the right or ability to dispute the amounts set forth in
such Statement. If after such inspection, Tenant still disputes such Additional Rent, a determination as to the proper amount shall be made, at Tenant’s expense, by an independent certified public accountant (the
“Accountant”) selected by Landlord and subject to Tenant’s reasonable approval; provided that if such Accountant determines that Direct Expenses were overstated by more than five percent (5%), then the cost of the
Accountant and the cost of such determination shall be paid for by Landlord, and Landlord shall reimburse Tenant for the cost of the Tenant’s Accountant (provided that such cost shall be a reasonable market cost for such services). Tenant
hereby acknowledges that Tenant’s sole right to inspect Landlord’s books and records and to contest the amount of Direct Expenses payable by Tenant shall be as set forth in this Section 4.6, and Tenant hereby waives any and all other
rights pursuant to applicable law to inspect such books and records and/or to contest the amount of Direct Expenses payable by Tenant. 

5.    USE OF PREMISES. 

5.1    Permitted Use. Tenant shall use the Premises solely for the Permitted Use set forth in Section 7
of the Summary and Tenant shall not use or permit the Premises or the Project to be used for any other purpose or purposes whatsoever without the prior written consent of Landlord, which may be withheld in Landlord’s sole discretion. 

5.2    Prohibited Uses. Tenant further covenants and agrees that Tenant shall not use or permit any person
or persons to use, the Premises or any part thereof for any use or purpose in violation of the laws of the United States of America, the State of California, or the ordinances, regulations or requirements of the local municipal or county governing
body or other lawful authorities having jurisdiction over the Project) including, without limitation, any such laws, ordinances, regulations or requirements relating to hazardous materials or substances, as those terms are defined by applicable laws
now or hereafter in effect. Landlord shall have the right to impose reasonable, nondiscriminatory and customary rules and regulations regarding the use of the Project that do not unreasonably interfere with Tenant’s use of the Premises, as
reasonably deemed necessary by Landlord with respect to the orderly operation of the Project, and Tenant shall comply with such reasonable rules and regulations. Tenant shall not do or permit anything to be done in or about the Premises which will
in any way obstruct or interfere with the rights of other tenants or occupants of the Building, or injure or annoy them or use or allow the Premises to be used for any improper, unlawful or objectionable purpose, nor shall Tenant cause, maintain or
permit any nuisance in, on or about the Premises. Tenant shall comply with, and Tenant’s rights and obligations under the Lease and Tenant’s use of the Premises shall be subject and subordinate to, all recorded easements, covenants,
conditions, and restrictions now or hereafter affecting the Project, so long as the same do not unreasonably interfere with Tenant’s use of the Premises or parking rights or materially increase Tenant’s obligations or decrease
Tenant’s rights under this Lease. 
 5.3    Hazardous Materials. 

5.3.1    Tenant’s Obligations. 

5.3.1.1    Prohibitions. As a material inducement to Landlord to enter into this Lease with Tenant,
Tenant has fully and accurately completed Landlord’s Pre-Leasing Environmental Exposure Questionnaire (the “Environmental Questionnaire”), which is attached as Exhibit E. Tenant
agrees that except for those chemicals or materials, and their respective quantities, specifically 

  

					
		 	-17-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 
listed on the Environmental Questionnaire (as the same may be updated from time to time as provided below), neither Tenant nor Tenant’s employees, contractors and subcontractors of any tier,
entities with a contractual relationship with Tenant (other than Landlord), or any entity acting as an agent or sub-agent of Tenant (collectively, “Tenant’s
Agents”) will produce, use, store or generate any “Hazardous Materials,” as that term is defined below, on, under or about the Premises, nor cause any Hazardous Material to be brought upon, placed, stored, manufactured,
generated, blended, handled, recycled, used or “Released,” as that term is defined below, on, in, under or about the Premises. If any information provided to Landlord by Tenant on the Environmental Questionnaire, or otherwise relating to
information concerning Hazardous Materials is intentionally false, incomplete, or misleading in any material respect, the same shall be deemed a default by Tenant under this Lease. Upon Landlord’s request, or in the event of any material change
in Tenant’s use of Hazardous Materials in the Premises, Tenant shall deliver to Landlord an updated Environmental Questionnaire at least once a year. Tenant shall notify Landlord prior to using any Hazardous Materials in the Premises not
described on the initial Environmental Questionnaire, and, to the extent such use would, in Landlord’s reasonable judgment, cause a material increase in the risk of liability compared to the uses previously allowed in the Premises, such
additional use shall be subject to Landlord’s prior consent, which may be withheld in Landlord’s reasonable discretion. Tenant shall not install or permit Tenant’s Agents to install any underground storage tank on the Premises. For
purposes of this Lease, “Hazardous Materials” means all flammable explosives, petroleum and petroleum products, waste oil, radon, radioactive materials, toxic pollutants, asbestos, polychlorinated biphenyls
(“PCBs”), medical waste, chemicals known to cause cancer or reproductive toxicity, pollutants, contaminants, hazardous wastes, toxic substances or related materials, including without limitation any chemical, element,
compound, mixture, solution, substance, object, waste or any combination thereof, which is or may be hazardous to human health, safety or to the environment due to its radioactivity, ignitability, corrosiveness, reactivity, explosiveness, toxicity,
carcinogenicity, infectiousness or other harmful or potentially harmful properties or effects, or defined as, regulated as or included in, the definition of “hazardous substances,” “hazardous wastes,” “hazardous
materials,” or “toxic substances” under any Environmental Laws. For purposes of this Lease, “Release” or “Released” or “Releases” shall mean any release, deposit,
discharge, emission, leaking, spilling, seeping, migrating, injecting, pumping, pouring, emptying, escaping, dumping, disposing, or other movement of Hazardous Materials into the environment. Landlord acknowledges that Tenant will be installing and
using fume hoods in the Premises and that emissions of Hazardous Materials into the air in compliance with all Environmental Laws shall not be considered Releases. 

5.3.1.2    Notices to Landlord. Tenant shall notify Landlord in writing as soon as possible but in
no event later than five (5) days after (i) the occurrence of any actual, alleged or threatened Release of any Hazardous Material in, on, under, from, about or in the vicinity of the Premises (whether past or present), regardless of the
source or quantity of any such Release, or (ii) Tenant becomes aware of any regulatory actions, inquiries, inspections, investigations, directives, or any cleanup, compliance, enforcement or abatement proceedings (including any threatened or
contemplated investigations or proceedings) relating to or potentially affecting the Premises, or (iii) Tenant becomes aware of any claims by any person or entity relating to any Hazardous Materials in, on, under, from, about or in the vicinity
of the Premises, whether relating to damage, contribution, cost recovery, compensation, loss or injury. Collectively, the matters set forth in clauses (i), (ii) and (iii) above are hereinafter referred to as “Hazardous Materials
Claims”. Tenant shall promptly forward to Landlord copies of all orders, notices, permits, applications and other communications and reports in connection with any Hazardous Materials Claims. Additionally, Tenant shall promptly advise
Landlord in writing of Tenant’s discovery of any occurrence or condition on, in, under or about the Premises that could subject Tenant or Landlord to any liability, or restrictions on ownership, occupancy, transferability or use of the Premises
under any “Environmental Laws,” as that term is defined below. Tenant shall not enter into any legal proceeding or other action, settlement, consent decree or other compromise with respect to any Hazardous Materials Claims without first
notifying Landlord of Tenant’s intention to do so and affording Landlord the opportunity to join and participate, as a party if Landlord so elects, in such proceedings and in no event shall Tenant enter into any agreements which are binding on
Landlord or the Premises without Landlord’s prior written consent. Landlord shall have the right to appear at and participate in, any and all legal or other administrative proceedings concerning any Hazardous Materials Claim. For purposes of
this Lease, “Environmental Laws” means all applicable present and future laws relating to the protection of human health, safety, wildlife or the environment, including, without limitation, (i) all requirements
pertaining to 

  

					
		 	-18-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 
reporting, licensing, permitting, investigation and/or remediation of emissions, discharges, Releases, or threatened Releases of Hazardous Materials, whether solid, liquid, or gaseous in nature,
into the air, surface water, groundwater, or land, or relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport, or handling of Hazardous Materials; and (ii) all requirements pertaining to the health
and safety of employees or the public. Environmental Laws include, but are not limited to, the Comprehensive Environmental Response, Compensation and Liability Act of 1980, 42 USC § 9601, et seq., the Hazardous Materials Transportation
Authorization Act of 1994, 49 USC § 5101, et seq., the Solid Waste Disposal Act, as amended by the Resource Conservation and Recovery Act of 1976, and Hazardous and Solid Waste Amendments of 1984, 42 USC § 6901, et seq., the Federal Water
Pollution Control Act, as amended by the Clean Water Act of 1977, 33 USC § 1251, et seq., the Clean Air Act of 1966, 42 USC § 7401, et seq., the Toxic Substances Control Act of 1976, 15 USC § 2601, et seq., the Safe Drinking Water Act
of 1974, 42 USC §§ 300f through 300j, the Occupational Safety and Health Act of 1970, as amended, 29 USC § 651 et seq., the Oil Pollution Act of 1990, 33 USC § 2701 et seq., the Emergency Planning and Community Right-To-Know Act of 1986, 42 USC § 11001 et seq., the National Environmental Policy Act of 1969, 42 USC § 4321 et seq., the Federal Insecticide, Fungicide and
Rodenticide Act of 1947, 7 USC § 136 et seq., California Carpenter-Presley-Tanner Hazardous Substance Account Act, California Health & Safety Code §§ 25300 et seq., Hazardous Materials Release Response Plans and Inventory
Act, California Health & Safety Code, §§ 25500 et seq., Underground Storage of Hazardous Substances provisions, California Health & Safety Code, §§ 25280 et seq., California Hazardous Waste Control Law,
California Health & Safety Code, §§ 25100 et seq., and any other state or local law counterparts, as amended, as such applicable laws, are in effect as of the Lease Commencement Date, or thereafter adopted, published, or
promulgated. 
 5.3.1.3    Releases of Hazardous Materials. If any Release of any Hazardous
Material in, on, under, from or about the Premises shall occur at any time during the Lease by Tenant or Tenant’s Agents, in addition to notifying Landlord as specified above, Tenant, at its own sole cost and expense, shall (i) immediately
comply with any and all reporting requirements imposed pursuant to any and all Environmental Laws, (ii) provide a written certification to Landlord indicating that Tenant has complied with all applicable reporting requirements, (iii) take
any and all necessary investigation, corrective and remedial action in accordance with any and all applicable Environmental Laws, utilizing an environmental consultant approved by Landlord, all in accordance with the provisions and requirements of
this Section 5.3, including, without limitation, Section 5.3.4, and (iv) take any such additional investigative, remedial and corrective actions as Landlord shall in its reasonable discretion deem necessary such that the Premises are
remediated to the condition existing prior to such Release. 
 5.3.1.4    Indemnification. 

5.3.1.4.1    In General. Without limiting in any way Tenant’s obligations under any other provision of
this Lease, Tenant shall be solely responsible for and shall protect, defend, indemnify and hold the Landlord Parties harmless from and against any and all claims, judgments, losses, damages, costs, expenses, penalties, enforcement actions, taxes,
fines, remedial actions, liabilities (including, without limitation, actual attorneys’ fees, litigation, arbitration and administrative proceeding costs, expert and consultant fees and laboratory costs) including, without limitation,
consequential damages and sums paid in settlement of claims, which arise during or after the Lease Term, whether foreseeable or unforeseeable, that arise during or after the Lease Term in whole or in part, foreseeable or unforeseeable, directly or
indirectly arising out of or attributable to the Release of Hazardous Materials in, on, under or about the Premises by Tenant or Tenant’s Agents. 

5.3.1.4.2    Limitations. Notwithstanding anything in Section 5.3.1.4, above, to the contrary,
Tenant’s indemnity of Landlord as set forth in Section 5.3.1.4, above, shall not be applicable to claims based upon Hazardous Materials not Released by Tenant or Tenant’s Agents. 

5.3.1.4.3    Landlord Indemnity. Under no circumstance shall Tenant be liable for, and Landlord shall
indemnify, defend, protect and hold harmless Tenant and Tenant’s Agents from and against, all losses, costs, claims, liabilities and damages (including attorneys’ and consultants’ fees) arising out of any Hazardous Materials that
exist in, on or about the Project as of the date 

  

					
		 	-19-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 
hereof, or Hazardous Material Released by Landlord or any Landlord Parties. Landlord will provide Tenant with any Hazardous Material reports relating to the Building that Landlord has in its
immediate possession. The provision of such reports shall be for informational purposes only, and Landlord does not make any representation or warranty as to the correctness or completeness of any such reports. 

5.3.1.5    Compliance with Environmental Laws. Without limiting the generality of Tenant’s
obligation to comply with applicable laws as otherwise provided in this Lease, Tenant shall, at its sole cost and expense, comply with all Environmental Laws related to the use of Hazardous Materials by Tenant and Tenant’s Agents. Tenant shall
obtain and maintain any and all necessary permits, licenses, certifications and approvals appropriate or required for the use, handling, storage, and disposal of any Hazardous Materials used, stored, generated, transported, handled, blended, or
recycled by Tenant on the Premises. Landlord shall have a continuing right, without obligation, to require Tenant to obtain, and to review and inspect any and all such permits, licenses, certifications and approvals, together with copies of any and
all Hazardous Materials management plans and programs, any and all Hazardous Materials risk management and pollution prevention programs, and any and all Hazardous Materials emergency response and employee training programs respecting Tenant’s
use of Hazardous Materials. Upon request of Landlord, Tenant shall deliver to Landlord a narrative description explaining the nature and scope of Tenant’s activities involving Hazardous Materials and showing to Landlord’s satisfaction
compliance with all Environmental Laws and the terms of this Lease. 
 5.3.2    Assurance of Performance.

 5.3.2.1    Environmental Assessments In General. Landlord may, but
shall not be required to, engage from time to time such contractors as Landlord determines to be appropriate (and which are reasonably acceptable to Tenant) to perform environmental assessments of a scope reasonably determined by Landlord (an
“Environmental Assessment”) to ensure Tenant’s compliance with the requirements of this Lease with respect to Hazardous Materials. 

5.3.2.2    Costs of Environmental Assessments. All costs and expenses incurred by Landlord in
connection with any such Environmental Assessment initially shall be paid by Landlord; provided that if any such Environmental Assessment shows that Tenant has failed to comply with the provisions of this Section 5.3, then all of the costs and
expenses of such Environmental Assessment shall be reimbursed by Tenant as Additional Rent within thirty (30) days after receipt of written demand therefor. 

5.3.3    Tenant’s Obligations upon Surrender. At the expiration or earlier termination of the Lease
Term, Tenant, at Tenant’s sole cost and expense, shall: (i) cause an Environmental Assessment of the Premises to be conducted in accordance with Section 15.3; (ii) cause all Hazardous Materials brought onto the Premises by Tenant or
Tenant’s Agents to be removed from the Premises and disposed of in accordance with all Environmental Laws and as necessary to allow the Premises to be used for the purposes allowed as of the date of this Lease; and (iii) cause to be
removed all containers installed or used by Tenant or Tenant’s Agents to store any Hazardous Materials on the Premises, and cause to be repaired any damage to the Premises caused by such removal. 

5.3.4    Clean-up. 

5.3.4.1    Environmental Reports; Clean-Up. If
any written report, including any report containing results of any Environmental Assessment (an “Environmental Report”) shall indicate (i) the presence of any Hazardous Materials as to which Tenant has a removal or
remediation obligation under this Section 5.3, and (ii) that as a result of same, the investigation, characterization, monitoring, assessment, repair, closure, remediation, removal, or other clean-up
(the “Clean-up”) of any Hazardous Materials is required, Tenant shall immediately prepare and submit to Landlord within thirty (30) days after receipt of the Environmental Report a
comprehensive plan, subject to Landlord’s written approval, specifying the actions to be taken by Tenant to perform the Clean-up so that the Premises are restored to the conditions required by this Lease.
Upon Landlord’s approval of the Clean-up plan, Tenant shall, at Tenant’s sole cost and expense, without limitation on any rights and remedies of Landlord under

  

					
		 	-20-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 
this Lease, immediately implement such plan with a consultant reasonably acceptable to Landlord and proceed to Clean-Up Hazardous Materials in accordance
with all applicable laws. If, within thirty (30) days after receiving a copy of such Environmental Report, Tenant fails either (a) to complete such Clean-up, or (b) with respect to any Clean-up that cannot be completed within such thirty-day period, fails to proceed with diligence to prepare the Clean-up plan and
complete the Clean-up as promptly as practicable, then Landlord shall have the right, but not the obligation, and without waiving any other rights under this Lease, to carry out any Clean-up recommended by the Environmental Report or required by any governmental authority having jurisdiction over the Premises, and recover all of the costs and expenses thereof from Tenant as Additional Rent,
payable within ten (10) days after receipt of written demand therefor. 
 5.3.4.2    No Rent
Abatement. Tenant shall continue to pay all Rent due or accruing under this Lease during any Clean-up, and shall not be entitled to any reduction, offset or deferral of any Base Rent or Additional Rent
due or accruing under this Lease during any such Clean-up. 

5.3.4.3    Surrender of Premises. Tenant shall complete any
Clean-up prior to surrender of the Premises upon the expiration or earlier termination of this Lease. Tenant shall obtain and deliver to Landlord a letter or other written determination from the overseeing
governmental authority confirming that the Clean-up has been completed in accordance with all requirements of such governmental authority and that no further response action of any kind is required for the
unrestricted use of the Premises (“Closure Letter”). Upon the expiration or earlier termination of this Lease, Tenant shall also be obligated to close all permits obtained in connection with Hazardous Materials used by Tenant
or Tenant’s Agents in accordance with applicable laws. 
 5.3.4.4    Failure to Timely Clean-Up. Should any Clean-up for which Tenant is responsible not be completed, or should Tenant not receive the Closure Letter and any governmental approvals required
under Environmental Laws in conjunction with such Clean-up prior to the expiration or earlier termination of this Lease, then, commencing on the later of the termination of this Lease and three
(3) business days after Landlord’s delivery of notice of such failure and that it elects to treat such failure as a holdover, Tenant shall be liable to Landlord as a holdover tenant (as more particularly provided in Article 16) until
Tenant has fully complied with its obligations under this Section 5.3. 
 5.3.5    Confidentiality.
Unless compelled to do so by applicable law, Tenant agrees that Tenant shall not disclose, discuss, disseminate or copy any information, data, findings, communications, conclusions and reports regarding the environmental condition of the Premises to
any Person (other than Tenant’s consultants, attorneys, property managers, employees, shareholders and potential and actual investors, lenders, business and merger partners, subtenants and assignees that have a need to know such information),
including any governmental authority, without the prior written consent of Landlord. In the event Tenant reasonably believes that disclosure is compelled by applicable law, it shall provide Landlord ten (10) days’ advance notice of
disclosure of confidential information so that Landlord may attempt to obtain a protective order. Tenant may additionally release such information to bona fide prospective purchasers, investors or lenders, subject to any such parties’ written
agreement to be bound by the terms of this Section 5.3. 
 5.3.6    Copies of Environmental Reports.
Within thirty (30) days of receipt thereof, Tenant shall provide Landlord with a copy of any and all environmental assessments, audits, studies and reports regarding Tenant’s activities with respect to the Premises, or ground water beneath
the Land, or the environmental condition or Clean-up thereof. Tenant shall be obligated to provide Landlord with a copy of such materials without regard to whether such materials are generated by Tenant or
prepared for Tenant, or how Tenant comes into possession of such materials. 
 5.3.7    Signs, Response
Plans, Etc. Tenant shall be responsible for posting on the Premises any signs required under applicable Environmental Laws with respect to the use of Hazardous Materials by Tenant or Tenant’s Agents. Tenant shall also complete and file any
business response plans or inventories required by any applicable laws. Tenant shall concurrently file a copy of any such business response plan or inventory with Landlord. 

  

					
		 	-21-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 5.3.8    Survival. Each covenant, agreement,
representation, warranty and indemnification made by Tenant set forth in this Section 5.3 shall survive the expiration or earlier termination of this Lease and shall remain effective until all of Tenant’s obligations under this
Section 5.3 have been completely performed and satisfied. 
 6.    SERVICES AND UTILITIES. 

6.1    In General. Landlord will be responsible, at Tenant’s sole cost and expense (subject to the terms
of Section 4.2.4, above), for the furnishing of heating, ventilation and air-conditioning, electricity, and water services to the Premises. Landlord shall not provide janitorial or telephone services for
the Premises. Tenant shall be solely responsible for performing all janitorial services and other cleaning of the Premises, all in compliance with applicable laws. The janitorial and cleaning of the Premises shall be adequate to maintain the
Premises in a manner consistent with First Class Life Sciences Projects. 
 Tenant shall cooperate fully with Landlord at all times and
abide by all reasonable regulations and requirements that Landlord may reasonably prescribe for the proper functioning and protection of the HVAC, electrical, mechanical and plumbing systems. Provided that Landlord agrees to provide and maintain and
keep in continuous service utility connections to the Project, including electricity, water and sewage connections, Landlord shall have no obligation to provide any services or utilities (including process utilities) to the Building, including, but
not limited to heating, ventilation and air-conditioning, electricity, water, telephone, janitorial and interior Building security services, except as set forth in this Section 6.1, above. 

6.2    Tenant Payment of Utilities Costs. After the Lease Commencement Date to the extent that any utilities
(including without limitation, electricity, gas, sewer and water) to the Building are separately metered or sub-metered to the Premises, such utilities shall either be contracted for and paid directly by
Tenant to the applicable utility provider, or reimbursed by Tenant to Landlord within thirty (30) days after billing. After the Lease Commencement Date, to the extent that any utilities (including without limitation, electricity, gas, sewer and
water) to the Building are not separately metered to the Premises, then Tenant shall pay to Landlord, within thirty (30) days after billing, an equitable portion of the Building utility costs, based on Tenant’s proportionate use thereof.
The majority of utilities to the Building will be separately metered (or sub-metered) in the Premises. To the extent any utilities are not separately metered, Tenant shall be responsible for its equitable
share of such utility costs. 
 6.3    Interruption of Use. Tenant agrees that Landlord shall not be
liable for damages, by abatement of Rent or otherwise, for failure to furnish or delay in furnishing any service or utility (including, without limitation, telephone and telecommunication services, UPS services, or other laboratory services or
utilities), or for any diminution in the quality or quantity thereof, when such failure or delay or diminution is occasioned, in whole or in part, by breakage, repairs, replacements, or improvements, by any strike, lockout or other labor trouble, by
inability to secure electricity, gas, water, or other fuel at the Building or Project after reasonable effort to do so, by any riot or other dangerous condition, emergency, accident or casualty whatsoever, by act or default of Tenant or other
parties, or by any other cause; and such failures or delays or diminution shall never be deemed to constitute an eviction or disturbance of Tenant’s use and possession of the Premises or relieve Tenant from paying Rent or performing any of its
obligations under this Lease. Notwithstanding the foregoing, Landlord may be liable for damages to the extent caused by the negligence or willful misconduct of Landlord or the Landlord Parties, provided that Landlord shall not be liable under any
circumstances for injury to, or interference with, Tenant’s business, including, without limitation, loss of profits, however occurring, through or in connection with or incidental to a failure to furnish any of the services or utilities as set
forth in this Article 6. 
 6.4    Energy Performance Disclosure Information. Tenant hereby acknowledges
that Landlord may be required to disclose certain information concerning the energy performance of the Building pursuant to California Public Resources Code Section 25402.10 and the regulations adopted pursuant thereto (collectively the
“Energy Disclosure Requirements”). Tenant hereby acknowledges prior receipt of the Data Verification Checklist, as defined in the Energy Disclosure Requirements (the “Energy Disclosure Information”),
and agrees that Landlord has timely complied in full with Landlord’s obligations 

  

					
		 	-22-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 
under the Energy Disclosure Requirements. Tenant acknowledges and agrees that (i) Landlord makes no representation or warranty regarding the energy performance of the Building or the
accuracy or completeness of the Energy Disclosure Information, (ii) the Energy Disclosure Information is for the current occupancy and use of the Building and that the energy performance of the Building may vary depending on future occupancy
and/or use of the Building, and (iii) Landlord shall have no liability to Tenant for any errors or omissions in the Energy Disclosure Information. If and to the extent not prohibited by applicable laws, Tenant hereby waives any right Tenant may
have to receive the Energy Disclosure Information, including, without limitation, any right Tenant may have to terminate this Lease as a result of Landlord’s failure to disclose such information. Further, Tenant hereby releases Landlord from
any and all losses, costs, damages, expenses and/or liabilities relating to, arising out of and/or resulting from the Energy Disclosure Requirements, including, without limitation, any liabilities arising as a result of Landlord’s failure to
disclose the Energy Disclosure Information to Tenant prior to the execution of this Lease. Tenant’s acknowledgment of the AS-IS condition of the Premises pursuant to the terms of this Lease shall be
deemed to include the energy performance of the Building. Tenant further acknowledges that pursuant to the Energy Disclosure Requirements, Landlord may be required in the future to disclose information concerning Tenant’s energy usage to
certain third parties, including, without limitation, prospective purchasers, lenders and tenants of the Building (the “Tenant Energy Use Disclosure”). Tenant hereby (A) consents to all such Tenant Energy Use
Disclosures, and (B) acknowledges that Landlord shall not be required to notify Tenant of any Tenant Energy Use Disclosure. Further, Tenant hereby releases Landlord from any and all losses, costs, damages, expenses and liabilities relating to,
arising out of and/or resulting from any Tenant Energy Use Disclosure. The terms of this Section 6.3 shall survive the expiration or earlier termination of this Lease. 

6.5    800 Building Generator. Commencing on the date of this Lease, Tenant and its subtenants shall have
the right to connect to the back-up generator serving the 800 Building and Initial Premises only (the “Generator”), for Tenant’s Share of the Generator’s capacity to provide back-up generator services to the Initial Premises. During the Lease Term, Landlord shall maintain the Generator in good condition and repair, and Tenant shall be responsible for a share of the costs of such
maintenance and repair based on the proportion of the Generator capacity allocated to the Initial Premises. Notwithstanding the foregoing, Landlord shall not be liable for any damages whatsoever resulting from any failure in operation of the
Generator, or the failure of the Generator to provide suitable or adequate back-up power to the Initial Premises, including but not limited to, loss of profits, loss of rents or other revenues, loss of
business opportunity, loss of goodwill or loss of use, in each case, however occurring, or loss to inventory, scientific research, scientific experiments, laboratory animals, products, specimens, samples, and/or scientific, business, accounting and
other records of every kind and description kept at the Premises and any and all income derived or derivable therefrom. 

6.6    Equipment Pad. Tenant shall have the right to use the two (2) existing equipment pads adjacent
to the Premises (collectively, the “Pad”). Subject to Landlord’s review of more detailed plans therefor(subject to the same being approved by the city), Tenant shall have the right to install a roof on the existing
enclosures on the Pad and supplemental concrete pads on the Pad (the “Pad Improvements”) and install a back-up generator, nitrogen generator, chemical storage bunker and air compressor
and other equipment thereon to service the Premises (the “Pad Equipment”). The installation of the Pad Improvements and the Pad Equipment shall be done as an Alteration (in which case such installation shall be governed by
the terms of Article 8). In the event such Pad, Pad Improvements and Pad Equipment are installed or used, then during the Lease Term, Tenant shall maintain such Pad, Pad Improvements and Pad Equipment at Tenant’s sole cost and expense.
Notwithstanding the foregoing, Landlord shall not be liable for any damages whatsoever resulting from any failure in operation of the Pad Equipment, or the failure of the Pad Equipment to provide suitable or adequate services to the Premises,
including but not limited to, loss of profits, loss of rents or other revenues, loss of business opportunity, loss of goodwill or loss of use, in each case, however occurring, or loss to inventory, scientific research, scientific experiments,
laboratory animals, products, specimens, samples, and/or scientific, business, accounting and other records of every kind and description kept at the Premises and any and all income derived or derivable therefrom. Tenant’s obligations with
respect to the Premises, including the insurance and indemnification obligations contained in Article 10, below, and obligations to comply with applicable law shall apply to Tenant’s use of the Pad and Pad Equipment and Tenant shall carry
industry standard machinery insurance covering the Pad Equipment. Tenant shall maintain all required permits in connection with the Pad and Pad 

  

					
		 	-23-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 
Equipment throughout the Lease Term. Tenant shall surrender the Pad, Pad Improvements and Pad Equipment concurrent with the surrender of the Premises to Landlord as required hereunder in good
operating and working order, with all permits current, unless Landlord notifies Tenant in writing at least six (6) months prior to the expiration of the Lease Term that Tenant must remove the Pad Equipment, and Tenant shall remove all Pad
Equipment from the Pad prior to the Lease Expiration Date. Tenant shall have the exclusive right to use the Pad for placement of the Pad Equipment and Hazardous Materials storage. 

6.7    Rooftop Use. Tenant shall have the right, at Tenant’s sole cost and expense and in accordance
with the applicable provisions of this Lease, to install telecommunications, mechanical, exhaust and air handling equipment approved by Landlord (the “Rooftop Equipment”) upon the roof of the Building. Tenant shall be
responsible for all costs associated with the installation, operation, maintenance, repair, compliance with laws and removal of the Rooftop Equipment. The use of the Rooftop Equipment shall be for Tenant’s sole purpose and may not be assigned,
subleased, transferred or otherwise used by any other person or entity. The physical appearance and all plans and specifications of the Rooftop Equipment (including, without limitation, the manner in which the Rooftop Equipment is affixed to the
roof and the means by which the same is connected to the Premises) shall be subject to Landlord’s reasonable approval. Tenant shall be responsible, at Tenant’s sole cost and expense, for (i) obtaining all permits or other governmental
approvals required in connection with the Rooftop Equipment, (ii) repairing and maintaining and causing the Rooftop Equipment to comply with all Applicable Laws, (iii) any repairs to the roof of the Building resulting from Tenant’s
use of or access to the Rooftop Equipment, and (iv) prior to the expiration or earlier termination of this Lease, removal of the Rooftop Equipment and all associated wiring/cabling (and the restoration of all affected areas to the condition
existing prior to the installation thereof) if Landlord notifies Tenant in writing at least six (6) months prior to the expiration of the Lease Term that Tenant must remove any of the Rooftop Equipment. 

7.    REPAIRS. 

7.1    Tenant Repair Obligations. Tenant shall, throughout the Term, at its sole cost and expense, maintain,
repair or replace as required, the Premises in a good standard of maintenance, repair and replacement as required, and in good and sanitary condition, all in accordance with the standards of First Class Life Sciences Projects, except for the
Landlord Repair Obligations, whether or not such maintenance, repair, replacement or improvement is required in order to comply with applicable Laws (“Tenant’s Repair Obligations”), including
without limitation, all electrical facilities and equipment, including lighting fixtures, lamps, fans and any exhaust equipment and systems, electrical motors and all other appliances and equipment of every kind and nature located in the Premises;
all communications systems serving the Premises; all of Tenant’s security systems in or about or serving the Premises; Tenant’s signage; interior demising walls and partitions (including painting and wall coverings), equipment, floors.
Tenant shall additionally be responsible, at Tenant’s sole cost and expense, to furnish all expendables, including light bulbs, paper goods and soaps, used in the Premises. 

7.2    Landlord Repair Obligations. Landlord shall be responsible, as a part of Operating Expenses, for
repairs to and routine maintenance of the Building including without limitation: (1) exterior windows, window frames, window casements (including the repairing, resealing, cleaning and replacing of exterior windows); (2) exterior doors, door
frames and door closers; (3) the Building (as opposed to the Premises) and Project plumbing, sewer, drainage, electrical, fire protection, life safety and security systems and equipment, existing heating, ventilation and air-conditioning systems, and all other mechanical and HVAC systems and equipment (collectively, the “Building Systems”), (4) the exterior glass, exterior walls, foundation and roof of the
Building, the structural portions of the floors of the Building, including, without limitation, any painting, sealing, patching and waterproofing of exterior walls, and (5) repairs to the elevator in the Building and underground utilities,
except to the extent that any such repairs are required due to the negligence or willful misconduct of Tenant (the “Landlord Repair Obligations”); provided, however, that if such repairs are due to the negligence or
willful misconduct of Tenant, Landlord shall nevertheless make such repairs at Tenant’s expense, or, if covered by Landlord’s insurance, Tenant shall only be obligated to pay any deductible in connection therewith. Costs expended by
Landlord in connection with the Landlord Repair Obligations shall be included in Operating Expenses to the extent allowed pursuant to the terms of Article 4, above. Landlord shall cooperate with Tenant to enforce any warranties that Landlord holds
that could reduce Tenant’s maintenance obligations under this Lease. 

  

					
		 	-24-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 7.3    Tenant’s Right to Make
Repairs. Notwithstanding any provision to the contrary contained in this Lease, if Tenant provides written notice to Landlord of an event or circumstance which requires the action of Landlord under this Lease with respect to repair and/or
maintenance required in the Initial Premises only (and Tenant acknowledges the terms of this Section 7.3 shall not apply to the Additional Premises unless Tenant leases all of the rentable space in the 900 Building, in which case references
herein to the Initial Premises and the 800 Building will also to be Additional Premises and 900 Building), including repairs to the portions of the 800 Building located within the Initial Premises that are Landlord’s responsibility under
Section 7.2 (the “Base Building”), which event or circumstance with respect to the Base Building materially and adversely affects the conduct of Tenant’s business from the Initial Premises, and Landlord fails to
commence corrective action within a reasonable period of time, given the circumstances, after the receipt of such notice, but in any event not later than thirty (30) days after receipt of said notice (unless Landlord’s obligation cannot
reasonably be performed within thirty (30) days, in which event Landlord shall be allowed additional time as is reasonably necessary to perform the obligation so long as Landlord begins performance within the initial thirty (30) days and
diligently pursues performance to completion), or, in the event of an Emergency (as defined below), not later than five (5) business days after receipt of such notice, then Tenant shall have the right to undertake such actions as may be
reasonably necessary to make such repairs if Landlord thereafter fails to commence corrective action within five (5) business days following Landlord’s receipt of a second written notice from Tenant specifying that Tenant will undertake
such actions if Landlord fails to timely do so (provided that such notice shall include the following language in bold, capitalized text: “IF LANDLORD FAILS TO COMMENCE THE REPAIRS DESCRIBED IN THIS LETTER WITHIN FIVE
(5) BUSINESS DAYS FROM LANDLORD’S RECEIPT OF THIS LETTER, TENANT WILL PERFORM SUCH REPAIRS AT LANDLORD’S EXPENSE”; provided, however, that in no event shall Tenant undertake
any actions that could materially or adversely affect the Base Building. Notwithstanding the foregoing, in the event of an Emergency, no second written notice shall be required as long as Tenant advises Landlord in the first written notice of
Tenant’s intent to perform such Emergency repairs if Landlord does not commence the same within such five (5) business day period, utilizing the language required in second notices. If such action was required under the terms of this Lease
to be taken by Landlord and was not commenced by Landlord within such five (5) business day period and thereafter diligently pursued to completion, then Tenant shall be entitled to prompt reimbursement by Landlord of the reasonable out-of-pocket third-party costs and expenses actually incurred by Tenant in taking such action. If Tenant undertakes such corrective actions pursuant to this Section 7.3,
then (a) the insurance and indemnity provisions set forth in this Lease shall apply to Tenant’s performance of such corrective actions, (b) Tenant shall proceed in accordance with all applicable laws, (c) Tenant shall retain to
perform such corrective actions only such reputable contractors and suppliers as are duly licensed and qualified, (d) Tenant shall effect such repairs in a good and workmanlike and commercially reasonable manner, and (e) Tenant shall use
new or like new materials. Promptly following completion of any work taken by Tenant pursuant to the terms of this Section 7.3, Tenant shall deliver a detailed invoice of the work completed, the materials used and the costs relating thereto,
and Landlord shall reimburse Tenant the amounts expended by Tenant in connection with such work, provided that Landlord shall have the right to object if Landlord claims that such action did not have to be taken by Landlord pursuant to the terms of
this Lease or that the charges are excessive (in which case Landlord shall pay the amount it contends would not have been excessive). For purposes of this Section 7.5, an “Emergency” shall mean an event threatening
immediate and material danger to people located in the 800 Building or immediate, material damage to the 800 Building, Base Building, or creating a realistic possibility of an immediate and material interference with, or immediate and material
interruption of a material aspect of Tenant’s business operations. 
 8.    ADDITIONS AND
ALTERATIONS. 
 8.1    Landlord’s Consent to Alterations. Tenant may not make any
improvements, alterations, additions or changes to the Premises or any mechanical, plumbing or HVAC facilities or systems pertaining to the Premises (collectively, the “Alterations”) without first procuring the prior written
consent of Landlord to such Alterations, which consent shall be requested by Tenant not less than ten (10) business 

  

					
		 	-25-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 
days prior to the commencement thereof, and which consent shall not be unreasonably withheld by Landlord (and shall be provided or withheld within ten (10) business days of request by
Tenant), provided it shall be deemed reasonable for Landlord to withhold its consent to any Alteration which adversely affects the structural portions or the systems or equipment of the Building or is visible from the exterior of the Building.
Notwithstanding the foregoing, Tenant shall be permitted to make Alterations following ten (10) business days’ notice to Landlord (as to Alterations costing more than $10,000 only), but without Landlord’s prior consent, to the extent
that such Alterations (i) do not materially or adversely affect the building systems or equipment (other than minor changes such as adding or relocating electrical outlets and thermostats), (ii) are not visible from the exterior of the
Building, and (iii) cost less than $100,000.00 for a particular job of work. The construction of the Tenant Improvements to the Premises shall be governed by the terms of the Tenant Work Letter and not the terms of this Article 8. 

8.2    Manner of Construction. Landlord may impose, as a condition of its consent to any and all Alterations
of the Premises or about the Premises, such requirements as Landlord in its reasonable discretion may deem desirable, including, but not limited to, the requirement that upon Landlord’s request, Tenant shall, at Tenant’s expense, remove
such Alterations upon the expiration or any early termination of the Lease Term. Tenant shall construct such Alterations in a good and workmanlike manner, in conformance with any and all applicable federal, state, county or municipal laws, rules and
regulations and pursuant to a valid building permit, issued by the city in which the Building is located (or other applicable governmental authority). Tenant shall not use (and upon notice from Landlord shall cease using) contractors, services,
workmen, labor, materials or equipment that, in Landlord’s reasonable judgment, would disturb labor harmony with the workforce or trades engaged in performing other work, labor or services in or about the Building or the Common Areas. Upon
completion of any Alterations, Tenant shall deliver to Landlord final lien waivers from all contractors, subcontractors and materialmen who performed such work. 

In addition to Tenant’s obligations under Article 9 of this Lease, upon completion of any Alterations, Tenant agrees to cause a Notice of
Completion to be recorded in the office of the Recorder of the County of San Mateo in accordance with Section 3093 of the Civil Code of the State of California or any successor statute, and Tenant shall deliver to the Project construction
manager a reproducible copy of the “as built” drawings of the Alterations as well as all permits, approvals and other documents issued by any governmental agency in connection with the Alterations. 

8.3    Payment for Improvements. In connection with any Alterations that affect the Building systems (other
than minor changes such as adding or relocating electrical outlets and thermostats), or which have a cost in excess of $100,000, Tenant shall reimburse Landlord for Landlord’s reasonable, actual, out-of-pocket costs and expenses actually incurred in connection with Landlord’s review of such work. 

8.4    Construction Insurance. In addition to the requirements of Article 10 of this Lease, in the event
that Tenant makes any Alterations, prior to the commencement of such Alterations, Tenant shall provide Landlord with evidence that Tenant or Tenant’s contractor carries “Builder’s All
Risk” insurance (to the extent that the cost of such work shall exceed $100,000) in an amount approved by Landlord covering the construction of such Alterations, and such other insurance as Landlord may reasonably require, it being
understood and agreed that all of such Alterations shall be insured by Landlord pursuant to Article 10 of this Lease immediately upon completion thereof. In addition, Tenant’s contractors and subcontractors shall be required to carry Commercial
General Liability Insurance in an amount approved by Landlord and otherwise in accordance with the requirements of Article 10 of this Lease. In connection with Alterations with a cost in excess of $250,000, Landlord may, in its reasonable
discretion, require Tenant to obtain a lien and completion bond or some alternate form of security satisfactory to Landlord in an amount sufficient to ensure the lien-free completion of such Alterations and naming Landlord as a co-obligee. 

8.5    Landlord’s Property. All Alterations, improvements, fixtures, equipment and/or appurtenances
which may be installed or placed in or about the Premises, from time to time, shall be at the sole cost of Tenant and all Alterations and improvements, shall be and become the property of Landlord 

  

					
		 	-26-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 
and remain in place at the Premises following the expiration or earlier termination of this Lease. Notwithstanding the foregoing, Landlord may, by written notice to Tenant given at the time it
consents to an Alteration, require Tenant, at Tenant’s expense, to remove any Alterations within the Premises and to repair any damage to the Premises and Building caused by such removal. If Tenant fails to complete such removal and/or to
repair any damage caused by the removal of any Alterations, Landlord may do so and may charge the cost thereof to Tenant. Tenant hereby protects, defends, indemnifies and holds Landlord harmless from any liability, cost, obligation, expense or claim
of lien in any manner relating to the installation, placement, removal or financing of any such Alterations, improvements, fixtures and/or equipment in, on or about the Premises, which obligations of Tenant shall survive the expiration or earlier
termination of this Lease. Notwithstanding the foregoing, except to the extent the same are paid for by the Tenant Improvement Allowance, the items set forth in Exhibit F attached hereto (the “Tenant’s
Property”) shall at all times be and remain Tenant’s property. Exhibit F may be updated from time to time by agreement of the parties. Tenant may remove the Tenant’s Property from the Premises at any time, provided that Tenant
repairs all damage caused by such removal. Landlord shall have no lien or other interest in the Tenant’s Property. 

9.    COVENANT AGAINST LIENS. Tenant shall keep the Project and Premises free from any liens or encumbrances
arising out of the work performed, materials furnished or obligations incurred by or on behalf of Tenant, and shall protect, defend, indemnify and hold Landlord harmless from and against any claims, liabilities, judgments or costs (including,
without limitation, reasonable attorneys’ fees and costs) arising out of same or in connection therewith. Except as to Alterations as to which no notice is required under the second sentence of Section 8.1, Tenant shall give Landlord
notice at least ten (10) business days prior to the commencement of any such work on the Premises (or such additional time as may be necessary under applicable laws) to afford Landlord the opportunity of posting and recording appropriate
notices of non-responsibility (to the extent applicable pursuant to then applicable laws). Tenant shall remove any such lien or encumbrance by bond or otherwise within ten (10) business days after notice
by Landlord, and if Tenant shall fail to do so, Landlord may pay the amount necessary to remove such lien or encumbrance, without being responsible for investigating the validity thereof. 

10.    INSURANCE. 

10.1    Indemnification and Waiver. Except as provided in Section 10.5 or to the extent due to the
negligence, willful misconduct or violation of this Lease by Landlord or the Landlord Parties, Tenant hereby assumes all risk of damage to property in, upon or about the Premises from any cause whatsoever (including, but not limited to, any personal
injuries resulting from a slip and fall in, upon or about the Premises) and agrees that Landlord, its partners, subpartners and their respective officers, agents, servants, employees, and independent contractors (collectively, “Landlord
Parties”) shall not be liable for, and are hereby released from any responsibility for, any damage either to person or property or resulting from the loss of use thereof, which damage is sustained by Tenant or by other persons claiming
through Tenant. Tenant shall indemnify, defend, protect, and hold harmless the Landlord Parties from any and all loss, cost, damage, expense and liability (including without limitation court costs and reasonable attorneys’ fees) incurred in
connection with or arising from any cause in, on or about the Premises (including, but not limited to, a slip and fall), any acts, omissions or negligence of Tenant or of any person claiming by, through or under Tenant, or of the contractors,
agents, servants, employees, invitees, guests or licensees of Tenant or any such person, in, on or about the Project or any breach of the terms of this Lease, either prior to, during, or after the expiration of the Lease Term, provided that the
terms of the foregoing indemnity and release shall not apply to the negligence or willful misconduct of Landlord or its agents, employees, contractors, licensees or invitees, or Landlord’s violation of this Lease. Should Landlord be named as a
defendant in any suit brought against Tenant in connection with or arising out of Tenant’s occupancy of the Premises, Tenant shall pay to Landlord its costs and expenses incurred in such suit, including without limitation, its actual
professional fees such as reasonable appraisers’, accountants’ and attorneys’ fees. Notwithstanding anything to the contrary in this Lease, Landlord shall not be released or indemnified from, and shall indemnify, defend, protect and
hold harmless Tenant from, all losses, damages, liabilities, claims, attorneys’ fees, costs and expenses arising from the gross negligence or willful misconduct of Landlord or its agents, contractors, licensees or invitees, or a violation of
Landlord’s obligations or representations under this Lease. The provisions of this Section 10.1 shall survive the expiration or sooner termination of this Lease with respect to any claims or liability arising in connection with any event
occurring prior to such expiration or termination. 

  

					
		 	-27-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 10.2    Tenant’s Compliance With Landlord’s Property
Insurance. Landlord shall insure the Building, Tenant Improvements and any Alterations during the Lease Term against loss or damage under an “all risk” property insurance policy. Such coverage shall be in such amounts, from such
companies, and on such other terms and conditions, as Landlord may from time to time reasonably determine. Additionally, at the option of Landlord, such insurance coverage may include the risks of earthquakes and/or flood damage and additional
hazards, a rental loss endorsement and one or more loss payee endorsements in favor of the holders of any mortgages or deeds of trust encumbering the interest of Landlord in the Building or the ground or underlying lessors of the Building, or any
portion thereof. The costs of such insurance shall be included in Operating Expenses, subject to the terms of Section 4.2.4. Tenant shall, at Tenant’s expense, comply with all insurance company requirements pertaining to the use of the
Premises. If Tenant’s conduct or use of the Premises causes any increase in the premium for such insurance policies then Tenant shall reimburse Landlord for any such increase. Tenant, at Tenant’s expense, shall comply with all rules,
orders, regulations or requirements of the American Insurance Association (formerly the National Board of Fire Underwriters) and with any similar body. Notwithstanding anything to the contrary in this Lease, Tenant shall not be required to comply
with or cause the Premises to comply with any laws, rules, regulations or insurance requirements requiring the construction of alterations unless such compliance is necessitated solely due to Tenant’s particular use of the Premises. 

10.3    Tenant’s Insurance. Tenant shall maintain the following coverages in the following amounts
during the Lease Term (except Tenant shall carry the insurance described in Section 10.3.1 during any period in which it enters the Premises). 

10.3.1    Commercial General Liability Insurance on an occurrence form covering the insured against claims of
bodily injury and property damage (including loss of use thereof) arising out of Tenant’s operations, and contractual liabilities including a contractual coverage for limits of liability (which limits may be met together with umbrella liability
insurance) of not less than: 
  

			
	 Bodily Injury and
	  	$4,000,000 each occurrence
	 Property Damage Liability
	  	$4,000,000 annual aggregate
		
	 Personal Injury Liability
	  	$4,000,000 annual aggregate

 10.3.2    Property Insurance covering all office furniture, business and trade
fixtures, office and lab equipment, free-standing cabinet work, movable partitions, merchandise and all other items of Tenant’s property on the Premises installed by, for, or at the expense of Tenant. Such insurance shall be written on a
special form causes of loss form, for the full replacement cost value (subject to reasonable deductible amounts) new without deduction for depreciation of the covered items and in amounts that meet any
co-insurance clauses of the policies of insurance and shall include coverage for damage or other loss caused by fire or other peril including, but not limited to, vandalism and malicious mischief, theft, water
damage (excluding flood), including sprinkler leakage, bursting or stoppage of pipes, and explosion, and providing business interruption coverage for a period of ninety (90) days. 

10.3.3    Business Income Interruption insurance. 

10.3.4    Worker’s Compensation and Employer’s Liability or other similar insurance pursuant to all
applicable state and local statutes and regulations. The policy shall include a waiver of subrogation in favor of Landlord, its employees, Lenders and any property manager or partners. 

10.4    Form of Policies. The minimum limits of policies of insurance required of Tenant under this Lease
shall in no event limit the liability of Tenant under this Lease. Such insurance shall (i) name Landlord, its subsidiaries and affiliates, its property manager (if any) and any other party the Landlord

  

					
		 	-28-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 
so specifies, as an additional insured on the liability insurance, including Landlord’s managing agent, if any; (ii) be issued by an insurance company having a rating of not less than A-:VII in Best’s Insurance Guide or which is otherwise acceptable to Landlord and authorized to do business in the State of California; and (iv) be primary insurance as to all claims thereunder and provide
that any insurance carried by Landlord is excess and is non-contributing with any insurance required of Tenant. Tenant shall not cause said insurance to be canceled unless thirty (30) days’ prior
written notice shall have been given to Landlord and any mortgagee of Landlord (unless such cancellation is the result of non-payment of premiums, in which case note less than five (5) days’ notice
shall be provided). Tenant shall deliver said certificates thereof to Landlord on or before the Lease Commencement Date and before the expiration dates thereof. In the event Tenant shall fail to procure such insurance, or to deliver such policies or
certificate, Landlord may, at its option, procure such policies for the account of Tenant, and the cost thereof shall be paid to Landlord within five (5) days after delivery to Tenant of bills therefor. 

10.5    Subrogation. Landlord and Tenant hereby agree to look solely to, and seek recovery only from, their
respective insurance carriers in the event of a property or business interruption loss to the extent that such coverage is agreed to be provided hereunder, notwithstanding the negligence of either party. Notwithstanding anything to the contrary in
this Lease, the parties each hereby waive all rights and claims against each other for such losses, and waive all rights of subrogation of their respective insurers. The parties agree that their respective insurance policies do now, or shall,
contain the waiver of subrogation. 
 10.6    Additional Insurance Obligations. Tenant shall carry and
maintain during the entire Lease Term, at Tenant’s sole cost and expense, increased amounts of the insurance required to be carried by Tenant pursuant to this Article 10 and such other reasonable types of insurance coverage and in such
reasonable amounts covering the Premises and Tenant’s operations therein, as may be reasonably requested by Landlord or Landlord’s lender, but in no event in excess of the amounts and types of insurance then being required by landlords of
buildings comparable to and in the vicinity of the Building. 
 11.    DAMAGE AND DESTRUCTION. 

11.1    Repair of Damage to Premises by Landlord. Tenant shall promptly notify Landlord of any damage to the
Premises resulting from fire or any other casualty. If the Premises or any Common Areas serving or providing access to the Premises shall be damaged by fire or other casualty, Landlord shall promptly and diligently, subject to reasonable delays for
insurance adjustment or other matters beyond Landlord’s reasonable control, and subject to all other terms of this Article 11, restore the Premises and such Common Areas. Such restoration shall be to substantially the same condition of the
Premises and the Common Areas prior to the casualty, except for modifications required by zoning and building codes and other laws or any other modifications to the Common Areas deemed desirable by Landlord, which are consistent with the character
of the Project, provided that access to the Premises shall not be materially impaired. Landlord shall not be liable for any inconvenience or annoyance to Tenant or its visitors, or injury to Tenant’s business resulting in any way from such
damage or the repair thereof; provided however, that if such fire or other casualty shall have damaged the Premises or Common Areas necessary to Tenant’s occupancy, and the damaged portions of the Premises are not occupied by Tenant as a result
thereof, then during the time and to the extent the Premises are unfit for occupancy, the Rent shall be abated in proportion to the ratio that the amount of rentable square feet of the Premises which is unfit for occupancy for the purposes permitted
under this Lease bears to the total rentable square feet of the Premises. 
 11.2    Landlord’s Option to
Repair. Notwithstanding the terms of Section 11.1 of this Lease, Landlord may elect not to rebuild and/or restore the Premises, Building and/or Project, and instead terminate this Lease, by notifying Tenant in writing of such termination
within sixty (60) days after the date of discovery of the damage, such notice to include a termination date giving Tenant sixty (60) days to vacate the Premises, but Landlord may so elect only if the Building shall be damaged by fire or
other casualty or cause, and one or more of the following conditions is present: (i) in Landlord’s reasonable judgment, repairs cannot reasonably be completed within one (1) year after the date of discovery of the damage (when such
repairs are made without the payment of overtime or other premiums); (ii) the damage is due to a risk that 

  

					
		 	-29-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 
Landlord is not required to insure under this Lease, and the cost of restoration exceed five percent (5%) of the replacement cost of the Building (unless Tenant agrees to pay any uninsured amount
in excess of such five percent (5%)); or (iii) the damage occurs during the last twelve (12) months of the Lease Term and will take more than sixty (60) days to restore; provided, however, that if Landlord does not elect to
terminate this Lease pursuant to Landlord’s termination right as provided above, and the repairs cannot, in the reasonable opinion of Landlord, be completed within six (6) months days after the date of discovery of the damage (or are not
in fact completed within seven (7) months after the date of discovery of the damage), Tenant may elect, no earlier than sixty (60) days after the date of the damage and not later than ninety (90) days after the date of such damage, or
within thirty (30) days after such repairs are not timely completed, to terminate this Lease by written notice to Landlord effective as of the date specified in the notice, which date shall not be less than thirty (30) days nor more than
sixty (60) days after the date such notice is given by Tenant. 
 11.3    Waiver of Statutory
Provisions. The provisions of this Lease, including this Article 11, constitute an express agreement between Landlord and Tenant with respect to any and all damage to, or destruction of, all or any part of the Premises, the Building or the
Project, and any statute or regulation of the State of California, including, without limitation, Sections 1932(2) and 1933(4) of the California Civil Code, with respect to any rights or obligations concerning damage or destruction in the absence of
an express agreement between the parties, and any other statute or regulation, now or hereafter in effect, shall have no application to this Lease or any damage or destruction to all or any part of the Premises, the Building or the Project. 

11.4    Partial Termination. Notwithstanding anything to the contrary in this Article 11 or Article 13, if
the subject casualty or taking only applies to either the 800 Building or the 900 Building, the termination rights in Articles 11 and 13 shall apply only to the portion of the Premises in such Building and this Lease shall continue as to the portion
of the Premises located in the other Building, with a pro rata reduction in the Base Rent, Tenant’s Share and L-C Amount; provided, however, if this Lease terminates as to only a portion of the
Premises, Tenant shall have the right, by delivering written notice thereof to Landlord within six (6) months after the date of such termination, to terminate this Lease entirely, which termination shall be effective six (6) months after
the date of such notice by Tenant. 
 12.    NONWAIVER. No provision of this Lease shall be deemed waived
by either party hereto unless expressly waived in a writing signed thereby. The waiver by either party hereto of any breach of any term, covenant or condition herein contained shall not be deemed to be a waiver of any subsequent breach of same or
any other term, covenant or condition herein contained. The subsequent acceptance of Rent hereunder by Landlord shall not be deemed to be a waiver of any preceding breach by Tenant of any term, covenant or condition of this Lease, other than the
failure of Tenant to pay the particular Rent so accepted, regardless of Landlord’s knowledge of such preceding breach at the time of acceptance of such Rent. No acceptance of a lesser amount than the Rent herein stipulated shall be deemed a
waiver of Landlord’s right to receive the full amount due, nor shall any endorsement or statement on any check or payment or any letter accompanying such check or payment be deemed an accord and satisfaction, and Landlord may accept such check
or payment without prejudice to Landlord’s right to recover the full amount due. No receipt of monies by Landlord from Tenant after the termination of this Lease shall in any way alter the length of the Lease Term or of Tenant’s right of
possession hereunder, or after the giving of any notice shall reinstate, continue or extend the Lease Term or affect any notice given Tenant prior to the receipt of such monies, it being agreed that after the service of notice or the commencement of
a suit, or after final judgment for possession of the Premises, Landlord may receive and collect any Rent due, and the payment of said Rent shall not waive or affect said notice, suit or judgment. 

13.    CONDEMNATION. If the whole or any part of the Premises shall be taken by power of eminent
domain or condemned by any competent authority for any public or quasi-public use or purpose, or if any adjacent property or street shall be so taken or condemned, or reconfigured or vacated by such authority in such manner as to require the use or
reconstruction of any part of the Premises, or if Landlord shall grant a deed or other instrument in lieu of such taking by eminent domain or condemnation, Landlord shall have the option to terminate this Lease effective as of the date possession is
required to be surrendered to the authority. Tenant shall not because of such taking assert any claim against Landlord or 

  

					
		 	-30-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 
the authority for any compensation because of such taking and Landlord shall be entitled to the entire award or payment in connection therewith, except that Tenant shall have the right to file
any separate claim available to Tenant for any taking of Tenant’s personal property and fixtures belonging to Tenant and removable by Tenant upon expiration of the Lease Term pursuant to the terms of this Lease, for moving expenses, for the
unamortized value of any improvements paid for by Tenant and for the Lease “bonus value”, so long as such claims are payable separately to Tenant. All Rent shall be apportioned as of the date of such termination. If any part of the
Premises shall be taken, and this Lease shall not be so terminated, the Rent shall be proportionately abated. Tenant hereby waives any and all rights it might otherwise have pursuant to Section 1265.130 of The California Code of Civil
Procedure. Notwithstanding anything to the contrary contained in this Article 13, in the event of a temporary taking of all or any portion of the Premises for a period of one hundred and eighty (180) days or less, then this Lease shall not
terminate but the Base Rent and the Additional Rent shall be abated for the period of such taking in proportion to the ratio that the amount of rentable square feet of the Premises taken bears to the total rentable square feet of the Premises.
Landlord shall be entitled to receive the entire award made in connection with any such temporary taking. 

14.    ASSIGNMENT AND SUBLETTING. 

14.1    Transfers. Tenant shall not, without the prior written consent of Landlord, assign, mortgage, pledge,
hypothecate, encumber, or permit any lien to attach to, or otherwise transfer, this Lease or any interest hereunder, permit any assignment, or other transfer of this Lease or any interest hereunder by operation of law, sublet the Premises or any
part thereof, or enter into any license or concession agreements or otherwise permit the occupancy or use of the Premises or any part thereof by any persons other than Tenant and its employees and contractors (all of the foregoing are hereinafter
sometimes referred to collectively as “Transfers” and any person to whom any Transfer is made or sought to be made is hereinafter sometimes referred to as a “Transferee”). If Tenant desires
Landlord’s consent to any Transfer, Tenant shall notify Landlord in writing, which notice (the “Transfer Notice”) shall include (i) the proposed effective date of the Transfer, which shall not be less than thirty
(30) days nor more than one hundred eighty (180) days after the date of delivery of the Transfer Notice, (ii) a description of the portion of the Premises to be transferred (the “Subject Space”), (iii) all of
the terms of the proposed Transfer and the consideration therefor, including calculation of the “Transfer Premium”, as that term is defined in Section 14.3 below, in connection with such Transfer, the name and address of
the proposed Transferee, and a copy of all existing executed and/or proposed documentation pertaining to the proposed Transfer, and (iv) current financial statements of the proposed Transferee certified by an officer, partner or owner thereof,
and any other information reasonably required by Landlord which will enable Landlord to determine the financial responsibility, character, and reputation of the proposed Transferee, nature of such Transferee’s business and proposed use of the
Subject Space. Any Transfer made without Landlord’s prior written consent shall, at Landlord’s option, be null, void and of no effect, and shall, at Landlord’s option, constitute a default by Tenant under this Lease. Whether or not
Landlord consents to any proposed Transfer, Tenant shall pay Landlord’s reasonable review and processing fees, as well as any reasonable professional fees (including, without limitation, attorneys’, accountants’, architects’,
engineers’ and consultants’ fees) incurred by Landlord (not to exceed $3,500 in the aggregate for any particular Transfer), within thirty (30) days after written request by Landlord. 

14.2    Landlord’s Consent. Landlord shall not unreasonably withhold or delay its consent to any
proposed Transfer of the Subject Space to the Transferee on the terms specified in the Transfer Notice and shall respond to Tenant’s consent request within thirty (30) days. Without limitation as to other reasonable grounds for withholding
consent, the parties hereby agree that it shall be reasonable under this Lease and under any applicable law for Landlord to withhold consent to any proposed Transfer where one or more of the following apply: 

14.2.1    The Transferee is of a character or reputation or engaged in a business which is not consistent with the
quality of the Building or the Project; 
 14.2.2    The Transferee is either a governmental agency or
instrumentality thereof; 

  

					
		 	-31-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 14.2.3    The Transferee is not a party of reasonable financial
worth and/or financial stability in light of the responsibilities to be undertaken in connection with the Transfer on the date consent is requested; or 

14.2.4    The proposed Transfer would cause a violation of another lease for space in the Project, or would give
an occupant of the Project a right to cancel its lease. 
 If Landlord consents to any Transfer pursuant to the terms of this
Section 14.2 (and does not exercise any recapture rights Landlord may have under Section 14.4 of this Lease), Tenant may within six (6) months after Landlord’s consent, but not later than the expiration of said six-month period, enter into such Transfer of the Premises or portion thereof, upon substantially the same terms and conditions as are set forth in the Transfer Notice furnished by Tenant to Landlord pursuant to
Section 14.1 of this Lease, provided that if there are any changes in the terms and conditions from those specified in the Transfer Notice such that Landlord would initially have been entitled to refuse its consent to such Transfer under this
Section 14.2, Tenant shall again submit the Transfer to Landlord for its approval and other action under this Article 14 (including Landlord’s right of recapture, if any, under Section 14.4 of this Lease). Notwithstanding anything to
the contrary in this Lease, if Tenant or any proposed Transferee claims that Landlord has unreasonably withheld or delayed its consent under Section 14.2 or otherwise has breached or acted unreasonably under this Article 14, their sole remedies
shall be a suit for contract damages (other than damages for injury to, or interference with, Tenant’s business including, without limitation, loss of profits, however occurring) or declaratory judgment and an injunction for the relief sought,
and Tenant hereby waives all other remedies, including, without limitation, any right at law or equity to terminate this Lease, on its own behalf and, to the extent permitted under all applicable laws, on behalf of the proposed Transferee. 

14.3    Transfer Premium. If Landlord consents to a Transfer, as a condition thereto which the parties
hereby agree is reasonable, Tenant shall pay to Landlord fifty percent (50%) of any “Transfer Premium,” as that term is defined in this Section 14.3, received by Tenant from such Transferee. “Transfer
Premium” shall mean all rent, additional rent or other consideration payable by such Transferee in connection with the Transfer in excess of the Rent and Additional Rent payable by Tenant under this Lease (including any Additional
Tenant Improvement Allowance Payment) during the term of the Transfer on a per rentable square foot basis if less than all of the Premises is transferred, and after deduction of (i) any costs of improvements made to the Subject Space in
connection with such Transfer (which may include the unamortized cost of the Tenant Improvements or Alterations to the extent paid for by Tenant directly rather than through the Additional TI Allowance), (ii) brokerage commissions paid in connection
with such Transfer, and (iii) reasonable legal fees incurred in connection with such Transfer. “Transfer Premium” shall also include, but not be limited to, key money, bonus money or other cash consideration paid by
Transferee to Tenant in connection with such Transfer, and any payment in excess of fair market value for services rendered by Tenant to Transferee or for assets, fixtures, inventory, equipment, or furniture transferred by Tenant to Transferee in
connection with such Transfer. The determination of the amount of Landlord’s applicable share of the Transfer Premium shall be made on a monthly basis as rent or other consideration is received by Tenant under the Transfer. 

14.4    Landlord’s Option as to Subject Space. Notwithstanding anything to the contrary
contained in this Article 14, in the event Tenant contemplates a Transfer other than to a Permitted Transferee which, together with all prior Transfers then remaining in effect, would cause fifty percent (50%) or more of the Premises to be
Transferred for more than fifty percent (50%) of the then remaining Lease Term (taking into account any extension of the Lease Term which has irrevocably exercised by Tenant), Tenant shall give Landlord notice (the “Intention to Transfer
Notice”) of such contemplated Transfer (whether or not the contemplated Transferee or the terms of such contemplated Transfer have been determined). The Intention to Transfer Notice shall specify the portion of and amount of rentable
square feet of the Premises which Tenant intends to Transfer in the subject Transfer (the “Contemplated Transfer Space”), the contemplated date of commencement of the Contemplated Transfer (the “Contemplated
Effective Date”), and the contemplated length of the term of such contemplated Transfer. Thereafter, Landlord shall have the option, by giving written notice to Tenant within thirty (30) days after receipt of any Intention to
Transfer Notice, to recapture the Contemplated Transfer Space. Such recapture shall cancel and terminate this Lease with respect to such Contemplated Transfer Space as of the Contemplated 

  

					
		 	-32-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 
Effective Date. In the event of a recapture by Landlord, if this Lease shall be canceled with respect to less than the entire Premises, the Rent reserved herein shall be prorated on the basis of
the number of rentable square feet retained by Tenant in proportion to the number of rentable square feet contained in the Premises, and this Lease as so amended shall continue thereafter in full force and effect, and upon request of either party,
the parties shall execute written confirmation of the same. If Landlord declines, or fails to elect in a timely manner, to recapture such Contemplated Transfer Space under this Section 14.4, then, subject to the other terms of this Article 14,
for a period of nine (9) months (the “Nine Month Period”) commencing on the last day of such thirty (30) day period, Landlord shall not have any right to recapture the Contemplated Transfer Space with respect to any
Transfer made during the Nine Month Period, provided that any such Transfer is substantially on the terms set forth in the Intention to Transfer Notice, and provided further that any such Transfer shall be subject to the remaining terms of this
Article 14. If such a Transfer is not so consummated within the Nine Month Period (or if a Transfer is so consummated, then upon the expiration of the term of any Transfer of such Contemplated Transfer Space consummated within such Nine Month
Period), Tenant shall again be required to submit a new Intention to Transfer Notice to Landlord with respect any contemplated Transfer, as provided above in this Section 14.4. Tenant shall not be required to provide a separate Intention to
Transfer Notice and Tenant’s request for Landlord’s consent to a Transfer shall satisfy Tenant’s obligations in this Section 14.4. 

14.5    Effect of Transfer. If Landlord consents to a Transfer, (i) the terms and conditions of this
Lease shall in no way be deemed to have been waived or modified, (ii) such consent shall not be deemed consent to any further Transfer by either Tenant or a Transferee, (iii) Tenant shall deliver to Landlord, promptly after execution, an
original executed copy of all documentation pertaining to the Transfer in form reasonably acceptable to Landlord, (iv) Tenant shall furnish upon Landlord’s request a complete statement, certified by an independent certified public
accountant, or Tenant’s chief financial officer, setting forth in detail the computation of any Transfer Premium Tenant has derived and shall derive from such Transfer, and (v) no Transfer relating to this Lease or agreement entered into
with respect thereto, whether with or without Landlord’s consent, shall relieve Tenant or any guarantor of the Lease from any liability under this Lease, including, without limitation, in connection with the Subject Space. Landlord or its
authorized representatives shall have the right at all reasonable times to audit the books, records and papers of Tenant relating to any Transfer, and shall have the right to make copies thereof. If the Transfer Premium respecting any Transfer shall
be found understated, Tenant shall, within thirty (30) days after demand, pay the deficiency, and if understated by more than two percent (2%), Tenant shall pay Landlord’s costs of such audit. 

14.6    Additional Transfers. For purposes of this Lease, the term “Transfer” shall
also include if Tenant is a partnership, the withdrawal or change, voluntary, involuntary or by operation of law, of fifty percent (50%) or more of the partners, or transfer of fifty percent (50%) or more of partnership interests, within a twelve
(12)-month period, or the dissolution of the partnership without immediate reconstitution thereof. 

14.7    Occurrence of Default. Any Transfer hereunder shall be subordinate and subject to the provisions of
this Lease, and if this Lease shall be terminated during the term of any Transfer, Landlord shall have the right to: (i) treat such Transfer as cancelled and repossess the Subject Space by any lawful means, or (ii) require that such
Transferee attorn to and recognize Landlord as its landlord under any such Transfer. If Tenant shall be in default under this Lease, Landlord is hereby irrevocably authorized, as Tenant’s agent and attorney-in-fact, to direct any Transferee to make all payments under or in connection with the Transfer directly to Landlord (which Landlord shall apply towards Tenant’s obligations under this Lease)
until such default is cured. Such Transferee shall rely on any representation by Landlord that Tenant is in default hereunder, without any need for confirmation thereof by Tenant. Upon any assignment, the assignee shall assume in writing all
obligations and covenants of Tenant thereafter to be performed or observed under this Lease. No collection or acceptance of rent by Landlord from any Transferee shall be deemed a waiver of any provision of this Article 14 or the approval of any
Transferee or a release of Tenant from any obligation under this Lease, whether theretofore or thereafter accruing. In no event shall Landlord’s enforcement of any provision of this Lease against any Transferee be deemed a waiver of
Landlord’s right to enforce any term of this Lease against Tenant or any other person. If Tenant’s obligations hereunder have been guaranteed, Landlord’s consent to any Transfer shall not be effective unless the guarantor also
consents to such Transfer. 

  

					
		 	-33-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

14.8    Non-Transfers. Notwithstanding anything to the contrary
contained in this Article 14, (i) an assignment or subletting of all or a portion of the Premises to an affiliate of Tenant (an entity which is controlled by, controls, or is under common control with, Tenant), (ii) an assignment of the Premises to
an entity which acquires all or substantially all of the assets or interests (partnership, stock or other) of Tenant, (iii) an assignment of the Premises to an entity which is the resulting entity of a merger or consolidation of Tenant with
another entity, or (iv) a sale of corporate shares of capital stock in Tenant in connection with an initial public offering of Tenant’s stock on a nationally-recognized stock exchange (collectively, a “Permitted
Transferee”), shall not be deemed a Transfer under this Article 14, provided that (A) Tenant notifies Landlord of any such assignment or sublease and promptly supplies Landlord with any documents or information requested by
Landlord regarding such assignment or sublease or such affiliate, (B) such assignment or sublease is not a subterfuge by Tenant to avoid its obligations under this Lease, (C) such Permitted Transferee shall be of a character and reputation
consistent with the quality of the Building, and (D) such Permitted Transferee described in subpart (ii) or (iii) above shall have a tangible net worth (not including goodwill as an asset) computed in accordance with generally accepted
accounting principles (“Net Worth”) at least equal to the Net Worth of Tenant on the day immediately preceding the effective date of such assignment or sublease. An assignee of Tenant’s entire interest that is also a
Permitted Transferee may also be known as a “Permitted Assignee”. “Control,” as used in this Section 14.8, shall mean the ownership, directly or indirectly, of at least fifty-one percent (51%) of the voting securities of, or possession of the right to vote, in the ordinary direction of its affairs, of at least fifty-one percent (51%) of the
voting interest in, any person or entity. No such permitted assignment or subletting shall serve to release Tenant from any of its obligations under this Lease. 

14.9    Preapproved Sublease. Notwithstanding any contrary provision of this Article 14, Landlord hereby
preapproves Tenant’s sublease of portions of the Premises to (i) MapLight Therapeutics, Inc. and/or (ii) OncoMed (the “Approved Subtenants”), provided that the terms of such subleases shall not exceed fifty
percent (50%) of the then remaining Lease Term and subject to Landlord, Tenant and the applicable Approved Subtenant entering into a consent document and subject to the payment of any Transfer Premium therefor, provided, however,
(a) Landlord shall not charge any fees under Section 14.1 above for such subleases and (b) for purposes of calculating the Transfer Premium, such subleases shall be aggregated so that Tenant shall only be required to pay a Transfer
Premium to the extent rent received Tenant under both subleases exceeds the Rent and Additional Rent payable by Tenant under this Lease with respect to the space subleased under both subleases. Tenant shall promptly supply Landlord with any
documents or information requested by Landlord regarding such sublease. Notwithstanding the foregoing, such sublease shall in no event relieve Tenant from any liability under this Lease. 

15.    SURRENDER OF PREMISES; OWNERSHIP AND REMOVAL OF TRADE FIXTURES. 

15.1    Surrender of Premises. No act or thing done by Landlord or any agent or employee of Landlord during
the Lease Term shall be deemed to constitute an acceptance by Landlord of a surrender of the Premises unless such intent is specifically acknowledged in writing by Landlord. The delivery of keys to the Premises to Landlord or any agent or employee
of Landlord shall not constitute a surrender of the Premises or effect a termination of this Lease, whether or not the keys are thereafter retained by Landlord, and notwithstanding such delivery Tenant shall be entitled to the return of such keys at
any reasonable time upon request until this Lease shall have been properly terminated. The voluntary or other surrender of this Lease by Tenant, whether accepted by Landlord or not, or a mutual termination hereof, shall not work a merger, and at the
option of Landlord shall operate as an assignment to Landlord of all subleases or subtenancies affecting the Premises or terminate any or all such sublessees or subtenancies. 

15.2    Removal of Tenant Property by Tenant. Upon the expiration of the Lease Term, or upon any earlier
termination of this Lease, Tenant shall, subject to the provisions of this Article 15, quit and surrender possession of the Premises to Landlord in as good order and condition as when Tenant took possession (or as to the Additional Premises, the
date of this Lease) and as thereafter improved by Landlord 

  

					
		 	-34-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 
and/or Tenant, reasonable wear and tear, damage caused by casualty, repairs required as a result of condemnation, and repairs which are specifically made the responsibility of Landlord hereunder
excepted. Upon such expiration or termination, Tenant shall, without expense to Landlord, remove or cause to be removed from the Premises all debris and rubbish, and such items of furniture, equipment, free-standing cabinet work, movable partitions
(but not demountable walls) and other articles of personal property owned by Tenant or installed or placed by Tenant at its expense in the Premises, and such similar articles of any other persons claiming under Tenant, as Landlord may, in its sole
discretion, require to be removed, and Tenant shall repair at its own expense all damage to the Premises and Building resulting from such removal. 

15.3    Environmental Assessment. In connection with its surrender of the Premises, Tenant shall submit to
Landlord, at least fifteen (15) days prior to the expiration date of this Lease (or in the event of an earlier termination of this Lease, as soon as reasonably possible following such termination), an environmental Assessment of the Premises by
a competent and experienced environmental engineer or engineering firm reasonably satisfactory to Landlord (pursuant to a contract approved by Landlord and providing that Landlord can rely on the Environmental Assessment). If such Environmental
Assessment reveals that remediation or Clean-up is required under any Environmental Laws that Tenant is responsible for under this Lease, Tenant shall submit a remediation plan prepared by a recognized
environmental consultant and shall be responsible for all costs of remediation and Clean-up, as more particularly provided in Section 5.3, above. 

15.4    Condition of the Building and Premises Upon Surrender. In addition to the above requirements of this
Article 15, upon the expiration of the Lease Term, or upon any earlier termination of this Lease, Tenant shall, surrender the Premises and Building with Tenant having complied with all of Tenant’s obligations under this Lease, including those
relating to improvement, repair, maintenance, compliance with law, testing and other related obligations of Tenant set forth in Article 7 of this Lease. In the event that the Building and Premises shall be surrendered in a condition which does not
comply with the terms of this Section 15.4, because Tenant failed to comply with its obligations set forth in Lease, then following thirty (30) days’ notice to Tenant, during which thirty (30) day period Tenant shall have the
right to cure such noncompliance, Landlord shall be entitled to expend all reasonable costs in order to cause the same to comply with the required condition upon surrender and Tenant shall immediately reimburse Landlord for all such costs upon
notice and, commencing on the later of the termination of this Lease and three (3) business days after Landlord’s delivery of notice of such failure and that it elects to treat such failure as a holdover, Tenant shall be deemed during the
period that Tenant or Landlord, as the case may be, perform obligations relating to the Surrender Improvements to be in holdover under Article 16 of this Lease. 

16.    HOLDING OVER. If Tenant holds over after the expiration of the Lease Term or earlier termination thereof,
with the express or implied consent of Landlord, such tenancy shall be from month-to-month only, and shall not constitute a renewal hereof or an extension for any further term. If Tenant holds over after the expiration of the Lease Term of earlier
termination thereof, without the express or implied consent of Landlord, such tenancy shall be deemed to be a tenancy by sufferance only, and shall not constitute a renewal hereof or an extension for any further term. In either case, Base Rent shall
be payable at a monthly rate equal to one hundred fifty percent (150%) of the Base Rent applicable during the last rental period of the Lease Term under this Lease. Such month-to-month tenancy or tenancy by sufferance, as the case may be, shall be
subject to every other applicable term, covenant and agreement contained herein. Nothing contained in this Article 16 shall be construed as consent by Landlord to any holding over by Tenant, and Landlord expressly reserves the right to require
Tenant to surrender possession of the Premises to Landlord as provided in this Lease upon the expiration or other termination of this Lease. The provisions of this Article 16 shall not be deemed to limit or constitute a waiver of any other rights or
remedies of Landlord provided herein or at law. If Tenant fails to surrender the Premises upon the termination or expiration of this Lease, in addition to any other liabilities to Landlord accruing therefrom, Tenant shall protect, defend, indemnify
and hold Landlord harmless from all loss, costs (including reasonable attorneys’ fees) and liability resulting from such failure, including, without limiting the generality of the foregoing, any claims made by any succeeding tenant founded upon
such failure to surrender and any lost profits to Landlord resulting therefrom. 

  

					
		 	-35-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 17.    ESTOPPEL CERTIFICATES. Within ten
(10) business days following a request in writing by Landlord, Tenant shall execute, acknowledge and deliver to Landlord an estoppel certificate, which, as submitted by Landlord, shall be substantially in the form of Exhibit D, attached hereto
(or such other form as may be reasonably required by any prospective mortgagee or purchaser of the Project, or any portion thereof), indicating therein any exceptions thereto that may exist at that time, and shall also contain any other information
reasonably requested by Landlord or Landlord’s mortgagee or prospective mortgagee. Any such certificate may be relied upon by any prospective mortgagee or purchaser of all or any portion of the Project. Tenant shall execute and deliver whatever
other instruments may be reasonably required for such purposes. At any time during the Lease Term, in connection with a sale or financing of the Building by Landlord, Landlord may require Tenant to provide Landlord with its most recent annual
financial statement and annual financial statements of the preceding two (2) years. Such statements shall be prepared in accordance with generally accepted accounting principles and, if such is the normal practice of Tenant, shall be audited by
an independent certified public accountant. Landlord shall hold such statements confidential. Failure of Tenant to timely execute, acknowledge and deliver such estoppel certificate or other instruments shall constitute an acceptance of the Premises
and an acknowledgment by Tenant that statements included in the estoppel certificate are true and correct, without exception. 

18.    SUBORDINATION. Landlord hereby represents and warrants to Tenant that the Project is not
currently subject to any ground lease, or to the lien of any mortgage or deed of trust. This Lease shall be subject and subordinate to all future ground or underlying leases of the Building or Project and to the lien of any mortgage, trust deed or
other encumbrances now or hereafter in force against the Building or Project or any part thereof, if any, and to all renewals, extensions, modifications, consolidations and replacements thereof, and to all advances made or hereafter to be made upon
the security of such mortgages or trust deeds, unless the holders of such mortgages, trust deeds or other encumbrances, or the lessors under such ground lease or underlying leases, require in writing that this Lease be superior thereto. The
subordination of this Lease to any such future ground or underlying leases of the Building or Project or to the lien of any mortgage, trust deed or other encumbrances, shall be subject to Tenant’s receipt of a commercially reasonable
subordination, non-disturbance, and attornment agreement in favor of Tenant. Tenant covenants and agrees in the event any proceedings are brought for the foreclosure of any such mortgage or deed in lieu
thereof (or if any ground lease is terminated), to attorn, without any deductions or set-offs whatsoever, to the lienholder or purchaser or any successors thereto upon any such foreclosure sale or deed in lieu
thereof (or to the ground lessor), if so requested to do so by such purchaser or lienholder or ground lessor, and to recognize such purchaser or lienholder or ground lessor as the lessor under this Lease, provided such lienholder or purchaser or
ground lessor shall agree to accept this Lease and not disturb Tenant’s occupancy, so long as Tenant timely pays the rent and observes and performs the terms, covenants and conditions of this Lease to be observed and performed by Tenant.
Landlord’s interest herein may be assigned as security at any time to any lienholder. Tenant shall, within ten (10) days of request by Landlord, execute such further instruments or assurances as Landlord may reasonably deem necessary to
evidence or confirm the subordination or superiority of this Lease to any such mortgages, trust deeds, ground leases or underlying leases. Tenant waives the provisions of any current or future statute, rule or law which may give or purport to give
Tenant any right or election to terminate or otherwise adversely affect this Lease and the obligations of the Tenant hereunder in the event of any foreclosure proceeding or sale. 

19.    DEFAULTS; REMEDIES. 

19.1    Events of Default. The occurrence of any of the following shall constitute a default of this Lease by
Tenant: 
 19.1.1    Any failure by Tenant to pay any Rent or any other charge required to be paid under this
Lease, or any part thereof, when due unless such failure is cured within five (5) business days after notice; or 

19.1.2    Except where a specific time period is otherwise set forth for Tenant’s performance in this Lease,
in which event the failure to perform by Tenant within such time period shall be a default by Tenant under this Section 19.1.2, any failure by Tenant to observe or perform any other 

  

					
		 	-36-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 
provision, covenant or condition of this Lease to be observed or performed by Tenant where such failure continues for thirty (30) days after written notice thereof from Landlord to Tenant;
provided that if the nature of such default is such that the same cannot reasonably be cured within a thirty (30) day period, Tenant shall not be deemed to be in default if it diligently commences such cure within such period and thereafter
diligently proceeds to rectify and cure such default; or 
 19.1.3    Abandonment or vacation of all or a
substantial portion of the Premises by Tenant while Tenant is in default under the Lease; or 
 19.1.4    The
failure by Tenant to observe or perform according to the provisions of Articles 5, 14, 17 or 18 of this Lease where such failure continues for more than five (5) business days after notice from Landlord. 

19.2    Remedies Upon Default. Upon the occurrence of any event of default by Tenant, Landlord shall have,
in addition to any other remedies available to Landlord at law or in equity (all of which remedies shall be distinct, separate and cumulative), the option to pursue any one or more of the following remedies, each and all of which shall be cumulative
and nonexclusive, without any notice or demand whatsoever. 
 19.2.1    Terminate this Lease, in which event
Tenant shall immediately surrender the Premises to Landlord, and if Tenant fails to do so, Landlord may, without prejudice to any other remedy which it may have for possession or arrearages in rent, enter upon and take possession of the Premises and
expel or remove Tenant and any other person who may be occupying the Premises or any part thereof, without being liable for prosecution or any claim or damages therefor; and Landlord may recover from Tenant the following: 

(i)    The worth at the time of award of the unpaid rent which has been earned at the time of such termination;
plus 
 (ii)    The worth at the time of award of the amount by which the unpaid rent which would have been
earned after termination until the time of award exceeds the amount of such rental loss that Tenant proves could have been reasonably avoided; plus 

(iii)    The worth at the time of award of the amount by which the unpaid rent for the balance of the Lease Term
after the time of award exceeds the amount of such rental loss that Tenant proves could have been reasonably avoided; plus 

(iv)    Any other amount necessary to compensate Landlord for all the detriment proximately caused by
Tenant’s failure to perform its obligations under this Lease or which in the ordinary course of things would be likely to result therefrom, specifically including but not limited to, in each case to the extent allocable to the remaining Lease
Term, brokerage commissions and advertising expenses incurred to obtain a new tenant, expenses of remodeling the Premises or any portion thereof for a new tenant, whether for the same or a different use, and any special concessions made to obtain a
new tenant; and 
 (v)    At Landlord’s election, such other amounts in addition to or in lieu of the
foregoing as may be permitted from time to time by applicable law. 
 The term “rent” as used in this Section 19.2 shall be
deemed to be and to mean all sums of every nature required to be paid by Tenant pursuant to the terms of this Lease, whether to Landlord or to others. As used in Sections 19.2.1(i) and (ii), above, the “worth at the time of award” shall be
computed by allowing interest at the rate set forth in Article 25 of this Lease, but in no case greater than the maximum amount of such interest permitted by law. As used in Section 19.2.1(iii) above, the “worth at the time of award”
shall be computed by discounting such amount at the discount rate of the Federal Reserve Bank of San Francisco at the time of award plus one percent (1%). 

  

					
		 	-37-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 19.2.2    Landlord shall have the remedy described in California
Civil Code Section 1951.4 (lessor may continue lease in effect after lessee’s breach and abandonment and recover rent as it becomes due, if lessee has the right to sublet or assign, subject only to reasonable limitations). Accordingly, if
Landlord does not elect to terminate this Lease on account of any default by Tenant, Landlord may, from time to time, without terminating this Lease, enforce all of its rights and remedies under this Lease, including the right to recover all rent as
it becomes due. 
 19.2.3    Landlord shall at all times have the rights and remedies (which shall be cumulative
with each other and cumulative and in addition to those rights and remedies available under Sections 19.2.1 and 19.2.2, above, or any law or other provision of this Lease), without prior demand or notice except as required by applicable law, to seek
any declaratory, injunctive or other equitable relief, and specifically enforce this Lease, or restrain or enjoin a violation or breach of any provision hereof. 

19.3    Subleases of Tenant. If Landlord elects to terminate this Lease on account of any default by Tenant,
as set forth in this Article 19, Landlord shall have the right to terminate any and all subleases, licenses, concessions or other consensual arrangements for possession entered into by Tenant and affecting the Premises or may, in Landlord’s
sole discretion, succeed to Tenant’s interest in such subleases, licenses, concessions or arrangements. In the event of Landlord’s election to succeed to Tenant’s interest in any such subleases, licenses, concessions or arrangements,
Tenant shall, as of the date of notice by Landlord of such election, have no further right to or interest in the rent or other consideration receivable thereunder. 

19.4    Efforts to Relet. No re-entry, repairs, maintenance,
changes, alterations and additions, appointment of a receiver to protect Landlord’s interests hereunder, or any other action or omission by Landlord shall be construed as an election by Landlord to terminate this Lease or Tenant’s right to
possession, or to accept a surrender of the Premises, nor shall same operate to release Tenant in whole or in part from any of Tenant’s obligations hereunder, unless express written notice of such intention is sent by Landlord to Tenant. 

20.    COVENANT OF QUIET ENJOYMENT. Landlord covenants that Tenant, on paying the Rent, charges for services
and other payments herein reserved and on keeping, observing and performing all the other terms, covenants, conditions, provisions and agreements herein contained on the part of Tenant to be kept, observed and performed, shall, during the Lease
Term, peaceably and quietly have, hold and enjoy the Premises subject to the terms, covenants, conditions, provisions and agreements hereof without interference by any persons lawfully claiming by or through Landlord. The foregoing covenant is in
lieu of any other covenant express or implied. 
 21.    LETTER OF CREDIT. 

21.1    Delivery of Letter of Credit. Tenant shall deliver to Landlord, within ten (10) business days
after Tenant’s execution of this Lease, an unconditional, clean, irrevocable letter of credit (the “L-C”) in the amount set forth in Section 8 of the Lease Summary (the
“L-C Amount”), which L-C shall be issued by a money-center, solvent and nationally recognized bank (a bank which accepts deposits, maintains
accounts, has a local San Francisco Bay Area office which will negotiate a letter of credit, and whose deposits are insured by the FDIC) reasonably acceptable to Landlord (such approved, issuing bank being referred to herein as the
“Bank”), which Bank must have a rating from Standard and Poors Corporation of A- or better (or any equivalent rating thereto from any successor or substitute rating service selected by
Lessor) and a letter of credit issuer rating from Moody’s Investor Service of A3 or better (or any equivalent rating thereto from any successor rating agency thereto)) (collectively, the “Bank’s
Credit Rating Threshold”), and which L-C shall be in the form of Exhibit H, attached hereto. Tenant shall pay all expenses, points and/or fees incurred by Tenant in obtaining the L-C. Tenant shall, on or before the Additional Premises Lease Commencement Date, deliver to Landlord a new L-C, or an amendment to the original
L-C, such that the L-C is in the full amount required by Section 8 of the Summary. The L-C shall (i) be
“callable” at sight, irrevocable and unconditional, (ii) be maintained in effect, whether through renewal or extension, for the period commencing on the date of this Lease and continuing until the date (the “L-C Expiration Date”) that is no less than sixty (60) days after the expiration of the Lease Term as the same 

  

					
		 	-38-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 
may be extended, and Tenant shall deliver a new L-C or certificate of renewal or extension to Landlord at least thirty (30) days prior to the
expiration of the L-C then held by Landlord, without any action whatsoever on the part of Landlord, (iii) be fully assignable by Landlord, its successors and assigns, (iv) permit partial draws and
multiple presentations and drawings, and (v) be otherwise subject to the Uniform Customs and Practices for Documentary Credits (1993-Rev), International Chamber of Commerce Publication #500, or the
International Standby Practices-ISP 98, International Chamber of Commerce Publication #590. Landlord, or its then managing agent, shall have the right to draw down an amount up to the face amount of the L-C if any of the following shall have occurred or be applicable: (A) such amount is due to Landlord under the terms and conditions of this Lease, and has not been paid within applicable notice and cure periods
(or, if Landlord is prevented by law from providing notice, within the period for payment set forth in the Lease), or (B) Tenant has filed a voluntary petition under the U. S. Bankruptcy Code or any state bankruptcy code (collectively,
“Bankruptcy Code”), or (C) an involuntary petition has been filed against Tenant under the Bankruptcy Code that is not dismissed within thirty (30) days, or (D) the Lease has been rejected, or is deemed
rejected, under Section 365 of the U.S. Bankruptcy Code, following the filing of a voluntary petition by Tenant under the Bankruptcy Code, or the filing of an involuntary petition against Tenant under the Bankruptcy Code, or (E) the Bank
has notified Landlord that the L-C will not be renewed or extended through the L-C Expiration Date, and Tenant has not provided a replacement L-C that satisfies the requirements of this Lease at least thirty (30) days prior to such expiration, or (F) Tenant is placed into receivership or conservatorship, or becomes subject to similar proceedings
under Federal or State law, or (G) Tenant executes an assignment for the benefit of creditors, or (H) if (1) any of the Bank’s (other than Silicon Valley Bank) Fitch Ratings (or other comparable ratings to the extent the Fitch Ratings
are no longer available) have been reduced below the Bank’s Credit Rating Threshold, or (2) there is otherwise a material adverse change in the financial condition of the Bank, and Tenant has failed to provide Landlord with a replacement
letter of credit, conforming in all respects to the requirements of this Article 21 (including, but not limited to, the requirements placed on the issuing Bank more particularly set forth in this Section 21.1 above), in the amount of the
applicable L-C Amount, within ten (10) days following Landlord’s written demand therefor (with no other notice or cure or grace period being applicable thereto, notwithstanding anything in this Lease
to the contrary) (each of the foregoing being an “L-C Draw Event”). The L-C shall be honored by the Bank regardless of whether Tenant disputes
Landlord’s right to draw upon the L-C. In addition, in the event the Bank is placed into receivership or conservatorship by the Federal Deposit Insurance Corporation or any successor or similar entity,
then, effective as of the date such receivership or conservatorship occurs, said L-C shall be deemed to fail to meet the requirements of this Article 21, and, within ten (10) days following
Landlord’s notice to Tenant of such receivership or conservatorship (the “L-C FDIC Replacement Notice”), Tenant shall replace such L-C with
a substitute letter of credit from a different issuer (which issuer shall meet or exceed the Bank’s Credit Rating Threshold and shall otherwise be acceptable to Landlord in its reasonable discretion) and that complies in all respects with the
requirements of this Article 21. If Tenant fails to replace such L-C with such conforming, substitute letter of credit pursuant to the terms and conditions of this Section 21.1, then, notwithstanding
anything in this Lease to the contrary, Landlord shall have the right to declare Tenant in default of this Lease for which there shall be no notice or grace or cure periods being applicable thereto (other than the aforesaid ten (10) day
period). Tenant shall be responsible for the payment of any and all Tenant’s and Bank’s costs incurred with the review of any replacement L-C, which replacement is required pursuant to this Section
or is otherwise requested by Tenant. In the event of an assignment by Tenant of its interest in the Lease (and irrespective of whether Landlord’s consent is required for such assignment), the acceptance of any replacement or substitute letter
of credit by Landlord from the assignee shall be subject to Landlord’s prior written approval, in Landlord’s reasonable discretion, and the actual and reasonable attorney’s fees incurred by Landlord in connection with such
determination shall be payable by Tenant to Landlord within ten (10) days of billing. 

21.2    Application of L-C. Tenant hereby acknowledges and agrees
that Landlord is entering into this Lease in material reliance upon the ability of Landlord to draw upon the L-C upon the occurrence of any L-C Draw Event. In the event
of any L-C Draw Event, Landlord may, but without obligation to do so, and without notice to Tenant (except in connection with an L-C Draw Event under
Section 21.1(H) above), draw upon the L-C, in part or in whole, in the amount necessary to cure any such L-C Draw Event and/or to compensate Landlord for any and
all damages of any kind or nature sustained or which Landlord reasonably estimates that it will sustain resulting from Tenant’s breach or default of the Lease or other L-C Draw Event and/or to compensate
Landlord for any and all damages arising out of, or incurred in connection 

  

					
		 	-39-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 
with, the termination of this Lease, including, without limitation, those specifically identified in Section 1951.2 of the California Civil Code. The use, application or retention of the L-C, or any portion thereof, by Landlord shall not prevent Landlord from exercising any other right or remedy provided by this Lease or by any applicable law, it being intended that Landlord shall not first be
required to proceed against the L-C, and such L-C shall not operate as a limitation on any recovery to which Landlord may otherwise be entitled. Tenant agrees and
acknowledges that (i) the L-C constitutes a separate and independent contract between Landlord and the Bank, (ii) Tenant is not a third party beneficiary of such contract, (iii) Tenant has no
property interest whatsoever in the L-C or the proceeds thereof, and (iv) in the event Tenant becomes a debtor under any chapter of the Bankruptcy Code, Tenant is placed into receivership or
conservatorship, and/or there is an event of a receivership, conservatorship or a bankruptcy filing by, or on behalf of, Tenant, neither Tenant, any trustee, nor Tenant’s bankruptcy estate shall have any right to restrict or limit
Landlord’s claim and/or rights to the L-C and/or the proceeds thereof by application of Section 502(b)(6) of the U. S. Bankruptcy Code or otherwise. 

21.3    Maintenance of L-C by Tenant. If, as a result of any drawing
by Landlord of all or any portion of the L-C, the amount of the L-C shall be less than the L-C Amount, Tenant shall, within five
(5) days thereafter, provide Landlord with additional letter(s) of credit in an amount equal to the deficiency, and any such additional letter(s) of credit shall comply with all of the provisions of this Article 21. Tenant further covenants and
warrants that it will neither assign nor encumber the L-C or any part thereof and that neither Landlord nor its successors or assigns will be bound by any such assignment, encumbrance, attempted assignment or
attempted encumbrance. Without limiting the generality of the foregoing, if the L-C expires earlier than the L-C Expiration Date, Landlord will accept a renewal thereof
(such renewal letter of credit to be in effect and delivered to Landlord, as applicable, not later than thirty (30) days prior to the expiration of the L-C), which shall be irrevocable and automatically
renewable as above provided through the L-C Expiration Date upon the same terms as the expiring L-C or such other terms as may be acceptable to Landlord in its sole
discretion. If Tenant exercises its option to extend the Lease Term pursuant to Section 2.2 of this Lease then, not later than thirty (30) days prior to the commencement of the Option Term, Tenant shall deliver to Landlord a new L C or
certificate of renewal or extension evidencing the L-C Expiration Date as thirty (30) days after the expiration of the Option Term. However, if the L-C is not
timely renewed, or if Tenant fails to maintain the L-C in the amount and in accordance with the terms set forth in this Article 21, Landlord shall have the right to present the
L-C to the Bank in accordance with the terms of this Article 21, and the proceeds of the L-C may be applied by Landlord against any Rent payable by Tenant under this
Lease that is not paid when due and/or to pay for all losses and damages that Landlord has suffered or that Landlord reasonably estimates that it will suffer as a result of any breach or default by Tenant under this Lease. In the event Landlord
elects to exercise its rights as provided above, (I) any unused proceeds shall constitute the property of Landlord (and not Tenant’s property or, in the event of a receivership, conservatorship, or a bankruptcy filing by, or on behalf of,
Tenant, property of such receivership, conservatorship or Tenant’s bankruptcy estate) and need not be segregated from Landlord’s other assets, and (II) Landlord agrees to pay to Tenant within thirty (30) days after the L-C Expiration Date the amount of any proceeds of the L-C received by Landlord and not applied against any Rent payable by Tenant under this Lease that was not paid when due
or used to pay for any losses and/or damages suffered by Landlord (or reasonably estimated by Landlord that it will suffer) as a result of any breach or default by Tenant under this Lease; provided, however, that if prior to the L-C Expiration Date a voluntary petition is filed by Tenant, or an involuntary petition is filed against Tenant by any of Tenant’s creditors, under the Bankruptcy Code, then Landlord shall not be obligated to
make such payment in the amount of the unused L-C proceeds until either all preference issues relating to payments under this Lease have been resolved in such bankruptcy or reorganization case or such
bankruptcy or reorganization case has been dismissed. If Landlord draws on the L-C due to Tenant’s failure to timely renew or provide a replacement L-C, such
failure shall not be considered a default under this Lease and Landlord shall return such cash proceeds upon Tenant’s presentation of a replacement L-C that satisfies the requirements of this Lease,
subject to reasonable satisfaction of any preference risk to Landlord. 
 21.4    Transfer and
Encumbrance. The L-C shall also provide that Landlord may, at any time and without notice to Tenant and without first obtaining Tenant’s consent thereto, transfer (one or more times) all or any
portion of its interest in and to the L-C to another party, person or entity, regardless of whether or not such transfer is from or as a part of the assignment by Landlord of its rights and interests

  

					
		 	-40-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 
in and to this Lease. In the event of a transfer of Landlord’s interest in under this Lease, Landlord shall transfer the L-C, in whole or in part, to
the transferee and thereupon Landlord shall, without any further agreement between the parties, be released by Tenant from all liability therefor, and it is agreed that the provisions hereof shall apply to every transfer or assignment of the whole
of said L¬C to a new landlord. In connection with any such transfer of the L-C by Landlord, Tenant shall, at Tenant’s sole cost and expense, execute and submit to the Bank such applications, documents
and instruments as may be necessary to effectuate such transfer and, Tenant shall be responsible for paying the Bank’s transfer and processing fees in connection therewith; provided that, Landlord shall have the right (in its sole discretion),
but not the obligation, to pay such fees on behalf of Tenant, in which case Tenant shall reimburse Landlord within ten (10) days after Tenant’s receipt of an invoice from Landlord therefor. 

21.5    L-C Not a Security Deposit. Landlord and Tenant
(1) acknowledge and agree that in no event or circumstance shall the L-C or any renewal thereof or substitute therefor or any proceeds thereof be deemed to be or treated as a “security deposit”
under any law applicable to security deposits in the commercial context, including, but not limited to, Section 1950.7 of the California Civil Code, as such Section now exists or as it may be hereafter amended or succeeded (the
“Security Deposit Laws”), (2) acknowledge and agree that the L-C (including any renewal thereof or substitute therefor or any proceeds thereof) is not intended to serve as a
security deposit, and the Security Deposit Laws shall have no applicability or relevancy thereto, and (3) waive any and all rights, duties and obligations that any such party may now, or in the future will, have relating to or arising from the
Security Deposit Laws. Tenant hereby irrevocably waives and relinquishes the provisions of Section 1950.7 of the California Civil Code and any successor statute, and all other provisions of law, now or hereafter in effect, which
(x) establish the time frame by which a landlord must refund a security deposit under a lease, and/or (y) provide that a landlord may claim from a security deposit only those sums reasonably necessary to remedy defaults in the payment of
rent, to repair damage caused by a tenant or to clean the premises, it being agreed that Landlord may, in addition, claim those sums specified in this Article 21 and/or those sums reasonably necessary to (a) compensate Landlord for any loss or
damage caused by Tenant’s breach of this Lease, including any damages Landlord suffers following termination of this Lease, and/or (b) compensate Landlord for any and all damages arising out of, or incurred in connection with, the
termination of this Lease, including, without limitation, those specifically identified in Section 1951.2 of the California Civil Code. Tenant agrees not to interfere in any way with any payment to Landlord of the proceeds of the L-C, either prior to or following a “draw” by Landlord of all or any portion of the L-C, regardless of whether any dispute exists between Tenant and Landlord as to
Landlord’s right to draw down all or any portion of the L-C. No condition or term of this Lease shall be deemed to render the L-C conditional and thereby afford the
Bank a justification for failing to honor a drawing upon such L-C in a timely manner. Tenant shall not request or instruct the Bank of any L-C to refrain from paying
sight draft(s) drawn under such L-C. 
 21.6    Remedy for Improper
Drafts. Tenant’s sole remedy in connection with the improper presentment or payment of sight drafts drawn under any L-C shall be the right to obtain from Landlord a refund of the amount of any sight
draft(s) that were improperly presented or the proceeds of which were misapplied, and reasonable actual out-of-pocket attorneys’ fees, provided that at the time of
such refund, Tenant increases the amount of such L-C to the amount (if any) then required under the applicable provisions of this Lease. Tenant acknowledges that the presentment of sight drafts drawn under any
L-C, or the Bank’s payment of sight drafts drawn under such L-C, could not under any circumstances cause Tenant injury that could not be remedied by an award of
money damages, and that the recovery of money damages would be an adequate remedy therefor. In the event Tenant shall be entitled to a refund as aforesaid and Landlord shall fail to make such payment within ten (10) business days after demand,
Tenant shall have the right to deduct the amount thereof from the next installment(s) of Base Rent. 

22.    COMMUNICATIONS AND COMPUTER LINE. Tenant may install, maintain, replace, remove or use any
communications or computer wires and cables serving the Premises (collectively, the “Lines”), provided that Tenant shall obtain Landlord’s prior written consent, use an experienced and qualified contractor approved in
writing by Landlord, and comply with all of the other provisions of Articles 7 and 8 of this Lease. Tenant shall pay all costs in connection therewith. Landlord reserves the right, upon notice to Tenant prior to the expiration or earlier termination
of this Lease, to require that Tenant, at Tenant’s sole cost and expense, remove any Lines located in or serving the Premises prior to the expiration or earlier termination of this Lease. 

  

					
		 	-41-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 23.    SIGNS. 

23.1    Exterior Signage. Subject to Landlord’s prior written approval, which shall not be unreasonably
withheld, conditioned or delayed, and provided all signs are in keeping with the quality, design and style of the Building and Project, Tenant, at its sole cost and expense, may install (i) identification signage on the monument sign outside
the front entrance to the Building and at the Building entrance , and (ii) internal directional and lobby identification signage (collectively, “Tenant Signage”); provided, however, in no event shall Tenant’s
Signage include an “Objectionable Name,” as that term is defined in Section 23.3, of this Lease. All such signage shall be subject to Tenant’s obtaining all required governmental approvals. All permitted signs shall be maintained
by Tenant at its expense in a first-class and safe condition and appearance. Upon the expiration or earlier termination of this Lease, Tenant shall remove all of its signs at Tenant’s sole cost and expense. The graphics, materials, color,
design, lettering, lighting, size, illumination, specifications and exact location of Tenant’s Signage (collectively, the “Sign Specifications”) shall be subject to the prior written approval of Landlord, which approval
shall not be unreasonably withheld, conditioned or delayed, and shall be consistent and compatible with the quality and nature of the Project. Tenant hereby acknowledges that, notwithstanding Landlord’s approval of Tenant’s Signage,
Landlord has made no representation or warranty to Tenant with respect to the probability of obtaining all necessary governmental approvals and permits for Tenant’s Signage. In the event Tenant does not receive the necessary governmental
approvals and permits for Tenant’s Signage, Tenant’s and Landlord’s rights and obligations under the remaining terms of this Lease shall be unaffected. Except as required by applicable law, Landlord shall not install any other signage
on the Building. If Landlord elects to install a multi-tenant identification sign at the entrance to the Project, Tenant shall be entitled to install its name on such sign (subject to availability on a
pro-rata basis based on the relative square footages leased by the tenants of the Project), at Tenant’s sole cost and expense. 

23.2    Objectionable Name. Tenant’s Signage shall not include a name or logo which relates to an
entity which is of a character or reputation, or is associated with a political faction or orientation, which is inconsistent with the quality of the Project, or which would otherwise reasonably offend a landlord of the Comparable Buildings (an
“Objectionable Name”). Landlord agrees that “Bolt Biotherapeutics, Inc.” is not an Objectionable Name. 

23.3    Prohibited Signage and Other Items. Any signs, notices, logos, pictures, names or advertisements
which are installed and that have not been separately approved by Landlord may be removed without notice by Landlord at the sole expense of Tenant. Any signs, window coverings, or blinds (even if the same are located behind the Landlord-approved
window coverings for the Building), or other items visible from the exterior of the Premises or Building, shall be subject to the prior approval of Landlord, in its sole discretion. 

24.    COMPLIANCE WITH LAW. Tenant shall not do anything or suffer anything to be done in or about the
Premises or the Project which will in any way conflict with any law, statute, ordinance or other governmental rule, regulation or requirement now in force or which may hereafter be enacted or promulgated. At its sole cost and expense, Tenant shall
promptly comply with all such governmental measures. Should any standard or regulation now or hereafter be imposed on Landlord or Tenant by a state, federal or local governmental body charged with the establishment, regulation and enforcement of
occupational, health or safety standards for employers, employees, landlords or tenants, then Tenant agrees, at its sole cost and expense, to comply promptly with such standards or regulations. Tenant shall be responsible, at its sole cost and
expense, to make all alterations to the Building and Premises as are required to comply with the governmental rules, regulations, requirements or standards described in this Article 24. The judgment of any court of competent jurisdiction or the
admission of Tenant in any judicial action, regardless of whether Landlord is a party thereto, that Tenant has violated any of said governmental measures, shall be conclusive of that fact as between Landlord and Tenant. For purposes of
Section 1938 of the California Civil Code, Landlord hereby discloses to Tenant, and Tenant hereby acknowledges, that the Project, Building and Premises have not undergone inspection by a Certified Access Specialist (CASp).

  

					
		 	-42-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 
As required by Section 1938(e) of the California Civil Code, Landlord hereby states as follows: “A Certified Access Specialist (CASp) can inspect the subject premises and determine
whether the subject premises comply with all of the applicable construction-related accessibility standards under state law. Although state law does not require a CASp inspection of the subject premises, the commercial property owner or lessor may
not prohibit the lessee or tenant from obtaining a CASp inspection of the subject premises for the occupancy or potential occupancy of the lessee or tenant, if requested by the lessee or tenant. The parties shall mutually agree on the arrangements
for the time and manner of the CASp inspection, the payment of the fee for the CASp inspection, and the cost of making any repairs necessary to correct violations of construction-related accessibility standards within the premises.” In
furtherance of the foregoing, Landlord and Tenant hereby agree as follows with respect to any CASp inspection requested by Tenant: (a) any CASp inspection requested by Tenant shall be conducted, at Tenant’s sole cost and expense, by a CASp
approved in advance by Landlord; and (b) pursuant to Article 24 below, but subject to Section 10.2 above, Tenant, at its cost, is responsible for making any repairs within the Premises to correct violations of construction-related
accessibility standards identified in such inspection that are then required by law to be repaired; and, if anything done by or for Tenant in its use or occupancy of the Premises shall require repairs to the Building (outside the Premises) to
correct violations of construction-related accessibility standards, then Tenant shall, at Landlord’s option, either perform such repairs at Tenant’s sole cost and expense or reimburse Landlord upon demand, as Additional Rent, for the cost
to Landlord of performing such repairs. Tenant’s obligations under this Article 24 are subject to the limitation in Section 10.2, above. 

25.    LATE CHARGES. If any installment of Rent or any other sum due from Tenant shall not be received by
Landlord or Landlord’s designee within five (5) business days after Tenant’s receipt of written notice from Landlord that said amount is delinquent, then Tenant shall pay to Landlord a late charge equal to five percent (5%) of the
overdue amount plus any reasonable attorneys’ fees incurred by Landlord by reason of Tenant’s failure to pay Rent and/or other charges when due hereunder. The late charge shall be deemed Additional Rent and the right to require it shall be
in addition to all of Landlord’s other rights and remedies hereunder or at law and shall not be construed as liquidated damages or as limiting Landlord’s remedies in any manner. In addition to the late charge described above, any Rent or
other amounts owing hereunder which are not paid within ten (10) days after Tenant’s receipt of written notice that said amount is delinquent shall bear interest from the date when due until paid at a rate per annum equal to the lesser of
(i) the annual “Bank Prime Loan” rate cited in the Federal Reserve Statistical Release Publication G.13(415), published on the first Tuesday of each calendar month (or such other comparable index as Landlord and Tenant
shall reasonably agree upon if such rate ceases to be published) plus four (4) percentage points, and (ii) the highest rate permitted by applicable law. 

26.    LANDLORD’S RIGHT TO CURE DEFAULT; PAYMENTS BY TENANT. 

26.1    Landlord’s Cure. All covenants and agreements to be kept or performed by Tenant under this Lease
shall be performed by Tenant at Tenant’s sole cost and expense and without any reduction of Rent, except to the extent, if any, otherwise expressly provided herein. If Tenant shall fail to perform any obligation under this Lease, and such
failure shall continue in excess of the time allowed under Section 19.1.2, above, unless a specific time period is otherwise stated in this Lease, Landlord may, but shall not be obligated to, make any such payment or perform any such act on
Tenant’s part without waiving its rights based upon any default of Tenant and without releasing Tenant from any obligations hereunder. 

26.2    Tenant’s Reimbursement. Except as may be specifically provided to the contrary in this Lease,
Tenant shall pay to Landlord, upon delivery by Landlord to Tenant of statements therefor: (i) sums equal to expenditures reasonably made and obligations incurred by Landlord in connection with the remedying by Landlord of Tenant’s defaults
pursuant to the provisions of Section 26.1; (ii) sums equal to all losses, costs, liabilities, damages and expenses referred to in Article 10 of this Lease; and (iii) subject to Section 29.21, sums equal to all expenditures made and
obligations incurred by Landlord in collecting or attempting to collect the Rent or in enforcing or attempting to enforce any rights of Landlord under this Lease or pursuant to law, including, without limitation, all reasonable legal fees and other
amounts so expended. Tenant’s obligations under this Section 26.2 shall survive the expiration or sooner termination of the Lease Term. 

  

					
		 	-43-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 27.    ENTRY BY LANDLORD. Landlord reserves the right at
all reasonable times and upon reasonable notice to Tenant (except in the case of an Emergency) to enter the Premises to (i) inspect them; (ii) show the Premises to prospective purchasers, or to current or prospective mortgagees, ground or
underlying lessors or insurers or, during the last nine (9) months of the Lease Term, to prospective tenants; (iii) post notices of nonresponsibility (to the extent applicable pursuant to then applicable law); or (iv) repair the
Premises or the Building, or for structural repairs to the Building or the Building’s systems and equipment as provided under the Lease. Landlord may make any such entries without the abatement of Rent, except as otherwise provided in this
Lease, and may take such reasonable steps as required to accomplish the stated purposes. In an Emergency, Landlord shall have the right to use any means that Landlord may deem proper to open the doors in and to the Premises. Any entry into the
Premises by Landlord in the manner hereinbefore described shall not be deemed to be a forcible or unlawful entry into, or a detainer of, the Premises, or an actual or constructive eviction of Tenant from any portion of the Premises. Landlord shall
use commercially reasonable efforts to minimize any interference with Tenant’s use of or access to the Premises in connection with any such entry, and shall comply with Tenant’s reasonable security measures. Landlord shall hold
confidential any information regarding Tenant’s business that it may learn as a result of such entry. 

28.    TENANT PARKING. Tenant shall have the right, without the payment of any parking charge or fee (other
than as a reimbursement of operating expenses to the extent allowed pursuant to the terms or Article 4 of this Lease, above), commencing on the Lease Commencement Date, to use the amount of parking set forth in Section 9 of the Summary, in the on-site parking lot and garage which serves the Building. Tenant shall abide by all reasonable rules and regulations which are prescribed from time to time for the orderly operation and use of the parking facility
where the parking passes are located (including any sticker or other identification system established by Landlord and the prohibition of vehicle repair and maintenance activities in the parking facilities), and shall cooperate in seeing that
Tenant’s employees and visitors also comply with such rules and regulations. Tenant’s use of the Project parking facility shall be at Tenant’s sole risk and Tenant acknowledges and agrees that Landlord shall have no liability
whatsoever for damage to the vehicles of Tenant, its employees and/or visitors, or for other personal injury or property damage or theft relating to or connected with the parking rights granted herein or any of Tenant’s, its employees’
and/or visitors’ use of the parking facilities. 
 29.    MISCELLANEOUS PROVISIONS. 

29.1    Terms; Captions. The words “Landlord” and “Tenant” as
used herein shall include the plural as well as the singular. The necessary grammatical changes required to make the provisions hereof apply either to corporations or partnerships or individuals, men or women, as the case may require, shall in all
cases be assumed as though in each case fully expressed. The captions of Articles and Sections are for convenience only and shall not be deemed to limit, construe, affect or alter the meaning of such Articles and Sections. 

29.2    Binding Effect. Subject to all other provisions of this Lease, each of the covenants, conditions and
provisions of this Lease shall extend to and shall, as the case may require, bind or inure to the benefit not only of Landlord and of Tenant, but also of their respective heirs, personal representatives, successors or assigns, provided this clause
shall not permit any assignment by Tenant contrary to the provisions of Article 14 of this Lease. 

29.3    No Air Rights. No rights to any view or to light or air over any property, whether belonging to
Landlord or any other person, are granted to Tenant by this Lease. If at any time any windows of the Premises are temporarily darkened or the light or view therefrom is obstructed by reason of any repairs, improvements, maintenance or cleaning in or
about the Project, the same shall be without liability to Landlord and without any reduction or diminution of Tenant’s obligations under this Lease. 

29.4    Modification of Lease. Should any current or prospective mortgagee or ground lessor for the Building
or Project require a modification of this Lease, which modification will not cause an increased cost or expense to Tenant or in any other way materially and adversely change the rights and obligations of Tenant hereunder or interfere with
Tenant’s use of the Premises, then and in such event, 

  

					
		 	-44-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 
Tenant agrees that this Lease may be so modified and agrees to execute whatever documents are reasonably required therefor and to deliver the same to Landlord within ten (10) business days
following a request therefor. At the request of Landlord or any mortgagee or ground lessor, Tenant agrees to execute a short form of Lease and deliver the same to Landlord within ten (10) business days following the request therefor. 

29.5    Transfer of Landlord’s Interest. Tenant acknowledges that Landlord has the right to transfer
all or any portion of its interest in the Project or Building and in this Lease, and Tenant agrees that in the event of any such transfer, Landlord shall automatically be released from all liability under this Lease and Tenant agrees to look solely
to such transferee for the performance of Landlord’s obligations hereunder accruing after the date of transfer provided such transferee shall have fully assumed and agreed in writing to be liable for all obligations of this Lease to be
performed by Landlord, including the return of any security deposit or L-C, and Tenant shall attorn to such transferee. 

29.6    Prohibition Against Recording. Except as provided in Section 29.4 of this Lease, neither this
Lease, nor any memorandum, affidavit or other writing with respect thereto, shall be recorded by Tenant or by anyone acting through, under or on behalf of Tenant. 

29.7    Landlord’s Title. Landlord’s title is and always shall be paramount to the title of
Tenant. Nothing herein contained shall empower Tenant to do any act which can, shall or may encumber the title of Landlord. 

29.8    Relationship of Parties. Nothing contained in this Lease shall be deemed or construed by the parties
hereto or by any third party to create the relationship of principal and agent, partnership, joint venturer or any association between Landlord and Tenant. 

29.9    Payment under Protest. If Tenant in good faith disputes any amounts billed by Landlord, other than
(i) Base Rent, (ii) Tenant’s Share of Direct Expenses (as to which Tenant may exercise its rights under Section 4.6, above), Tenant may make payment of such amounts under protest, and reserve all of its rights with respect to
such amounts (the “Disputed Amounts”). Landlord and Tenant shall meet and confer to discuss the Disputed Amounts and attempt, in good faith, to resolve the particular dispute. If, despite such good faith efforts, Landlord and
Tenant are unable to reach agreement regarding the Disputed Amounts, either party may submit the matter to binding arbitration under the JAMS Streamlined Arbitration Rules & Procedures. The
non-prevailing party, as determined by JAMS, will be responsible to pay all fees and costs incurred in connection with the JAMS procedure, as well as all other costs and expenses, including reasonable
attorneys’ fees, incurred by the prevailing party. This Section 29.9 shall not apply to claims relating to Landlord’s exercise of any unlawful detainer rights pursuant to California law or rights or remedies used by Landlord to gain
possession of the Premises or terminate Lessee’s right of possession to the Premises. 
 29.10    Time of
Essence. Time is of the essence with respect to the performance of every provision of this Lease in which time of performance is a factor. 

29.11    Partial Invalidity. If any term, provision or condition contained in this Lease shall, to any
extent, be invalid or unenforceable, the remainder of this Lease, or the application of such term, provision or condition to persons or circumstances other than those with respect to which it is invalid or unenforceable, shall not be affected
thereby, and each and every other term, provision and condition of this Lease shall be valid and enforceable to the fullest extent possible permitted by law. 

29.12    No Warranty. In executing and delivering this Lease, Tenant has not relied on any representations,
including, but not limited to, any representation as to the amount of any item comprising Additional Rent or the amount of the Additional Rent in the aggregate or that Landlord is furnishing the same services to other tenants, at all, on the same
level or on the same basis, or any warranty or any statement of Landlord which is not set forth herein or in one or more of the exhibits attached hereto. 

  

					
		 	-45-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 29.13    Landlord Exculpation. The liability of Landlord
or the Landlord Parties to Tenant for any default by Landlord under this Lease or arising in connection herewith or with Landlord’s operation, management, leasing, repair, renovation, alteration or any other matter relating to the Project or
the Premises shall be limited solely and exclusively to an amount which is equal to the lesser of (a) the interest of Landlord in the Project or (b) the equity interest Landlord would have in the Project if the Project were encumbered by
third-party debt in an amount equal to eighty percent (80%) of the value of the Project (as such value is determined by Landlord), including any rental, condemnation, sales and insurance proceeds received by Landlord or the Landlord Parties in
connection with the Project, Building or Premises. No Landlord Parties (other than Landlord) shall have any personal liability therefor, and Tenant hereby expressly waives and releases such liability on behalf of itself and all persons claiming by,
through or under Tenant. The limitations of liability contained in this Section 29.13 shall inure to the benefit of Landlord’s and the Landlord Parties’ present and future partners, beneficiaries, officers, directors, trustees,
shareholders, agents and employees, and their respective partners, heirs, successors and assigns. Under no circumstances shall any present or future partner of Landlord (if Landlord is a partnership), or trustee or beneficiary (if Landlord or any
partner of Landlord is a trust), have any liability for the performance of Landlord’s obligations under this Lease. Notwithstanding any contrary provision herein, neither Landlord nor the Landlord Parties shall be liable under any circumstances
for injury or damage to, or interference with, Tenant’s business, including but not limited to, loss of profits, loss of rents or other revenues, loss of business opportunity, loss of goodwill or loss of use, in each case, however occurring, or
loss to inventory, scientific research, scientific experiments, laboratory animals, products, specimens, samples, and/or scientific, business, accounting and other records of every kind and description kept at the premises and any and all income
derived or derivable therefrom. 
 29.14    Entire Agreement. It is understood and acknowledged that there
are no oral agreements between the parties hereto affecting this Lease and this Lease constitutes the parties’ entire agreement with respect to the leasing of the Premises and supersedes and cancels any and all previous negotiations,
arrangements, brochures, agreements and understandings, if any, between the parties hereto or displayed by Landlord to Tenant with respect to the subject matter thereof, and none thereof shall be used to interpret or construe this Lease. None of the
terms, covenants, conditions or provisions of this Lease can be modified, deleted or added to except in writing signed by the parties hereto. 

29.15    Right to Lease. Landlord reserves the absolute right to effect such other tenancies in the Project
as Landlord in the exercise of its sole business judgment shall determine to best promote the interests of the Building or Project. Tenant does not rely on the fact, nor does Landlord represent, that any specific tenant or type or number of tenants
shall, during the Lease Term, occupy any space in the Building or Project. 
 29.16    Force Majeure.
Notwithstanding anything to the contrary contained in this Lease, any prevention, delay or stoppage due to strikes, lockouts, labor disputes, acts of God, acts of war, terrorist acts, inability to obtain services, labor, or materials or reasonable
substitutes therefor, governmental actions, civil commotions, fire or other casualty, actual or threatened public health emergency (including, without limitation, epidemic, pandemic, famine, disease, plague, quarantine, and other significant public
health risk), governmental edicts, actions, declarations or quarantines by a governmental entity or health organization (including, without limitation, any
shelter-in-place orders, stay at home orders or any restrictions on travel related thereto that preclude Tenant, its agents, contractors or its employees from accessing
the Premises, national or regional emergency), breaches in cybersecurity, and other causes beyond the reasonable control of the party obligated to perform, regardless of whether such other causes are (i) foreseeable or unforeseeable or
(ii) related to the specifically enumerated events in this paragraph (collectively, a “Force Majeure”), shall excuse the performance of such party for a period equal to any such prevention, delay or stoppage and,
therefore, if this Lease specifies a time period for performance of an obligation of either party, that time period shall be extended by the period of any delay in such party’s performance caused by a Force Majeure. Notwithstanding anything to
the contrary in this Lease, no event of Force Majeure shall (i) excuse Tenant’s obligations to pay Rent and other charges due pursuant to this Lease, (ii) be grounds for Tenant to abate any portion of Rent due pursuant to this Lease,
or entitle either party to terminate this Lease, except as allowed pursuant to Articles 11 and 13 of this Lease, or (iii) excuse Tenant’s obligations under Articles 5 and 24 of this Lease, provided, however, the foregoing delays
shall not apply to Tenant’s termination rights hereunder (except to the extent expressly set forth in Section 2.1 above). 

  

					
		 	-46-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 29.17    Intentionally Omitted. 

29.18    Notices. All notices, demands, statements, designations, approvals or other communications
(collectively, “Notices”) given or required to be given by either party to the other hereunder or by law shall be in writing, shall be (A) sent by United States certified or registered mail, postage prepaid, return
receipt requested (“Mail”), (B) delivered by a nationally recognized overnight courier, or (C) delivered personally. Any Notice shall be sent, transmitted, or delivered, as the case may be, to Tenant at the appropriate
address set forth in Section 10 of the Summary, or to such other place as Tenant may from time to time designate in a Notice to Landlord, or to Landlord at the addresses set forth below, or to such other places as Landlord may from time to time
designate in a Notice to Tenant. Any Notice will be deemed given (i) three (3) business days after the date it is posted if sent by Mail, (ii) the date the overnight courier delivery is made, or (iii) the date personal delivery is
made. As of the date of this Lease, any Notices to Landlord must be sent, transmitted, or delivered, as the case may be, to the following addresses: 

Healthpeak Properties, Inc. 

1920 Main Street, Suite 1200 

Irvine, CA 92614 
 Attention:
Legal Department 
 with a copy to: 

HCP Life Science Estates 
 950
Tower Lane, Suite 1650 
 Foster City, CA 94404 

Attention: Scott Bohn 
 and 

Allen Matkins Leck Gamble Mallory & Natsis LLP 

1901 Avenue of the Stars, Suite 1800 

Los Angeles, California 90067 

Attention: Anton N. Natsis, Esq. 

29.19    Joint and Several. If there is more than one tenant, the obligations imposed upon Tenant under this
Lease shall be joint and several. 
 29.20    Authority. If Tenant is a corporation, trust or partnership,
Tenant hereby represents and warrants that Tenant is a duly formed and existing entity qualified to do business in the State of California and that Tenant has full right and authority to execute and deliver this Lease and that each person signing on
behalf of Tenant is authorized to do so. 
 29.21    Attorneys’ Fees. In the event that either
Landlord or Tenant should bring suit for the possession of the Premises, for the recovery of any sum due under this Lease, or because of the breach of any provision of this Lease or for any other relief against the other, then all costs and
expenses, including reasonable attorneys’ fees, incurred by the prevailing party therein shall be paid by the other party, which obligation on the part of the other party shall be deemed to have accrued on the date of the commencement of such
action and shall be enforceable whether or not the action is prosecuted to judgment. 
 29.22    Governing
Law; WAIVER OF TRIAL BY JURY. This Lease shall be construed and enforced in accordance with the laws of the State of California. IN ANY ACTION OR PROCEEDING ARISING HEREFROM, LANDLORD AND TENANT HEREBY CONSENT TO (I) THE JURISDICTION OF ANY
COMPETENT COURT WITHIN THE STATE OF CALIFORNIA, (II) SERVICE OF PROCESS BY ANY MEANS AUTHORIZED BY CALIFORNIA LAW, AND (III) IN THE INTEREST OF SAVING TIME AND 

  

					
		 	-47-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 
EXPENSE, TRIAL WITHOUT A JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM BROUGHT BY EITHER OF THE PARTIES HERETO AGAINST THE OTHER OR THEIR SUCCESSORS IN RESPECT OF ANY MATTER ARISING OUT OF OR IN
CONNECTION WITH THIS LEASE, THE RELATIONSHIP OF LANDLORD AND TENANT, TENANT’S USE OR OCCUPANCY OF THE PREMISES, AND/OR ANY CLAIM FOR INJURY OR DAMAGE, OR ANY EMERGENCY OR STATUTORY REMEDY. IN THE EVENT LANDLORD COMMENCES ANY SUMMARY PROCEEDINGS
OR ACTION FOR NONPAYMENT OF BASE RENT OR ADDITIONAL RENT, TENANT SHALL NOT INTERPOSE ANY COUNTERCLAIM OF ANY NATURE OR DESCRIPTION (UNLESS SUCH COUNTERCLAIM SHALL BE MANDATORY) IN ANY SUCH PROCEEDING OR ACTION, BUT SHALL BE RELEGATED TO AN
INDEPENDENT ACTION AT LAW. 
 29.23    Submission of Lease. Submission of this instrument for examination
or signature by Tenant does not constitute a reservation of, option for or option to lease, and it is not effective as a lease or otherwise until execution and delivery by both Landlord and Tenant. 

29.24    Brokers. Landlord and Tenant hereby warrant to each other that they have had no dealings with any
real estate broker or agent in connection with the negotiation of this Lease, excepting only the real estate brokers or agents specified in Section 12 of the Summary (the “Brokers”), and that they know of no other real
estate broker or agent who is entitled to a commission in connection with this Lease. Each party agrees to indemnify and defend the other party against and hold the other party harmless from any and all claims, demands, losses, liabilities,
lawsuits, judgments, costs and expenses (including without limitation reasonable attorneys’ fees) with respect to any leasing commission or equivalent compensation alleged to be owing on account of any dealings with any real estate broker or
agent, other than the Brokers, occurring by, through, or under the indemnifying party. The terms of this Section 29.24 shall survive the expiration or earlier termination of the Lease Term. 

29.25    Independent Covenants. This Lease shall be construed as though the covenants herein between
Landlord and Tenant are independent and not dependent and Tenant hereby expressly waives the benefit of any statute to the contrary and agrees that if Landlord fails to perform its obligations set forth herein, Tenant shall not be entitled to make
any repairs or perform any acts hereunder at Landlord’s expense or to any setoff of the Rent or other amounts owing hereunder against Landlord. 

29.26    Project or Building Name, Address and Signage. Landlord shall have the right at any time to change
the name and/or address of the Project or Building (and Landlord shall reimburse Tenant its actual, reasonable costs incurred as a result of such change, if any) and, subject to Section 23.1, to install, affix and maintain any and all signs on
the exterior and on the interior of the Project or Building as Landlord may, in Landlord’s sole discretion, desire. Tenant shall not use the name of the Project or Building or use pictures or illustrations of the Project or Building in
advertising or other publicity or for any purpose other than as the address of the business to be conducted by Tenant in the Premises, without the prior written consent of Landlord. 

29.27    Counterparts. This Lease may be executed in counterparts with the same effect as if both parties
hereto had executed the same document. Both counterparts shall be construed together and shall constitute a single lease. 

29.28    Good Faith. Except (i) for matters for which there is a standard of consent or discretion
specifically set forth in this Lease; (ii) matters which could have an adverse effect on the Building Structure or the Building Systems, or which could affect the exterior appearance of the Building, or (iii) matters covered by Article 4
(Additional Rent), or Article 19 (Defaults; Remedies) of this Lease (collectively, the “Excepted Matters”), any time the consent of Landlord or Tenant is required, such consent shall not be unreasonably withheld or delayed,
and, except with regard to the Excepted Matters, whenever this Lease grants Landlord or Tenant the right to take action, exercise discretion, establish rules and regulations or make an allocation or other determination, Landlord and Tenant shall act
reasonably and in good faith. 

  

					
		 	-48-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 29.29    Development of the Project. 

29.29.1    Subdivision. Landlord reserves the right to subdivide all or a portion of the buildings
and Common Areas, so long as the same does not interfere with Tenant’s use of or access to the Premises or Tenant’s parking rights. Tenant agrees to execute and deliver, upon demand by Landlord and in the form requested by Landlord, any
additional documents needed to conform this Lease to the circumstances resulting from a subdivision and any all maps in connection therewith, so long as the same does not increase Tenant’s obligations or decrease Tenant’s rights under this
Lease. Notwithstanding anything to the contrary set forth in this Lease, the separate ownership of any buildings and/or Common Areas by an entity other than Landlord shall not affect the calculation of Direct Expenses or Tenant’s payment of
Tenant’s Share of Direct Expenses. 
 29.29.2    Construction of Property and Other
Improvements. Tenant acknowledges that portions of the Project may be under construction following Tenant’s occupancy of the Premises, and that such construction may result in levels of noise, dust, obstruction of access, etc. which are
in excess of that present in a fully constructed project. Tenant hereby waives any and all rent offsets or claims of constructive eviction which may arise in connection with such construction, so long as the same does not interfere with
Tenant’s use of or access to the Premises or Tenant’s parking rights. 
 29.30    No Violation.
Tenant hereby warrants and represents that neither its execution of nor performance under this Lease shall cause Tenant to be in violation of any agreement, instrument, contract, law, rule or regulation by which Tenant is bound, and Tenant shall
protect, defend, indemnify and hold Landlord harmless against any claims, demands, losses, damages, liabilities, costs and expenses, including, without limitation, reasonable attorneys’ fees and costs, arising from Tenant’s breach of this
warranty and representation. 
 29.31    Transportation Management. Tenant shall fully comply with all
present or future governmentally mandated programs intended to manage parking, transportation or traffic in and around the Project and/or the Building, and in connection therewith, Tenant shall take responsible action for the transportation planning
and management of all employees located at the Premises as required by law by working directly with Landlord, any governmental transportation management organization or any other transportation-related committees or entities. Such programs may
include, without limitation: (i) restrictions on the number of peak-hour vehicle trips generated by Tenant; (ii) increased vehicle occupancy; (iii) implementation of an in-house ridesharing
program and an employee transportation coordinator; (iv) working with employees and any Project, Building or area-wide ridesharing program manager; (v) instituting employer-sponsored incentives (financial or
in-kind) to encourage employees to rideshare; and (vi) utilizing flexible work shifts for employees. 

29.32    Signatures. The parties hereto consent and agree that this Lease may be signed and/or transmitted
by facsimile, e-mail of a .pdf document or using electronic signature technology (e.g., via DocuSign or similar electronic signature technology), and that such signed electronic record shall be valid and as
effective to bind the party so signing as a paper copy bearing such party’s handwritten signature. The parties further consent and agree that (1) to the extent a party signs this Lease using electronic signature technology, by clicking
“SIGN”, such party is signing this Lease electronically, and (2) the electronic signatures appearing on this Lease shall be treated, for purposes of validity, enforceability and admissibility, the same as handwritten
signatures. 
 [SIGNATURES ON NEXT PAGE.] 

  

					
		 	-49-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 IN WITNESS WHEREOF,
Landlord and Tenant have caused this Lease to be executed the day and date first above written. 
  

									
	LANDLORD:	 		 	TENANT”
			
	HCP LS REDWOOD CITY, LLC	 		 	BOLT THERAPEUTICS, INC.
	a Delaware limited liability company	 		 	a Delaware corporation
					
	By:	 	 /s/ Scott Bahn
	 		 	By:	 	 /s/ Grant Yonehiro

	Name:	 	Scott Bahn	 		 	Name:	 	Grant Yonehiro
	Its:	 	Senior Vice President	 		 	Its:	 	Chief Business Officer
					
		 		 		 	By:	 	  

		 		 		 	Name:	 	  

		 		 		 	Its:	 	  

  

					
		 	-50-	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 EXHIBIT A 

OUTLINE OF PREMISES; PROJECT SITE PLAN 

INITIAL PREMISES (FIRST FLOOR) 
  
 

 

  

					
		 	 EXHIBIT A

-1-
	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 INITIAL PREMISES (SECOND FLOOR) 

 
 

 

  

					
		 	 EXHIBIT A

-2-
	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 ADDITIONAL PREMISES 
  

 

  

					
		 	 EXHIBIT A

-3-
	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 PROJECT SITE PLAN 
 

 

  

					
		 	 EXHIBIT A

-4-
	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 EXHIBIT B 

TENANT WORK LETTER 

1.    Defined Terms. As used in this Tenant Work Letter, the following capitalized terms have the following
meanings: 
 (a)    Approved TI Plans: Plans and specifications prepared by the applicable Architect for
the Tenant Improvements and approved by Landlord and Tenant in accordance with Paragraph 2 of this Tenant Work Letter, subject to further modification from time to time to the extent provided in and in accordance with such Paragraph 2. 

(b)    Architect: Landlord shall engage CAC Architects with respect to any Tenant Improvements which
Landlord is to cause to be constructed pursuant to this Tenant Work Letter. 
 (c)    Tenant Change
Request: See definition in Paragraph 2(c)(ii) hereof. 
 (d)    Final TI Working Drawings: See
definition in Paragraph 2(a) hereof. 
 (e)    General Contractor: The general contractor selected by
Landlord and reasonably approved by Tenant with respect to Landlord’s TI Work. Tenant shall have no right to direct or control such General Contractor. 

(f)    Landlord’s TI Work: Any Tenant Improvements which Landlord is to construct or install pursuant
to this Tenant Work Letter or by mutual agreement of Landlord and Tenant from time to time. 
 (g)    Project
Manager. Project Management Advisors, Inc., or any other project manager designated by Landlord in its reasonable discretion from time to time to act in a supervisory, oversight, project management or other similar capacity on behalf of Landlord
in connection with the design and/or construction of the Tenant Improvements. 
 (h)    Punch List Work:
Minor corrections of construction or decoration details, and minor mechanical adjustments, that are required in order to cause any applicable portion of the Tenant Improvements or Landlord’s Work as constructed to conform to the Approved TI
Plans or this Tenant Work Letter in all material respects and that do not materially interfere with Tenant’s use or occupancy of the Building and the Initial Premises. 

(i)    Substantial Completion Certificate: See definition in Paragraph 3(a) hereof. 

(j)    Tenant Delay: Any of the following types of delay in the completion of construction of
Landlord’s TI Work (but in each instance, only to the extent that any of the following has actually and proximately caused substantial completion of Landlord’s TI Work to be delayed): 

(i)    Any delay resulting from Tenant’s failure to furnish, in a timely manner, information reasonably
requested by Landlord or by Landlord’s Project Manager in connection with the design or construction of Landlord’s TI Work, or from Tenant’s failure to approve in a timely manner any matters requiring approval by Tenant; 

(ii)    Any delay resulting from Tenant Change Requests initiated by Tenant, including any delay resulting from
the need to revise any drawings or obtain further governmental approvals as a result of any such Tenant Change Request; or 

  

					
		 	 EXHIBIT B

-1-
	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 (iii)    Any delay caused by Tenant (or Tenant’s
contractors, agents, subtenants or employees) materially interfering with the performance of Landlord’s TI Work (including in connection with any occupancy during the Beneficial Occupancy Period), provided that Landlord shall have given Tenant
prompt notice of such material interference and, before the first time a Tenant Delay is deemed to have occurred as a result of such delay, such interference has continued for more than twenty-four (24) hours after Tenant’s receipt of such
notice. 
 (k)    Tenant Improvements: The improvements to or within the 800 Building shown on the
Approved TI Plans from time to time and to be constructed by Landlord pursuant to the Lease and this Tenant Work Letter. The term “Tenant Improvements” does not include the improvements existing in the Building and Initial Premises on the
Effective Date. 
 (l)    Unavoidable Delays: Delays due to acts of God, acts of public agencies, labor disputes,
strikes, fires, freight embargoes, inability (despite the exercise of due diligence) to obtain supplies, materials, fuels or permits, or other causes or contingencies (excluding financial inability) beyond the reasonable control of Landlord or
Tenant, as applicable. Landlord shall use commercially reasonable efforts to provide Tenant with prompt notice of any Unavoidable Delays. 

(m)    Capitalized terms not otherwise defined in this Tenant Work Letter shall have the definitions set forth in
the Lease. 
 2.    Plans and Construction. Landlord and Tenant shall comply with the procedures set forth
in this Paragraph 2 in preparing, delivering and approving matters relating to the Tenant Improvements to be constructed in the Initial Premises only. Tenant hereby acknowledges that the terms of this Tenant Work Letter shall only apply to the
Initial Premises, and the Tenant Improvement Allowance may only be used in the Initial Premises. 

(a)    Approved Plans and Working Drawings for Tenant Improvements. Tenant shall promptly and diligently
work with the Architect to cause to be prepared and delivered to Landlord for approval (which approval shall not be unreasonably withheld, conditioned or delayed by Landlord) proposed schematic plans and outline specifications for the Tenant
Improvements. Landlord shall reimburse the Architect directly for the cost of the initial test-fit plans and outline specifications and one revision thereof, and such costs shall not be charged to the Tenant
Improvement Allowance. Following mutual approval of such proposed schematic plans and outline specifications by Landlord and by Tenant (as so approved, the “Approved Schematic Plans”), Tenant shall then work with the Architect to cause to
be prepared, promptly and diligently (assuming timely delivery by Landlord of any information and decisions required to be furnished or made by Landlord in order to permit preparation of final working drawings, all of which information and decisions
Landlord will deliver promptly and with reasonable diligence), and delivered to Landlord for approval (which approval shall not be unreasonably withheld, conditioned or delayed by Landlord) final detailed working drawings and specifications for the
Tenant Improvements, including (without limitation) any applicable life safety, mechanical, electrical and plumbing working drawings and final architectural drawings (collectively, “Final TI Working Drawings”), which Final TI Working
Drawings shall substantially conform to the Approved Schematic Plans. Upon receipt from Tenant of proposed schematic plans and outline specifications, proposed Final TI Working Drawings, any other plans and specifications, or any revisions or
resubmittals of any of the foregoing, as applicable, Landlord shall promptly and diligently (and in all events within 10 business days after receipt in the case of an initial submittal of schematic plans and outline specifications or proposed Final
TI Working Drawings, and within 5 business days after receipt in the case of any other plans and specifications or any revisions or resubmittals of any of the foregoing) either approve such proposed schematic plans and outline specifications or
proposed Final TI Working Drawings, as applicable, or set forth in writing with particularity any changes necessary to bring the aspects of such proposed schematic plans and outline specifications or proposed Final TI Working Drawings into a form
which will be reasonably acceptable to Landlord. Upon approval of the Final TI Working Drawings by Landlord and Tenant, the Final TI Working Drawings shall constitute the “Approved TI Plans,” superseding (to the extent of any
inconsistencies) any inconsistent features of the previously existing Approved Schematic Plans. Tenant shall respond to any request for information or approval of plans or drawings from Landlord or Architect within five (5) business days. 

  

					
		 	 EXHIBIT B

-2-
	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 (b)    Cost of Improvements. “Cost of
Improvement” shall mean, with respect to any item or component for which a cost must be determined in order to allocate such cost, or an increase in such cost, to Tenant pursuant to this Tenant Work Letter, the sum of the following (unless
otherwise agreed in writing by Landlord and Tenant with respect to any specific item or component or any category of items or components): (i) all sums paid to contractors or subcontractors for labor and materials furnished in connection with
construction of such item or component; (ii) all costs, expenses, payments, fees and charges (other than penalties) paid to or at the direction of any city, county or other governmental or quasi-governmental authority or agency which are
required to be paid in order to obtain all necessary governmental permits, licenses, inspections and approvals relating to construction of such item or component; (iii) engineering and architectural fees for services rendered in connection with
the design and construction of such item or component (including, but not limited to, the Architect for such item or component and an electrical engineer, mechanical engineer, structural engineer and civil engineer, if applicable); (iv) sales and
use taxes; (v) testing and inspection costs; (vi) the cost of power, water and other utility facilities and the cost of collection and removal of debris required in connection with construction of such item or component; (vii) costs
for builder’s risk insurance; and (viii) all other “hard” and “soft” costs incurred in the construction of such item or component in accordance with the Approved TI Plans (if applicable) and this Tenant Work Letter;
provided that the Cost of Improvements shall not include any internal or third-party costs incurred by Landlord except as provided in Section 2(e). 

(c)    Construction of Landlord’s TI Work. Following completion of the Approved TI Plans, Landlord
shall apply for and use reasonable efforts to obtain the necessary permits and approvals to allow construction of all Tenant Improvements. Upon receipt of such permits and approvals, Landlord shall, at Tenant’s expense (subject to
Landlord’s payment of the Tenant Improvement Allowance and, to the extent requested by Tenant, the Additional TI Allowance), construct and complete the Tenant Improvements substantially in accordance with the Approved TI Plans, subject to
Unavoidable Delays and Tenant Delays (if any). Landlord shall use commercially reasonable efforts to complete the Tenant Improvements on or before May 13, 2021, subject to Unavoidable Delays and Tenant Delays (if any). Such construction of the
Tenant Improvements and Landlord’s Work shall be performed in a neat, good and workmanlike manner, free of defects, using new materials and equipment of good quality, and shall materially conform to all applicable laws, rules, regulations,
codes, ordinances, requirements, covenants, conditions and restrictions applicable thereto in force at the time such work is completed. Landlord shall cause Landmark Builders and any other potential general contractors requested by Tenant and
reasonably approved by Landlord to bid on general conditions and fee for construction of the Tenant Improvements. All bids will be opened together with Tenant selecting the general contractor to construct the Tenant Improvements, subject to the
reasonable approval of Landlord. Tenant shall have the right to value engineer the proposed Tenant Improvements before the final bid is selected. Tenant shall also have the right to approve all subcontractors engaged by the General Contractor, which
subcontractors shall be competitively bid and which approval shall not be unreasonably withheld, conditioned or delayed. Landlord shall enter into a stipulated sum or guaranteed maximum price construction contract with the General Contractor as
selected by Tenant and approved by Landlord in the amount of the construction costs approved by Landlord and Tenant. 

(d)    Changes. 

(i)    If Landlord determines at any time that changes in the Final TI Working Drawings or in any other aspect of
the Approved TI Plans relating to any item of Landlord’s TI Work are required as a result of applicable law or governmental requirements, or are required as a result of unanticipated conditions encountered in the course of construction, then
Landlord shall promptly (A) advise Tenant of such circumstances and (B) at Tenant’s sole cost and expense, subject to Landlord’s payment of the Tenant Improvement Allowance and, to the extent requested by Tenant, the Additional
TI Allowance, cause revised Final TI Working Drawings to be prepared by the Architect and submitted to Tenant, for Tenant’s approval, which shall not be unreasonably withheld. Failure of Tenant to deliver to Landlord written notice of
disapproval and specification of such required changes on or before any deadline reasonably specified by Landlord (which shall not be less than three (3) business days after delivery thereof to Tenant) shall constitute and be deemed to be a
Tenant Delay to the extent Landlord is delayed in completing Landlord’s TI Work. 

  

					
		 	 EXHIBIT B

-3-
	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 (ii)    If Tenant at any time desires any changes, alterations
or additions to the Final TI Working Drawings, Tenant shall submit a detailed written request to Landlord specifying such changes, alterations or additions (a “Tenant Change Request”). Upon receipt of any such request, Landlord, within
five (5) business days, shall promptly notify Tenant of (A) whether the matters proposed in the Tenant Change Request are approved by Landlord (which approval shall not be unreasonably withheld, conditioned or delayed by Landlord), (B)
Landlord’s estimate of the number of days of delay, if any, which shall be caused in the construction of the Tenant Improvements by such Tenant Change Request if implemented (including, without limitation, delays due to the need to obtain any
revised plans or drawings and any governmental approvals), and (C) Landlord’s estimate of the increase, if any, which shall occur in the cost of design, permitting, project management and construction of the Tenant Improvements affected by
such Tenant Change Request if such Tenant Change Request is implemented (including, but not limited to, any costs of compliance with laws or governmental regulations that become applicable because of the implementation of the Tenant Change Request).
If Landlord approves the Tenant Change Request and Tenant notifies Landlord in writing, within three (3) business days after receipt of such notice from Landlord, of Tenant’s approval of the Tenant Change Request (including the estimated
delays and cost increases, if any, described in Landlord’s notice), then Landlord shall cause such Tenant Change Request to be implemented and Tenant shall be responsible for all actual costs or cost increases resulting from or attributable to
the implementation of the Tenant Change Request, and any delays resulting therefrom shall be deemed to be a Tenant Delay (subject to Landlord’s payment of the Tenant Improvement Allowance and, to the extent requested by Tenant, the Additional
TI Allowance). If Tenant fails to notify Landlord in writing of Tenant’s approval of such Tenant Change Request within said three (3) business day period, then such Tenant Change Request shall be deemed to be withdrawn and shall be of no
further effect. 
 (e)    Project Management. Unless and until revoked by Landlord by written notice
delivered to Tenant, Landlord hereby (i) delegates to Project Manager the authority to exercise all approval rights, supervisory rights and other rights or powers of Landlord under this Tenant Work Letter with respect to the design and
construction of the Tenant Improvements, and (ii) requests that Tenant work with Project Manager with respect to any logistical or other coordination matters arising in the course of construction of the Tenant Improvements, including monitoring
Tenant’s compliance with its obligations under this Tenant Work Letter and under the Lease with respect to the design and construction of the Tenant Improvements. Tenant acknowledges the foregoing delegation and request, and agrees to cooperate
reasonably with Project Manager as Landlord’s representative pursuant to such delegation and request. Fees and charges of Project Manager for such services shall be at Tenant’s sole expense, subject to Landlord’s payment of the Tenant
Improvement Allowance and, to the extent requested by Tenant, the Additional TI Allowance. Such fees shall be equal to 2.65% of all funds the Tenant Improvement Allowance or Additional Tenant Improvement Allowance used in connection with the
construction of the Tenant Improvements, and 2% of any additional funds provided by Tenant for such construction. 

3.    Completion. 

(a)    When Landlord receives written certification from Architect that construction of the Tenant Improvements and
Landlord’s Work has been completed in accordance with the Approved TI Plans and Section 3(e) below (except for Punch List Work), Landlord shall prepare and deliver to Tenant a certificate (or separate certificates for the Tenant
Improvements and Landlord’s Work) signed by Landlord, Architect and General Contractor (the “Substantial Completion Certificate”) (i) certifying that the construction of the Tenant Improvements and Landlord’s Work has been
substantially completed in a good and workmanlike manner in accordance with the Approved TI Plans and Section 3(e) below in all material respects, subject only to completion of Punch List Work, and specifying the date of that completion, and
(ii) certifying that the Tenant Improvements and Landlord’s Work comply in all material respects with all laws, rules, regulations, codes, ordinances, requirements, covenants, conditions and restrictions applicable thereto at the time of
such delivery, including the ADA and all building codes. Upon receipt by Tenant of the Substantial Completion Certificate and tender of possession of the Initial Premises by Landlord to Tenant, and receipt of any certificate of occupancy or its
legal equivalent, or other required sign-offs from any applicable governmental authority, allowing the legal occupancy of the Initial Premises, the Tenant Improvements will be deemed delivered to Tenant and “Ready for Occupancy” for all
purposes of the Lease (subject to Landlord’s continuing obligations with respect to any Punch List Work, and to any other express obligations of Landlord under the Lease or this Tenant Work Letter with respect to such Tenant Improvements). 

  

					
		 	 EXHIBIT B

-4-
	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 (b)    Immediately prior to delivery of the Substantial
Completion Certificate for the Tenant Improvements, Project Manager or other representatives of Landlord shall conduct one or more “walkthroughs” of the Building with Tenant and Tenant’s representatives, to identify any items of Punch
List Work that may require correction and to prepare a joint punch list reflecting any such items, following which Landlord shall diligently complete the Punch List Work reflected in such joint punch list. The Punch List Work shall be attached to
the Substantial Completion Certificate, and shall not include damage caused by Tenant or any of Tenant’s agents in connection with any work performed by Tenant in the Initial Premises, or required as a result of Tenant’s move-in to the Initial Premises. At any time within thirty (30) days after delivery of such Substantial Completion Certificate, Tenant shall be entitled to submit one or more lists to Landlord supplementing
such joint punch list by specifying any additional items of Punch List Work to be performed on the applicable Tenant Improvements and Landlord’s Work, and upon receipt of such list(s), Landlord shall diligently complete such additional Punch
List Work. Promptly after Landlord provides Tenant with the Substantial Completion Certificate and completes all applicable Punch List Work for the Building, Landlord shall cause the recordation of a Notice of Completion (as defined in the
California Civil Code) with respect to the Tenant Improvements. 
 (c)    All construction, product and equipment
warranties and guaranties obtained by Landlord with respect to the Tenant Improvements and Landlord’s Work shall, to the extent reasonably obtainable, include a provision that such warranties and guaranties shall also run to the benefit of
Tenant, and Landlord shall cooperate with Tenant in a commercially reasonable manner to assist in enforcing all such warranties and guaranties for the benefit of Tenant. 

(d)    Notwithstanding any other provisions of this Tenant Work Letter or of the Lease, if Landlord is delayed in
substantially completing any of the Tenant Improvements as a result of any Tenant Delay, and if the Lease Commencement Date is being determined under clause (i) of Section 3.2 of the Lease Summary, then notwithstanding any other provision
of the Lease to the contrary, then the Initial Premises shall be deemed to have been Ready for Occupancy on the date the Initial Premises would have been Ready for Occupancy absent such Tenant Delay. 

(e)    Notwithstanding any other provisions of this Tenant Work Letter or of the Lease, Landlord shall be
responsible, at Landlord’s sole cost and expense, and without deduction from the Tenant Improvement Allowance, to (i) perform the work for the items set forth on Schedule 1 to this Exhibit B which have an “x” in the “Replace
Prior to Rent Commencement” column of the spreadsheet attached thereto, and (ii) install push-button door openers for the elevator in the exterior lobby entrance of the 800 Building and the lobby vestibule doors (collectively,
“Landlord’s Work”). 
 4.    Payment of Costs. 

(a)    Tenant Improvement Allowance. Subject to any restrictions, conditions or limitations expressly set
forth in this Tenant Work Letter or in the Lease or as otherwise expressly provided by mutual written agreement of Landlord and Tenant, the cost of construction of the Tenant Improvements shall be paid or reimbursed by Landlord up to a maximum
amount as set forth in Section 5 of the Summary to the Lease (the “Tenant Improvement Allowance”), which amount is being made available by Landlord to be applied towards the Cost of Improvements for the construction of the Tenant
Improvements in the Initial Premises and Pad only (and not the Additional Premises) and, to the extent any of the Tenant Improvement Allowance remains after the Lease Commencement Date, to Alterations to be made by Tenant to the Initial Premises or
the Pad. Tenant shall be responsible, at its sole cost and expense, for payment of the entire Cost of Improvements of the Tenant Improvements in excess of the Tenant Improvement Allowance, including (but not limited to) any costs or cost increases
incurred as a result of delays (unless caused by Landlord), governmental requirements or unanticipated conditions (unless caused by Landlord), and for payment of any and all costs and expenses relating to any alterations, additions, improvements,
furniture, furnishings, equipment, fixtures and personal property items which are not eligible for application of Tenant Improvement Allowance funds under the restrictions expressly set forth below in this paragraph, but Tenant

  

					
		 	 EXHIBIT B

-5-
	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 
shall be entitled to use or apply the entire Tenant Improvement Allowance toward the Cost of Improvements of the Tenant Improvements (subject to any applicable restrictions, conditions,
limitations, reductions or charges set forth in the Lease or in this Tenant Work Letter) prior to being required to expend any of Tenant’s own funds for the Tenant Improvements. The funding of the Tenant Improvement Allowance shall be made on a
monthly basis or at other convenient intervals mutually approved by Landlord and Tenant and in all other respects shall be based on such commercially reasonable disbursement conditions and procedures as Landlord, Project Manager and Landlord’s
lender (if any) may reasonably prescribe. Notwithstanding the foregoing provisions, under no circumstances shall the Tenant Improvement Allowance or any portion thereof be used or useable by Tenant for any moving or relocation expenses of Tenant, or
for any Cost of Improvement (or any other cost or expense) associated with any moveable furniture or trade fixtures, personal property or any other item or element which, under the applicable provisions of the Lease, will not become Landlord’s
property and remain with the Building upon expiration or termination of the Lease, and (ii) except as otherwise expressly provided in this Tenant Work Letter or expressly approved by Landlord in writing, any portion of the Tenant Improvement
Allowance which has not been claimed or drawn by Tenant prior to the later of the Lease Commencement Date and the date which is twelve (12) moths following the date of the full execution and delivery of this Lease by Landlord and Tenant, shall
expire and shall no longer be available to Tenant thereafter, subject to extension by one (1) day for each day Tenant is delayed in competing its Alterations due to Landlord Delay or Unavoidable Delays. Notwithstanding anything to the contrary
herein, the Tenant Improvements shall not include (and Landlord shall be solely responsible for and the Tenant Improvement Allowance shall not be used for) the following: (a) costs incurred due to the presence of any Hazardous Materials in or
about the Initial Premises, if any; (b) costs to bring the Project into compliance with Applicable Laws to the extent required in order to allow Tenant to obtain a certificate of occupancy or its legal equivalent, for the Initial Premises for
the Permitted Use assuming a normal and customary office occupancy density; (c) construction costs in excess of the contract amount stated in the contract with the General Contractor, as approved by Tenant (not to be unreasonably withheld),
except for increases set forth in change orders approved by Tenant; (d) wages, labor and overhead for overtime and premium time unless approved by Tenant (which approval shall not be unreasonably withheld, conditioned or delayed); (e)
attorneys’ fees incurred in connection with negotiation of construction contracts, and attorneys’ fees, experts’ fees and other costs in connection with disputes with third parties; (f) interest and other costs of financing
construction costs; (g) costs incurred as a consequence construction defects or default by a contractor; (h) costs as a consequence of casualties; (i) penalties and late charges attributable to Landlord’s failure to pay
construction costs; and (j) costs due to compliance with the soil management plan for the Project or its appendices. 

(b)    Additional TI Allowance. In addition to the Tenant Improvement Allowance, Tenant shall have the
right, by written notice to Landlord given on or before the date which is twelve (12) months following the Lease Commencement Date, to use up to $913,800.00 (the “Additional TI Allowance”) towards the payment of the Costs of
Improvement for the Tenant Improvements or Alterations performed by Tenant. In the event Tenant exercises its right to use all or any portion of the Additional TI Allowance, Tenant shall be required to pay Landlord, commencing on the date the Tenant
Improvements or Alterations constructed with the Additional TI Allowance are completed (the “Additional Payment Commencement Date”) (provided however in connection with Alterations, in no event shall the Additional Payment Commencement
Date occur later than the later of the Lease Commencement Date and twelve (12) months following the date of the first disbursement of the Additional TI Allowance for such Alterations), the “Additional TI Allowance Payment,” as that
term is defined below, in consideration of Landlord provision of the Additional TI Allowance. To the extent that there is any remaining Additional TI Allowance as of the date which is twelve (12) months following the Lease Commencement Date,
Tenant shall have the right, upon not less than six (6) months prior written notice to delivered on or before the last day of the forty-eighth (48th) month of the Lease Term, to use such remaining Additional TI Allowance (up to a maximum of
$456,900.00 even if a greater amount of the Additional TI Allowance is then remaining). The “Additional TI Allowance Payment” shall be determined as the missing component of an annuity, which annuity shall have (i) the amount of the
Additional TI Allowance utilized by Tenant as the present value amount, (ii) a number equal to the number of full calendar months then remaining in the Lease Term as the number of payments, (iii) a monthly interest factor equal to
seventy-five one-hundredths percent (0.75%), which is equal to nine percent (9%) divided by twelve (12) months per year, and (iv) the Additional TI Allowance Payment as the missing component of the
annuity, and shall not be subject to annual escalations. Following the calculation of the Additional TI Allowance Payment, Landlord and Tenant will enter into a lease amendment in the form of Exhibit G attached to the Lease, to confirm the amount
thereof. 

  

					
		 	 EXHIBIT B

-6-
	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 (c)    Tenant Funds. Any additional funds required to
complete the cost of the work, that are in excess of or elected by the Tenant to be used in place of the Tenant Improvement Allowance and the Additional TI Allowance, shall be considered “Tenant Funds.” The total cost to construct the
Tenant Improvements as managed by Landlord and the Project Manager under this Work Letter shall be the “Project Budget.” Landlord understands that at the time of the agreed upon Guaranteed Maximum Price (GMP), the Tenant Funds amount is an
estimate and exact costs will not be known until project closeout. Tenant is required, at the time of agreement of the GMP, to provide a purchase order to the Landlord for the full estimated amount of the Tenant Funds. In the event the Tenant Funds
at project closeout are less than the amount agreed upon within the Project Budget, Landlord will only bill Tenant for the Tenant Funds that have been utilized. In the event the Tenant Funds exceed the amount agreed upon within the Project Budget,
through added scope changes, the Tenant shall provide additional purchases orders to the Landlord, which will be included in the Tenant Change Request process that the Landlord’s representative administers. 

5.    No Agency. Nothing contained in this Tenant Work Letter shall make or constitute Tenant as the agent
of Landlord. 
 6.    Tenant Access. In addition to the beneficial occupancy rights under Section 1.5
of the Lease, provided that Tenant and its agents do not interfere with Contactor’s work in the 800 Building and the Initial Premises (including by the use of non-union vendors without prior coordination
with Landlord), Contractor and Landlord shall allow Tenant access to the Initial Premises at least thirty (30) days prior to the Substantial Completion of the Landlord’s TI Work without payment of Rent for the purpose of Tenant installing
equipment or fixtures (including Tenant’s data and telephone equipment) in the Initial Premises and preparing the Initial Premises for occupancy. Prior to Tenant’s entry into the Initial Premises as permitted by the terms of this
Section 6, Tenant shall submit a schedule to Landlord and Contractor, for their approval, which schedule shall detail the timing and purpose of Tenant’s entry. Tenant shall hold Landlord harmless from and indemnify, protect and defend
Landlord against any loss or damage to the 800 Building or Initial Premises and against injury to any persons caused by Tenant’s actions pursuant to this Section 6. 

7.    Miscellaneous. All references in this Tenant Work Letter to a number of days shall be construed to
refer to calendar days, unless otherwise specified herein. In all instances where Landlord’s or Tenant’s approval is required, if no written notice of disapproval is given within the applicable time period, at the end of that period
Landlord or Tenant shall be deemed to have given approval (unless the provision requiring Landlord’s or Tenant’s approval expressly states that non-response is deemed to be a disapproval or
withdrawal of the pending action or request, in which event such express statement shall be controlling over the general statement set forth in this sentence) and the next succeeding time period shall commence. If any item requiring approval is
disapproved by Landlord or Tenant (as applicable) in a timely manner, the procedure for preparation of that item and approval shall be repeated. Provided that the initial Tenant Improvements constructed in the Premises pursuant to the terms of this
Tenant Work Letter are in material compliance with the Approved Schematic Plans, Tenant shall not be required to remove or restore such initial Tenant Improvements at the termination of the Lease. 

8.    Time Deadlines. Tenant shall use commercially reasonable, good faith, efforts and all due diligence to
cooperate with the Architect, General Contractor and Landlord to complete all phases of the construction drawings set forth in this Tenant Work Letter and the permitting process and to receive the permits as soon as possible after the execution of
the Lease. The applicable dates for approval of items, plans and drawings as described in this Tenant Work Letter are set forth and further elaborated upon in Schedule 2 to this Exhibit B attached hereto (the “Time Deadlines”), attached
hereto. Tenant agrees to utilize commercially reasonable efforts to comply with the Time Deadlines. 

9.    Occupancy During Construction; No Constructive Eviction. Tenant hereby acknowledges and agrees that
Tenant shall be in possession of the Initial Premises during the construction 

  

					
		 	 EXHIBIT B

-7-
	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 
of the Tenant Improvements, and the Tenant Improvements shall be performed during the Beneficial Occupancy Period. Notwithstanding any such occupancy by Tenant (or any subtenants of Tenant),
Landlord shall be permitted to perform the Tenant Improvements during normal business hours, and Tenant shall provide a clear working area for such work, if necessary (including, but not limited to, the moving of furniture, fixtures and
Tenant’s property away from the area in which Landlord is performing the Tenant Improvements). Further, Tenant shall cooperate with all reasonable Landlord requests made in connection with or related to Landlord’s completion of the Tenant
Improvements. Tenant hereby agrees that the performance of the Tenant Improvements shall in no way constitute a constructive eviction of Tenant nor entitle Tenant to any abatement of Rent. Landlord shall have no responsibility or for any reason be
liable to Tenant for any direct or indirect injury to or interference with Tenant’s business arising from the Tenant Improvements, nor shall Tenant be entitled to any compensation or damages from Landlord for loss of use of the whole or any
part of the Initial Premises or of Tenant’s personal property or improvements resulting from the Tenant Improvements or Landlord’s actions (or the actions of Landlord’s contractors, employees and/or agents) in connection with the
Tenant Improvements, or for any inconvenience or annoyance occasioned by the Tenant Improvements or Landlord’s actions (or the actions of Landlord’s contractors, employees and/or agents) in connection with the Tenant Improvements. 

  

					
		 	 EXHIBIT B

-8-
	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 SCHEDULE 1 TO EXHIBIT B 

LANDLORD’S WORK 
  

 
 8/5/2020 No. Unit Manufacturer Serial Number Year Estimated Remaining Useful Life By Healthpeak Replace Prior to Rent Commencement
One-Year Warranty 1 AHU-1 Scott Springfield K06-01969-M1 2006 7 to 12 years X 2 B1 Laars C112361145 2011 5 to 10 years X 3 B2 Laars CD5177938 2006 0 to 2 years X 4 HWP-1 Armstrong - 2011 5 to 10 years X 5 HWP-2 Armstrong - 2011 5 to 10 years X 6
HWP-3 Armstrong - 2011 5 to 10 years X 7 CH-1 York RNRM016979 2011 0 to 2 years X 8 CHWP1 Armstrong - 2011 1 to 5 years X 9 CU-1 Carrier - 2011 4 to 6 years X 10 CU1 Fujitsu HBN 004241 2011 4 to 6 years X 11 CU2 Fujitsu HBN 003453 2011 4 to 6 years
X 12 CT-1 BAC U110799301-01 2011 1 to 5 years X 13 H2O Treat Pulsatron LB645A-VTC1-XX2 2018 5 to 10 years X 14 Cold Box CU - - - N/A N/A N/A 15 Cool Tower Pump Bell & Gossett 971238 1988 0 to 2 years X 16 Heat Exchanger BAC 89200802 1988 0 to 2
years X 17 CWP1 Taco - 1988 0 to 2 years X 18 CWP2 Taco - 1988 0 to 2 years X 19 Dehumidifier Stulz 10016752 2011 5 to 10 years X 20 EF1 Greenheck 06L01607 2011 5 to 10 years X 21 EF1A Greenheck 06K00747 2011 5 to 10 years X 22 EF2 Greenheck
06K00746 2011 5 to 10 years X 23 EF3 Tri-Stack 10665032 2011 5 to 10 years X 24 EF4 Greenheck 06J05481 2011 5 to 10 years X 25 EF5 Greenheck 12392725 2011 5 to 10 years X 26 ET-1 Wessels - 2011 2 to 5 years X 27 ET-2 Wessels - 2011 2 to 5 years X 28
MUA-1 Greenheck 10443145 2006 2 to 5 years X 29 MUA-2 Greenheck 10665032 2006 2 to 5 years X 30 Replace Fouled Filters X 31 Replace Worn Belts X 32 Clean Coils X 33 1st Floor WSHPs - 2011 5 to 10 years X 34 1st Floor WSHPs - 1988 At/Exceeded Useful
Life X 35 2nd Floor WSHPs - 2011 5 to 10 years X 36 2nd Floor WSHPs - 1988 At/Exceeded Useful Life X 

  

					
		 	 EXHIBIT B

-9-
	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 Item #3: B2. Laars M# HH3600EN18LCACCQ S# C 06 177938. 

The boiler is in good working condition; recommend annual.\ 
  

	 	•	 	 Disassemble and remove the boiler access covers. 

 

	 	•	 	 Disconnect, remove and clean the burners and rack assy. 

 

	 	•	 	 Clean and check the firebox. 

 

	 	•	 	 Clean and check the heat exchanger. 

 

	 	•	 	 Reinstall the burners and rack assy. 

 

	 	•	 	 Clean and check the combustion air inlet screens. 

 

	 	•	 	 Check the integrity of the refractory and patch minor cracks. 

 

	 	•	 	 Reassemble the boiler casing. 

 

	 	•	 	 Clean the make-up water valve strainer screen and verify proper pressure
adjustment and operation. 

  

	 	•	 	 Check and verify proper hot water loop expansion tank integrity and pressure. 

 

	 	•	 	 Check and verify proper hot water pump operation. 

 

	 	•	 	 Clean and check the low water cut out safety control. 

 

	 	•	 	 Check and calibrate the boiler operating and safety controls. 

 

	 	•	 	 Check and verify proper inlet and leaving manifold gas pressures. 

 

	 	•	 	 Start up and verify proper boiler and hot water loop operation. 

Item #7: CH-1. York M# YCAV0177PA46VABSXTX S# RNRM016979. 

The unit is in working condition. 
 Condenser coil
on circuit 1 is bad, should be replaced. 
 Circuit 2 has a leak from the separator sight glasses. 

7B. Leak Check and repair on circuit 2. 
  

	 	•	 	 Reclaim the refrigerant from the unit. 

 

	 	•	 	 Pressurize the unit with dry nitrogen. 

 

	 	•	 	 Perform an electronic refrigerant leak check and repair of the system. 

 

	 	•	 	 Remove and replace the existing liquid line filter drier with new. 

 

	 	•	 	 Evacuate and recharge the system with refrigerant. 

 

	 	•	 	 Start system and verify proper operation. 

7C. Replace the condenser coil on circuit 1. 
  

	 	•	 	 Furnish a crane to facilitate the removal and replacement of the condenser coil. 

 

	 	•	 	 Reclaim the refrigerant from the unit. 

 

	 	•	 	 Remove and replace the failing condenser coil with new. 

 

	 	•	 	 Start system and verify proper operation. 

  

					
		 	 EXHIBIT B

-10-
	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 Item #15: Cooling Tower Pump. Bell and Gossett. M# 1510.3PP.91/2BF ID# 971238. 

The unit is in working condition. 
 Due to age and efficiency,
recommend replacement. 
  

	 	•	 	 Remove and replace the failing pump with new. 

 

	 	•	 	 Start up and verify proper operation. 

Item #16: Heat Exchanger 1. BAC M# HK-8-12-1-10 S# 89200802. 
 The unit is in working condition. 

Due to age and efficiency, recommend replacement. 
  

	 	•	 	 Remove and replace the failing heat exchanger with new. 

 

	 	•	 	 Furnish new fittings as needed for the new heat exchanger. 

 

	 	•	 	 Furnish and install new piping as needed for the new heat exchanger. 

 

	 	•	 	 Start up and verify proper operation. 

Item #17: CWP1. Taco M# FM2513 11.0 B2JILO S# N/A. 

The pump is in working condition. 
 Due to age (1988) and
efficiency, recommend replacement. 
  

	 	•	 	 Remove and replace the failing chill water pump with new. 

 

	 	•	 	 Start up and verify proper operation. 

Item #18: CWP2. Taco M# FM2513 11.0 B2JLD1L S# N/A. 

The pump is in working condition. 
 Due to age (1988) and
efficiency, recommend replacement. 
  

	 	•	 	 Remove and replace the failing chill water pump with new. 

 

	 	•	 	 Start up and verify proper operation. 

Item #30: Replace the fouled filters. 
  

	 	•	 	 Remove and replace (50) fouled filters with new. 

 

	 	•	 	 Properly dispose of fouled filters 

  

					
		 	 EXHIBIT B

-11-
	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 Item #31: Replace the worn belts. 

 

	 	•	 	 Remove and replace the (10) worn belts with new. 

 

	 	•	 	 Verify proper belt tension and alignment. 

 

	 	•	 	 Start up and verify proper operation. 

Item #32: Clean coils. 
 Clean indoor (evaporator)
coil(s). 
 Clean outdoor coil(s) (condenser). 
 Rinse the
coil(s) with clear water 

  

					
		 	 EXHIBIT B

-12-
	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 SCHEDULE 2 TO EXHIBIT B 

TIME DEADLINES 
 08/05/2020 

Tenant Improvement Milestone Schedule 
  

			
	08/17/2020  	  	Anticipated Start of Design
		
	09/04/2020	  	Tenant Approval of SD Drawing Package
		
	09/28/2020	  	Tenant Approval of DD Drawing Package
		
	11/04/2020	  	Anticipated Submission of IFP Package to City of Redwood City
		
	12/29/2020	  	Anticipated Construction Commencement
		
	02/11/2021	  	Anticipated Permit Receipt from City of Redwood City
		
	05/13/2021	  	Anticipated Substantial Completion

  

					
		 	 EXHIBIT B

-13-
	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 EXHIBIT C 

NOTICE OF LEASE TERM DATES 

 

	To:	
                       
                  

	    	
                       
                  

	    	
                       
                  

	    	
                       
                  

  

	 	Re:	 Lease dated             ,
20     between                     , a
                     (“Landlord”), and
                    , a                     
(“Tenant”) concerning Suite                      on floor(s)
             of the building located at                     , California.

 Gentlemen: 
 In accordance
with the Lease (the “Lease”), we wish to advise you and/or confirm as follows: 
  

	 	1.	 The Lease Term shall commence on or has commenced on
                     for a term of
                     ending on
                    . 

  

	 	2.	 Rent commenced to accrue on
                    , in the amount of
                    . 

  

	 	3.	 If the Lease Commencement Date is other than the first day of the month, the first billing will contain a pro
rata adjustment. Each billing thereafter, with the exception of the final billing, shall be for the full amount of the monthly installment as provided for in the Lease. 

 

	 	4.	 Your rent checks should be made payable to
                     at                     .

  

	 	5.	 The number of rentable/usable square feet within the Premises is approximately
                     square feet. 

  

	 	6.	 Tenant’s Share as adjusted based upon the exact number of usable square feet within the Premises is
    %, subject to Section 6 of the Summary of Basic Lease Information. 

  

			
	“Landlord”:
	
	                                    
                                         
         ,
	a	 	                                      
                                         
 
		
	By:	 	                                      
                                         
 
		 	Its:                                     
                                      

  

					
		 	 EXHIBIT C

-1-
	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

			
	 Agreed to and Accepted as
 of
            , 20    .

	
	“Tenant”:
	
	                                    
                                         
           
	a	 	                                      
                                         
 
		
	By:	 	                                      
                                         
 
		 	Its:                                     
                                      

  

					
		 	 EXHIBIT C

-2-
	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 EXHIBIT D 

FORM OF TENANT’S ESTOPPEL CERTIFICATE

 The undersigned as Tenant under that certain Lease (the “Lease”) made and entered into as of
            , 20 by and between                      as Landlord, and the undersigned as
Tenant, for Premises consisting of a portion of the building located at                     , California, certifies as follows: 

1.    Attached hereto as Exhibit A is a true and correct copy of the Lease and all amendments and modifications thereto.
The documents contained in Exhibit A represent the entire agreement between the parties as to the Premises. 
 2.    The
undersigned currently occupies the Premises described in the Lease, the Lease Term commenced on                     , and the Lease Term expires on
                    , and the undersigned has no option to terminate or cancel the Lease or to purchase all or any part of the Premises, the Building
and/or the Project, except as expressly set forth in the Lease. 
 3.    Base Rent became payable on
                    . 

4.    The Lease is in full force and effect and has not been modified, supplemented or amended in any way except as
provided in Exhibit A. 
 5.    Tenant has not transferred, assigned, or sublet any portion of the Premises nor entered
into any license or concession agreements with respect thereto except as follows: 
 6.    Tenant shall not modify the
documents contained in Exhibit A without the prior written consent of Landlord’s mortgagee. 
 7.    All monthly
installments of Base Rent, all Additional Rent and all monthly installments of estimated Additional Rent have been paid when due through
                    . The current monthly installment of Base Rent is $        . 

8.    To Tenant’s actual knowledge, without inquiry, all conditions of the Lease to be performed by Landlord
necessary to the enforceability of the Lease have been satisfied and Landlord is not in default thereunder. In addition, the undersigned has not delivered any notice to Landlord regarding a default by Landlord thereunder. The Lease does not require
Landlord to provide any rental concessions or to pay any leasing brokerage commissions except as expressly set forth therein. 

9.    No rental has been paid more than thirty (30) days in advance and no security has been deposited with Landlord
except as provided in the Lease. Neither Landlord, nor its successors or assigns, shall in any event be liable or responsible for, or with respect to, the retention, application and/or return to Tenant of any security deposit paid to any prior
landlord of the Premises, whether or not still held by any such prior landlord, unless and until the party from whom the security deposit is being sought, whether it be a lender, or any of its successors or assigns, has actually received for its own
account, as landlord, the full amount of such security deposit. 
 10.    To Tenant’s actual knowledge, without
inquiry, as of the date hereof, there are no existing defenses or offsets, or, to the undersigned’s knowledge, claims or any basis for a claim, that the undersigned has against Landlord. 

11.    If Tenant is a corporation or partnership, Tenant hereby represents and warrants that Tenant is a duly formed and
existing entity qualified to do business in California and that Tenant has full right and authority to execute and deliver this Estoppel Certificate and that each person signing on behalf of Tenant is authorized to do so. 

  

					
		 	 EXHIBIT D

-1-
	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 12.    There are no actions pending against the undersigned under the
bankruptcy or similar laws of the United States or any state. 
 13.    Tenant is in full compliance with all federal,
state and local laws, ordinances, rules and regulations affecting its use of the Premises, including, but not limited to, those laws, ordinances, rules or regulations relating to hazardous or toxic materials. Tenant has never permitted its agents,
employees or contractors to engage in the generation, manufacture, treatment, use, storage, disposal or discharge of any hazardous, toxic or dangerous waste, substance or material in, on, under or about the Project or the Premises or any adjacent
premises or property in violation of any federal, state or local law, ordinance, rule or regulation. 
 14.    To the
undersigned’s knowledge, all tenant improvement work to be performed by Landlord under the Lease has been completed in accordance with the Lease and has been accepted by the undersigned and all reimbursements and allowances due to the
undersigned under the Lease in connection with any tenant improvement work have been paid in full. All work (if any) in the common areas required by the Lease to be completed by Landlord has been completed and all parking spaces required by the
Lease have been furnished and/or all parking ratios required by the Lease have been met. 
 The undersigned acknowledges that this Estoppel
Certificate may be delivered to Landlord or to a prospective mortgagee or prospective purchaser, and acknowledges that said prospective mortgagee or prospective purchaser will be relying upon the statements contained herein in making the loan or
acquiring the property of which the Premises are a part and that receipt by it of this certificate is a condition of making such loan or acquiring such property. 

Executed at                      on the
     day of             , 20    . 
  

			
	“Tenant”:
	
	                                    
                                         
          ,
	a	 	                                      
                                         
 
		
	By:	 	                                      
                                         
 
		 	Its:                                     
                                      
		
	By:	 	                                      
                                         
 
		 	Its:                                     
                                      

  

					
		 	 EXHIBIT D

-2-
	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 EXHIBIT E 

ENVIRONMENTAL QUESTIONNAIRE 

ENVIRONMENTAL QUESTIONNAIRE 

FOR COMMERCIAL AND INDUSTRIAL PROPERTIES 
  

			
	Tenant Name:	 	  

	Lease Address:	 	  

			
	Lease Type (check correct box – right click to properties):	  	☐ Primary Lease/Lessee
		  	☐ Sublease from:                                 
                    

 Instructions: The following questionnaire is to be completed by the Lessee representative with knowledge of the planned
operations for the specified building/location. Please print clearly and attach additional sheets as necessary. 
  

	1.0	 PROCESS INFORMATION 

Describe planned site use, including a brief description of manufacturing processes and/or pilot plants planned for this site, if any. 

 
  

 
  

 
  

 

	2.0	 HAZARDOUS MATERIALS – OTHER THAN WASTE 

Will (or are) non-waste hazardous materials be/being used or stored at this site? If so, continue with
the next question. If not, go to Section 3.0. 
  

	 	2.1	 Are any of the following materials handled on the
Property?        ☐  Yes    ☐  No 

[A material is handled if it is used, generated, processed, produced, packaged, treated, stored, emitted, discharged, or disposed.] If
YES, check (right click to properties) the applicable correct Fire Code hazard categories below. 
  

											
	☐	  	Combustible dusts/fibers	  	☐	  	Explosives	  	☐	  	Flammable liquids
						
	☐	  	Combustible liquids (e.g., oils)	  	☐	  	Compressed gas - inert	  	☐	  	Flammable solids/pyrophorics
						
	☐	  	Cryogenic liquids - inert	  	☐	  	Compressed gas - flammable/pyrophoric	  	☐	  	Organic peroxides
						
	☐	  	Cryogenic liquids - flammable	  	☐	  	Compressed gas - oxidizing	  	☐	  	Oxidizers - solid or liquid
						
	☐	  	Cryogenic liquids - oxidizing	  	☐	  	Compressed gas - toxic	  	☐	  	Reactives - unstable or water reactive
						
	☐	  	Corrosives - solid or liquid	  	☐	  	Compressed gas - corrosive	  	☐	  	Toxics - solid or liquid

  

	 	2.2.	 For all materials checked in Section 2.1 above, please list the specific material(s), use(s), and
quantities of each used or stored on the site in the table below; or attach a separate inventory. NOTE: If proprietary, the constituents need not be named but the hazard information and volumes are required. 

  

					
		 	 EXHIBIT E

-3-
	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

											
	 Material/Chemical
	 	 Physical State

(Solid, Liquid,
 or
Gas)
	 	 Container

Size
	 	 Number of

Containers

Used &

Stored
	 	 Total

Quantity
	 	 Units (pounds

for solids,
 gallons or
liters
 for liquids, &

		 		 		 		 		 	
		 		 		 		 		 	
		 		 		 		 		 	
		 		 		 		 		 	
		 		 		 		 		 	
		 		 		 		 		 	
		 		 		 		 		 	
		 		 		 		 		 	
		 		 		 		 		 	
		 		 		 		 		 	
		 		 		 		 		 	
		 		 		 		 		 	
		 		 		 		 		 	
		 		 		 		 		 	
		 		 		 		 		 	
		 		 		 		 		 	
		 		 		 		 		 	
		 		 		 		 		 	
		 		 		 		 		 	
		 		 		 		 		 	
		 		 		 		 		 	
		 		 		 		 		 	
		 		 		 		 		 	
		 		 		 		 		 	

  

	 	2.3.	 Describe the planned storage area location(s) for the materials in
Section 2-2 above. Include site maps and drawings as appropriate. 

  

 
  

 

  

					
		 	 EXHIBIT E

-4-
	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

	 	2.4.	 Other hazardous materials. Check below (right click to properties) if applicable. NOTE: If either of
the latter two are checked (BSL-3 and/or radioisotope/radiation), be advised that not all lease locations/cities or lease agreements allow these hazards; and if either of these hazards are planned, additional
information will be required with copies of oversight agency authorizations/licenses as they become available. 

  

											
	☐	  	Risk Group 2/Biosafety Level-2 Biohazards	  	☐	  	Risk Group 3/Biosafety Level-3 Biohazards	  	☐	  	Radioisotopes/Radioation

  

	3.0	 HAZARDOUS WASTE (i.e., REGULATED CHEMICAL WASTE) 

Are (or will) hazardous wastes (be) generated?    ☐  Yes    ☐  No 

If YES, continue with the next question. If not, skip this section and go to section 4.0. 

 

	 	3.1	 Are or will any of the following hazardous (CHEMICAL) wastes generated, handled, or disposed of (where
applicable and allowed) on the property? 

  

											
	☐	  	Liquids	  	☐	  	Process sludges	  	☐	  	PCBs
						
	☐	  	Solids	  	☐	  	Metals	  	☐	  	wastewater

  

	 	3.2	 List and estimate the quantities of hazardous waste identified in Question
3-1 above. 

  

											
	 HAZARDOUS

(CHEMICAL)
 WASTE

GENERATED
	  	SOURCE	  	WASTE TYPE	  	APPROX.
MONTHLY
QUANTITY with
units	  	DISPOSITION [e.g.,
off-site landfill,
incineration, fuel
blending
scrap
metal; wastewater
neutralization
(onsite or off-site)]
	  	RCRA
listed
(federal)	  	Non-
RCRA
(California
ONLY or
recycle)
		  		  	☐	  	☐	  		  	
		  		  	☐	  	☐	  		  	
		  		  	☐	  	☐	  		  	
		  		  	☐	  	☐	  		  	
		  		  	☐	  	☐	  		  	
		  		  	☐	  	☐	  		  	

  

	 	3.3.	 Waste characterization by:        Process
knowledge  ☐  EPA lab analysis  ☐    Both  ☐ 

  

	 	3.4.	 Please include name, location, and permit number (e.g. EPA ID No.) for transporter and disposal facility if
applicable. Attach separate pages as necessary. If not yet known, write “TBD.” 

  

													
	 Hazardous Waste

Transporter/Disposal

Facility
Name                
	  	Facility Location	 	  	Transporter (T) or
Disposal (D)
Facility	 	  	Permit Number	 
		  				  				  			
		  				  				  			
		  				  				  			
		  				  				  			

  

					
		 	 EXHIBIT E

-5-
	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

	 	3.5.	 Are pollution controls or monitoring employed in the process to prevent or minimize the release of wastes into
the environment? NOTE: This does NOT mean fume hoods; examples include air scrubbers, cyclones, carbon or HEPA filters at building exhaust fans, sedimentation tanks, pH neutralization systems for wastewater, etc. 

☐  Yes    ☐  No 

If YES, please list/describe:
                                         
                                         
                                         
                                

                       
                                         
                                         
                                         
                                         
              

                       
                                         
                                         
                                         
                                         
              
  

	4.0	 OTHER REGULATED WASTE (i.e., REGULATED BIOLOGICAL WASTE, referred to as “Medical Waste” in
California) 

  

	 	4-1.	 Will (or do) you generate medical
waste?        ☐  Yes    ☐  No If NO, skip to Section 5.0. 

  

	 	4-2.	 Check the types of waste that will be generated, all of which fall under the California Medical Waste Act:

  

											
	☐	  	Contaminated sharps (i.e., if contaminated with 3 Risk Group 2 materials)	  	☐	  	Animal carcasses	  	☐	  	Pathology waste known or suspected to be contaminated with 3 Risk Group 2 pathogens)
						
	☐	  	Red bag biohazardous waste (i.e., with 3 Risk Group 2 materials) for autoclaving	  	☐	  	Human or non-human primate blood, tissues, etc. (e.g., clinical specimens)	  	☐	  	Trace Chemotherapeutic Waste and/or Pharmaceutical waste NOT otherwise regulated as RCRA chemical waste

  

	 	4.3.	 What vendor will be used for off-site autoclaving and/or incineration?

                       
                                         
                                         
                                         
                                         
              
  

	 	4-5.	 Do you have a Medical Waste Permit for this
site?    ☐  Yes    ☐  No, not required. 

                          
                                         
                                        
☐  No, but an application will be submitted. 
  

	5.0	 UNDERGROUND STORAGE TANKS (USTS) & ABOVEGROUND STORAGE TANKS (ASTS) 

 

	 	5-1.	 Are underground storage tanks (USTs), aboveground storage tanks (ASTs), or associated pipelines used for the
storage of petroleum products, chemicals, or liquid wastes present on site (lease renewals) or required for planned operations (new
tenants)?        ☐  Yes    ☐  No 

NOTE: If you will have your own diesel emergency power generator, then you will have at least one AST! 

[NOTE: If a backup generator services multiple tenants, then the landlord usually handles the permits.] 

If NO, skip to section 6.0. If YES, please describe capacity, contents, age, type of the USTs or ASTs, as well any associated leak
detection/spill prevention measures. Please attach additional pages if necessary. 
  

											
	 UST or

AST      
	  	Capacity
(gallons)	  	 Contents
	  	Year
Installed	  	Type (Steel,
Fiberglass,
etc.)	  	Associated Leak
Detection / Spill
Prevention
Measures*
		  		  		  		  		  	
		  		  		  		  		  	
		  		  		  		  		  	

  

					
		 	 EXHIBIT E

-6-
	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

	 	*NOTE:	 The following are examples of leak detection / spill prevention measures: integrity testing, inventory
reconciliation, leak detection system, overfill spill protection, secondary containment, cathodic protection. 

  

	 	5.2.	 Please provide copies of written tank integrity test results and/or monitoring documentation, if available.

  

	 	5.3.	 Is the UST/AST registered and permitted with the appropriate regulatory
agencies?        ☐  Yes    ☐  No, not yet 

If YES, please attach a copy of the required permit(s). See Section 7-1 for the oversight
agencies that issue permits, with the exception of those for diesel emergency power generators which are permitted by the local Air Quality District (Bay Area Air Quality Management District = BAAQMD; or San Diego Air Pollution Control District =
San Diego APCD). 
  

	 	5.4.	 If this Questionnaire is being completed for a lease renewal, and if any of the USTs/ASTs have leaked, please
state the substance released, the media(s) impacted (e.g., soil, water, asphalt, etc.), the actions taken, and all remedial responses to the incident. 

  

 
  

 
  

 
  

	 	5.5.	 If this Questionnaire is being completed for a lease renewal, have USTs/ASTs been removed from the Property?

 ☐  Yes    ☐  No 

If YES, please provide any official closure letters or reports and supporting documentation (e.g., analytical test results, remediation report
results, etc.). 
  

	 	5.6.	 For Lease renewals, are there any above or below ground pipelines on site used to transfer chemicals or wastes?

 ☐  Yes    ☐  No 

For new tenants, are installations of this type required for the planned operations? 

☐  Yes    ☐  No 

If YES to either question in this section 5-6, please describe. 

 
  

 
  

 
  

 

	6.0	 ASBESTOS CONTAINING BUILDING MATERIALS 

Please be advised that an asbestos survey may have been performed at the Property. If provided, please review the information that identifies
the locations of known asbestos containing material or presumed asbestos containing material. All personnel and appropriate subcontractors should be notified of the presence of these materials, and informed not to disturb these materials. Any
activity that involves the disturbance or removal of these materials must be done by an appropriately trained individual/contractor. 

  

					
		 	 EXHIBIT E

-7-
	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

	7.0	 OTHER REGULATORY PERMITS/REQUIREMENTS 

 

	 	7.1.	 Does the operation have or require an industrial wastewater permit to discharge into the local National
Pollutant Discharge Elimination System (NPDES)? [Example: This applies when wastewater from equipment cleaning is routed through a pH neutralization system prior to discharge into the sanitary or lab sewer for certain pharmaceutical
manufacturing wastewater; etc.] Permits are obtained from the regional sanitation district that is treating wastewater. 

☐  Yes    ☐  No    ☐  No, but one will be prepared and
submitted to the Landlord property management company. 
 If so, please attach a copy of this permit or provide it later when it has been
prepared. 
  

	 	7-2.	 Has a Hazardous Materials Business Plan (HMBP) been developed for the site and submitted via the State of
California Electronic Reporting System (CERS)? [NOTE: The trigger limits for having to do this are 3 200 cubic feet if any one type of compressed gas(except for carbon
dioxide and inert simple asphyxiant gases, which have a higher trigger limit of 3 1,000 cubic
feet);3> 55 gallons if any one type of hazardous chemical liquid; and 3 500 pounds of any one type
of hazardous chemical solid. So a full-sixe gas cylinder and a 260-liter of liquid nitrogen are triggers! Don’t forget the diesel fuel in a backup emergency generator if the diesel tank size is
3 55 gallons and it is permitted under the tenant (rather than under the landlord).] NOTE: Each local Certified Unified Program Agency (CUPA) in California governs the HMBP
process so start there. Examples: the CUPA for cities in San Mateo County is the County Environmental Health Department; the CUPA for the City of Hayward, CA is the Hayward Fire Department; the CUPA for Mountain View is the Mountain View Fire
Department; and, the CUPA for San Diego is the County of San Diego Hazardous Materials Division (HMD), 

☐  Yes    ☐  No, not required. ☐  No, but one will be prepared and
submitted, and a copy will be provided to the landlord property management company. 
 If one has been completed, please attach a copy.
Continue to provide updated versions as they are completed. This is a legal requirement in that State law requires that the owner/operator of a business located on leased or rented real property shall notify, in writing, the owner of the property
that the business is subject to and is in compliance with the Hazardous Materials Business Plan requirements (Health and Safety Code Chapter 6.95 Section 25505.1).  

 

	 	7-3.	 NOTE: Please be advised that if you are involved in any tenant improvements that require a construction
permit, you will be asked to provide the local city with a Hazardous Materials Inventory Statement (HMIS) to ensure that your hazardous chemicals fall within the applicable Fire Code fire control area limits for the applicable construction occupancy
of the particular building. The HMIS will include much of the information listed in Section 2-2. Neither the landlord nor the landlord’s property management company expressly warrants that the
inventory provided in Section 2-2 will necessarily meet the applicable California Fire Code fire control area limits for building occupancy, especially in shared tenant occupancy situations. It is the
responsibility of the tenant to ensure that a facility and site can legally handle the intended operations and hazardous materials desired/ needed for its operations, but the landlord is happy to assist in this determination when possible.

  

					
		 	 EXHIBIT E

-8-
	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 CERTIFICATION 

I am familiar with the real property described in this questionnaire. By signing below, I represent and warrant that the answers to the above questions are
complete and accurate to the best of my knowledge. I also understand that Lessor will rely on the completeness and accuracy of my answers in assessing any environmental liability risks associated with the property. 

 

			
	        Signature:	 	  

		
	        Name:	 	  

		
	        Title:	 	  

		
	        Date:	 	  

		
	        Telephone:	 	  

  

					
		 	 EXHIBIT E

-9-
	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 EXHIBIT F 

TENANT’S PROPERTY 

The following items, to the extent not purchased with the Tenant Improvement Allowance or Additional Improvement Allowance, shall be deemed
“Tenant’s Property”: 
  

	 	1.	 All moveable furniture and equipment that is not “built-in”.

  

	 	2.	 Moveable lab casework (other than “built-in” lab casework),
including moveable lab benches. 

  

	 	3.	 Servers, server racks and back-up batteries. 

 

	 	4.	 Furniture. 

  

	 	5.	 Portable fume hoods. 

 

	 	6.	 Biosafety cabinets. 

  

					
		 	 EXHIBIT F

-1-
	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 EXHIBIT G 

FORM OF AGREEMENT FOR ADDITIONAL MONTHLY
BASE RENT 
 FIRST AMENDMENT TO LEASE

 THIS FIRST AMENDMENT TO LASE
(“Amendment”) is made and entered into as of             , 2015, by and between HCP LS REDWOOD
CITY, LLC, a Delaware limited liability company (“Landlord”), and BOLT BIOTHERAPEUTICS, INC., a Delaware
corporation (“Tenant”). 
 R E C I T A L S : 

A.    Landlord and Tenant are parties to that certain Lease dated
            , 2020, (the “Lease”), pursuant to which Tenant leases premises on the first through fourth floors (the “Premises”) containing
approximately                      rentable square feet of space in the building located at 800 Chesapeake Drive, Redwood City, California (the
“Building”). 
 B.    Landlord and Tenant desire to amend the Lease on the terms and conditions
set forth in this Amendment. 
 A G R E E M E N T : 

NOW, THEREFORE, in consideration of the foregoing recitals and the mutual covenants
contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows: 

1.    Terms. All capitalized terms when used herein shall have the same respective meanings as are given such terms
in the Lease unless expressly provided otherwise in this Amendment. 
 2.    Additional TI Allowance. Pursuant to
the terms of Section 4 of the Tenant Work Letter attached to the Lease as Exhibit B, Tenant was entitled to an Additional TI Allowance of up to $ (the “Additional TI Allowance”). Notwithstanding any provision to the
contrary contained in the Lease, Landlord and Tenant hereby acknowledge and agree that Tenant has utilized and     /100 Dollars ($        .    ) of the Additional TI
Allowance (the “Utilized Additional TI Allowance”). 
 4.    Additional Monthly Base
Rent. As a result of Tenant’s use of the Utilized Additional TI Allowance, Tenant is required to pay Additional Monthly Base Rent calculated as provided in Section 4 of the Tenant Work Letter, which Additional Monthly Base Rent shall
be equal to $         per month, payable on or before the first (1st) day of each month commencing as of
                    , and continuing through the expiration of the initial Lease Term. 

5.    No Further Modification. Except as specifically set forth in this Amendment, all of the terms and provisions
of the Lease shall remain unmodified and in full force and effect. 

  

					
		 	 EXHIBIT G

-1-
	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 IN WITNESS WHEREOF, this
Amendment has been executed as of the day and year first above written. 
  

									
	LANDLORD:	 		 	TENANT”
			
	HCP LS REDWOOD CITY, LLC	 		 	BOLT THERAPEUTICS, INC.
	a Delaware limited liability company	 		 	a Delaware corporation
					
	By:	 	
                    

	 		 	By:	 	
                    

	Name:	 	  
	 		 	Name:	 	  

	Its:	 	  
	 		 	Its:	 	  

					
		 		 		 	By:	 	  

		 		 		 	Name:	 	  

		 		 		 	Its:	 	  

  

					
		 	 EXHIBIT G

-2-
	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 EXHIBIT H 

FORM OF LETTER OF CREDIT 

(Letterhead of a money center bank 

acceptable to the Landlord) 
  

			
	 FAX NO. [(        )     -         ]

SWIFT: [Insert No., if any]
	  	[Insert Bank Name And Address]
		
		  	DATE OF ISSUE:
                                        

		
	 BENEFICIARY:    :
 [Insert
Beneficiary Name And Address]
	  	 APPLICANT
 [Insert Applicant Name And
Address]

		
		  	LETTER OF CREDIT NO.             
		
	 EXPIRATION DATE:

                     AT OUR COUNTERS
	  	 AMOUNT AVAILABLE:
 USD[Insert Dollar Amount]

(U.S. DOLLARS [Insert Dollar Amount])

 LADIES AND GENTLEMEN: 
 WE
HEREBY ESTABLISH OUR IRREVOCABLE STANDBY LETTER OF CREDIT NO.      IN YOUR FAVOR FOR THE ACCOUNT OF [Insert Tenant’s Name], A [Insert Entity Type], UP TO THE AGGREGATE AMOUNT OF USD[Insert Dollar Amount] ([Insert Dollar
Amount] U.S. DOLLARS) EFFECTIVE IMMEDIATELY AND EXPIRING ON (Expiration Date) AVAILABLE         BY PAYMENT UPON PRESENTATION OF YOUR DRAFT AT SIGHT DRAWN ON [Insert Bank Name] WHEN ACCOMPANIED BY THE FOLLOWING
DOCUMENT(S): 
 1. THE ORIGINAL OF THIS IRREVOCABLE STANDBY LETTER OF CREDIT AND AMENDMENT(S), IF ANY. 

 

	 	2.	 BENEFICIARY’S SIGNED STATEMENT PURPORTEDLY SIGNED BY AN AUTHORIZED REPRESENTATIVE OF [Insert
Landlord’s Name], A [Insert Entity Type] (“LANDLORD”) STATING THE FOLLOWING: 

 “THE UNDERSIGNED
HEREBY CERTIFIES THAT THE LANDLORD, EITHER (A) UNDER THE LEASE (DEFINED BELOW), OR (B) AS A RESULT OF THE TERMINATION OF SUCH LEASE, HAS THE RIGHT TO DRAW DOWN THE AMOUNT OF USD          IN
ACCORDANCE WITH THE TERMS OF THAT CERTAIN OFFICE LEASE DATED [Insert Lease Date], AS AMENDED (COLLECTIVELY, THE “LEASE”), OR SUCH AMOUNT CONSTITUTES DAMAGES OWING BY THE TENANT TO BENEFICIARY RESULTING FROM THE BREACH OF SUCH LEASE BY THE
TENANT THEREUNDER, OR THE TERMINATION OF SUCH LEASE, AND SUCH AMOUNT REMAINS UNPAID AT THE TIME OF THIS DRAWING.” 
 OR 

“THE UNDERSIGNED HEREBY CERTIFIES THAT WE HAVE RECEIVED A WRITTEN NOTICE OF [Insert Bank Name]’S ELECTION NOT TO EXTEND ITS STANDBY
LETTER OF CREDIT NO.      AND HAVE NOT RECEIVED A REPLACEMENT LETTER OF CREDIT WITHIN AT LEAST THIRTY (30) DAYS PRIOR TO THE PRESENT EXPIRATION DATE.” 

  

					
		 	 EXHIBIT H

-1-
	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 OR 

“THE UNDERSIGNED HEREBY CERTIFIES THAT BENEFICIARY IS ENTITLED TO DRAW DOWN THE FULL AMOUNT OF LETTER OF CREDIT NO.
     AS THE RESULT OF THE FILING OF A VOLUNTARY PETITION UNDER THE U.S. BANKRUPTCY CODE OR A STATE BANKRUPTCY CODE BY THE TENANT UNDER THAT CERTAIN OFFICE LEASE DATED [Insert Lease Date], AS AMENDED (COLLECTIVELY, THE
“LEASE”), WHICH FILING HAS NOT BEEN DISMISSED AT THE TIME OF THIS DRAWING.” 
 OR 

“THE UNDERSIGNED HEREBY CERTIFIES THAT BENEFICIARY IS ENTITLED TO DRAW DOWN THE FULL AMOUNT OF LETTER OF CREDIT NO.
     AS THE RESULT OF AN INVOLUNTARY PETITION HAVING BEEN FILED UNDER THE U.S. BANKRUPTCY CODE OR A STATE BANKRUPTCY CODE AGAINST THE TENANT UNDER THAT CERTAIN OFFICE LEASE DATED [Insert Lease Date], AS AMENDED (COLLECTIVELY, THE
“LEASE”), WHICH FILING HAS NOT BEEN DISMISSED AT THE TIME OF THIS DRAWING.” 
 OR 

“THE UNDERSIGNED HEREBY CERTIFIES THAT BENEFICIARY IS ENTITLED TO DRAW DOWN THE FULL AMOUNT OF LETTER OF CREDIT NO.
     AS THE RESULT OF THE REJECTION, OR DEEMED REJECTION, OF THAT CERTAIN OFFICE LEASE DATED [Insert Lease Date], AS AMENDED, UNDER SECTION 365 OF THE U.S. BANKRUPTCY CODE.” 

SPECIAL CONDITIONS: 
 PARTIAL DRAWINGS AND MULTIPLE
PRESENTATIONS MAY BE MADE UNDER THIS STANDBY LETTER OF CREDIT, PROVIDED, HOWEVER, THAT EACH SUCH DEMAND THAT IS PAID BY US SHALL REDUCE THE AMOUNT AVAILABLE UNDER THIS STANDBY LETTER OF CREDIT. 

ALL INFORMATION REQUIRED WHETHER INDICATED BY BLANKS, BRACKETS OR OTHERWISE, MUST BE COMPLETED AT THE TIME OF DRAWING. [Please Provide The Required Forms For
Review, And Attach As Schedules To The Letter Of Credit.] 
 ALL SIGNATURES MUST BE MANUALLY EXECUTED IN ORIGINALS. 

ALL BANKING CHARGES ARE FOR THE APPLICANT’S ACCOUNT. 
 IT
IS A CONDITION OF THIS STANDBY LETTER OF CREDIT THAT IT SHALL BE DEEMED AUTOMATICALLY EXTENDED WITHOUT AMENDMENT FOR A PERIOD OF ONE YEAR FROM THE PRESENT OR ANY FUTURE EXPIRATION DATE, UNLESS AT LEAST SIXTY (60) DAYS PRIOR TO THE EXPIRATION
DATE WE SEND YOU NOTICE BY NATIONALLY RECOGNIZED OVERNIGHT COURIER SERVICE THAT WE ELECT NOT TO EXTEND THIS LETTER OF CREDIT FOR ANY SUCH ADDITIONAL PERIOD. SAID NOTICE WILL BE SENT TO THE ADDRESS INDICATED ABOVE, UNLESS A CHANGE OF ADDRESS IS
OTHERWISE NOTIFIED BY YOU TO US IN WRITING BY RECEIPTED MAIL OR COURIER. ANY NOTICE TO US WILL BE DEEMED EFFECTIVE ONLY UPON ACTUAL RECEIPT BY US AT OUR DESIGNATED OFFICE. IN NO EVENT, AND WITHOUT FURTHER NOTICE FROM OURSELVES, SHALL THE EXPIRATION
DATE BE EXTENDED BEYOND A FINAL EXPIRATION DATE OF          (120 days from the Lease Expiration Date). 

  

					
		 	 EXHIBIT H

-2-
	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 THIS LETTER OF CREDIT MAY BE TRANSFERRED SUCCESSIVELY IN WHOLE OR IN PART ONLY UP TO THE THEN AVAILABLE
AMOUNT IN FAVOR OF A NOMINATED TRANSFEREE (“TRANSFEREE”), ASSUMING SUCH TRANSFER TO SUCH TRANSFEREE IS IN COMPLIANCE WITH ALL APPLICABLE U.S. LAWS AND REGULATIONS. AT THE TIME OF TRANSFER, THE ORIGINAL LETTER OF CREDIT AND ORIGINAL
AMENDMENT(S) IF ANY, MUST BE SURRENDERED TO US TOGETHER WITH OUR TRANSFER FORM (AVAILABLE UPON REQUEST) AND PAYMENT OF OUR CUSTOMARY TRANSFER FEES, WHICH FEES SHALL BE PAYABLE BY APPLICANT (PROVIDED THAT BENEFICIARY MAY, BUT SHALL NOT BE OBLIGATED
TO, PAY SUCH FEES TO US ON BEHALF OF APPLICANT, AND SEEK REIMBURSEMENT THEREOF FROM APPLICANT). IN CASE OF ANY TRANSFER UNDER THIS LETTER OF CREDIT, THE DRAFT AND ANY REQUIRED STATEMENT MUST BE EXECUTED BY THE TRANSFEREE AND WHERE THE
BENEFICIARY’S NAME APPEARS WITHIN THIS STANDBY LETTER OF CREDIT, THE TRANSFEREE’S NAME IS AUTOMATICALLY SUBSTITUTED THEREFOR. 
 ALL DRAFTS
REQUIRED UNDER THIS STANDBY LETTER OF CREDIT MUST BE MARKED: “DRAWN UNDER [Insert Bank Name] STANDBY LETTER OF CREDIT NO.     .” 

WE HEREBY AGREE WITH YOU THAT IF DRAFTS ARE PRESENTED TO [Insert Bank Name] UNDER THIS LETTER OF CREDIT AT OR PRIOR TO [Insert Time – (e.g., 11:00
AM)], ON A BUSINESS DAY, AND PROVIDED THAT SUCH DRAFTS PRESENTED CONFORM TO THE TERMS AND CONDITIONS OF THIS LETTER OF CREDIT, PAYMENT SHALL BE INITIATED BY US IN IMMEDIATELY AVAILABLE FUNDS BY OUR CLOSE OF BUSINESS ON THE SUCCEEDING BUSINESS DAY.
IF DRAFTS ARE PRESENTED TO [Insert Bank Name] UNDER THIS LETTER OF CREDIT AFTER [Insert Time – (e.g., 11:00 AM)], ON A BUSINESS DAY, AND PROVIDED THAT SUCH DRAFTS CONFORM WITH THE TERMS AND CONDITIONS OF THIS LETTER OF CREDIT, PAYMENT
SHALL BE INITIATED BY US IN IMMEDIATELY AVAILABLE FUNDS BY OUR CLOSE OF BUSINESS ON THE SECOND SUCCEEDING BUSINESS DAY. AS USED IN THIS LETTER OF CREDIT, “BUSINESS DAY” SHALL MEAN ANY DAY OTHER THAN A SATURDAY, SUNDAY OR A DAY ON WHICH
BANKING INSTITUTIONS IN THE STATE OF CALIFORNIA ARE AUTHORIZED OR REQUIRED BY LAW TO CLOSE. IF THE EXPIRATION DATE FOR THIS LETTER OF CREDIT SHALL EVER FALL ON A DAY WHICH IS NOT A BUSINESS DAY THEN SUCH EXPIRATION DATE SHALL AUTOMATICALLY BE
EXTENDED TO THE DATE WHICH IS THE NEXT BUSINESS DAY. 
 PRESENTATION OF A DRAWING UNDER THIS LETTER OF CREDIT MAY BE MADE ON OR PRIOR TO THE THEN CURRENT
EXPIRATION DATE HEREOF BY HAND DELIVERY, COURIER SERVICE, OVERNIGHT MAIL, OR FACSIMILE. PRESENTATION BY FACSIMILE TRANSMISSION SHALL BE BY TRANSMISSION OF THE ABOVE REQUIRED SIGHT DRAFT DRAWN ON US TOGETHER WITH THIS LETTER OF CREDIT TO OUR
FACSIMILE NUMBER, [Insert Fax Number – (    )         -         ], ATTENTION: [Insert Appropriate Recipient], WITH TELEPHONIC CONFIRMATION OF
OUR RECEIPT OF SUCH FACSIMILE TRANSMISSION AT OUR TELEPHONE NUMBER [Insert Telephone Number – ( — )         -         ] OR TO SUCH OTHER FACSIMILE OR TELEPHONE
NUMBERS, AS TO WHICH YOU HAVE RECEIVED WRITTEN NOTICE FROM US AS BEING THE APPLICABLE SUCH NUMBER. WE AGREE TO NOTIFY YOU IN WRITING, BY NATIONALLY RECOGNIZED OVERNIGHT COURIER SERVICE, OF ANY CHANGE IN SUCH DIRECTION. ANY FACSIMILE PRESENTATION
PURSUANT TO THIS PARAGRAPH SHALL ALSO STATE THEREON THAT THE ORIGINAL OF SUCH SIGHT DRAFT AND LETTER OF CREDIT ARE BEING REMITTED, FOR DELIVERY ON THE NEXT BUSINESS DAY, TO [Insert Bank Name] AT THE APPLICABLE ADDRESS FOR PRESENTMENT PURSUANT TO THE
PARAGRAPH FOLLOWING THIS ONE. 
 WE HEREBY ENGAGE WITH YOU THAT ALL DOCUMENT(S) DRAWN UNDER AND IN COMPLIANCE WITH THE TERMS OF THIS STANDBY LETTER OF
CREDIT WILL BE DULY HONORED IF DRAWN AND PRESENTED FOR PAYMENT AT OUR OFFICE LOCATED AT [Insert Bank Name], [Insert Bank Address], ATTN: [Insert Appropriate Recipient], ON OR BEFORE THE EXPIRATION DATE OF THIS CREDIT, (Expiration Date) . 

  

					
		 	 EXHIBIT H

-3-
	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 IN THE EVENT THAT THE ORIGINAL OF THIS STANDBY LETTER OF CREDIT IS LOST, STOLEN, MUTILATED, OR OTHERWISE
DESTROYED, WE HEREBY AGREE TO ISSUE A DUPLICATE ORIGINAL HEREOF UPON RECEIPT OF A WRITTEN REQUEST FROM YOU AND A CERTIFICATION BY YOU (PURPORTEDLY SIGNED BY YOUR AUTHORIZED REPRESENTATIVE) OF THE LOSS, THEFT, MUTILATION, OR OTHER DESTRUCTION OF THE
ORIGINAL HEREOF. 
 EXCEPT SO FAR AS OTHERWISE EXPRESSLY STATED HEREIN, THIS STANDBY LETTER OF CREDIT IS SUBJECT TO THE “INTERNATIONAL STANDBY
PRACTICES” (ISP 98) INTERNATIONAL CHAMBER OF COMMERCE (PUBLICATION NO. 590). 
  

			
	Very truly yours,
	
	(Name of Issuing Bank)
		
	By:	 	  

  

					
		 	 EXHIBIT H

-4-
	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

 LEASE 

BRITANNIA SEAPORT CENTRE 

HCP LS REDWOOD CITY, LLC, 

a Delaware limited liability company 

as Landlord, 
 and 

BOLT BIOTHERAPEUTICS, INC., 

a Delaware corporation 
 as Tenant

 TABLE OF CONTENTS 

 

					
	 	  	Page	 
	 1.  PREMISES, BUILDING, PROJECT, AND COMMON AREAS
	  	 	5	 
		
	 2.  LEASE TERM; OPTION TERM
	  	 	8	 
		
	 3.  BASE RENT
	  	 	11	 
		
	 4.  ADDITIONAL RENT
	  	 	11	 
		
	 5.  USE OF PREMISES
	  	 	17	 
		
	 6.  SERVICES AND UTILITIES
	  	 	22	 
		
	 7.  REPAIRS
	  	 	24	 
		
	 8.  ADDITIONS AND ALTERATIONS
	  	 	25	 
		
	 9.  COVENANT AGAINST LIENS
	  	 	27	 
		
	 10.  INSURANCE
	  	 	27	 
		
	 11.  DAMAGE AND DESTRUCTION
	  	 	29	 
		
	 12.  NONWAIVER
	  	 	30	 
		
	 13.  CONDEMNATION
	  	 	30	 
		
	 14.  ASSIGNMENT AND SUBLETTING
	  	 	31	 
		
	 15.  SURRENDER OF PREMISES; OWNERSHIP AND REMOVAL OF TRADE FIXTURES
	  	 	34	 
		
	 16.  HOLDING OVER
	  	 	35	 
		
	 17.  ESTOPPEL CERTIFICATES
	  	 	36	 
		
	 18.  SUBORDINATION
	  	 	36	 
		
	 19.  DEFAULTS; REMEDIES
	  	 	36	 
		
	 20.  COVENANT OF QUIET ENJOYMENT
	  	 	38	 
		
	 21.  LETTER OF CREDIT
	  	 	38	 
		
	 22.  COMMUNICATIONS AND COMPUTER LINE
	  	 	41	 
		
	 23.  SIGNS
	  	 	42	 
		
	 24.  COMPLIANCE WITH LAW
	  	 	42	 
		
	 25.  LATE CHARGES
	  	 	43	 
		
	 26.  LANDLORD’S RIGHT TO CURE DEFAULT; PAYMENTS BY TENANT
	  	 	43	 
		
	 27.  ENTRY BY LANDLORD
	  	 	44	 
		
	 28.  TENANT PARKING
	  	 	44	 
		
	 29.  MISCELLANEOUS PROVISIONS
	  	 	44	 

  

					
		 	(i)	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

			
	EXHIBITS
		
	A	 	OUTLINE OF PREMISES; PROJECT SITE PLAN
	B    	 	TENANT WORK LETTER
	C	 	FORM OF NOTICE OF LEASE TERM DATES
	D	 	FORM OF TENANT’S ESTOPPEL CERTIFICATE
	E	 	ENVIRONMENTAL QUESTIONNAIRE
	F	 	TENANT’S PROPERTY
	G	 	FORM OF AMENDMENT RE: ADDITIONAL MONTHLY BASE RENT
	H	 	FORM OF LETTER OF CREDIT

  

					
		 	(ii)	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

					
	 INDEX
  
	  			
	 	  	Page(s)	 
	 Accountant
	  	 	17	 
	 Additional Rent
	  	 	12	 
	 Advocate Arbitrators
	  	 	10	 
	 Alterations
	  	 	25	 
	 as built
	  	 	26	 
	 Bank
	  	 	38	 
	 Bank’s Credit Rating Threshold
	  	 	38	 
	 Bankruptcy Code
	  	 	39	 
	 Base Building
	  	 	25	 
	 Base Rent
	  	 	11	 
	 Brokers
	  	 	48	 
	 Builder’s All Risk
	  	 	26	 
	 Building Systems
	  	 	24	 
	 Clean-up
	  	 	20	 
	 Closure Letter
	  	 	21	 
	 Common Areas
	  	 	6	 
	 Comparable Buildings
	  	 	10	 
	 Comparable Transactions
	  	 	10	 
	 Concessions
	  	 	10	 
	 Contemplated Effective Date
	  	 	32	 
	 Contemplated Transfer Space
	  	 	32	 
	 Control
	  	 	34	 
	 Direct Expenses
	  	 	12	 
	 Disputed Amounts
	  	 	45	 
	 Emergency
	  	 	25	 
	 Energy Disclosure Information
	  	 	22	 
	 Energy Disclosure Requirements
	  	 	22	 
	 Environmental Assessment
	  	 	20	 
	 Environmental Laws
	  	 	18	 
	 Environmental Questionnaire
	  	 	17	 
	 Environmental Report
	  	 	20	 
	 Estimate
	  	 	16	 
	 Estimate Statement
	  	 	16	 
	 Estimated Direct Expenses
	  	 	16	 
	 Excepted Matters
	  	 	48	 
	 Expense Year
	  	 	12	 
	 Fair Rental Value
	  	 	9	 
	 First Class Life Sciences Projects
	  	 	3	 
	 First Offer Notice
	  	 	7	 
	 First Offer Space
	  	 	6	 
	 First Offer Space Expiration Date
	  	 	7	 
	 First Offer Space Lease
	  	 	7	 
	 Force Majeure
	  	 	46	 
	 Fundamental Terms
	  	 	7	 
	 Generator
	  	 	23	 
	 Hazardous Materials
	  	 	18	 
	 Hazardous Materials Claims
	  	 	18	 
	 Intention to Transfer Notice
	  	 	32	 
	 Intervening Leases
	  	 	7	 
	 Landlord
	  	 	1	 
	 Landlord Parties
	  	 	27	 

  

					
		 	(iii)	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

					
	 	  	Page(s)	 
	 Landlord Repair Obligations
	  	 	24	 
	 L-C
	  	 	38	 
	 L-C Amount
	  	 	38	 
	 L-C Draw Event 
	  	 	39	 
	 L-C Expiration Date
	  	 	38	 
	 L-C FDIC Replacement Notice
	  	 	39	 
	 Lease
	  	 	1	 
	 Lease Commencement Date
	  	 	8	 
	 Lease Expiration Date
	  	 	9	 
	 Lease Term
	  	 	8	 
	 Lease Year
	  	 	9	 
	 Lines
	  	 	41	 
	 Mail
	  	 	47	 
	 Net Worth
	  	 	34	 
	 Neutral Arbitrator
	  	 	10	 
	 Nine Month Period
	  	 	33	 
	 Notices
	  	 	47	 
	 Objectionable Name
	  	 	42	 
	 Operating Expenses
	  	 	12	 
	 Option Conditions
	  	 	9	 
	 Option Rent
	  	 	9	 
	 Option Term
	  	 	9	 
	 Original Tenant
	  	 	7	 
	 Outside Agreement Date
	  	 	10	 
	 PCBs
	  	 	18	 
	 Permitted Assignee
	  	 	34	 
	 Permitted Transferee
	  	 	34	 
	 Premises
	  	 	5	 
	 Project
	  	 	6	 
	 Release
	  	 	18	 
	 Released
	  	 	18	 
	 Releases
	  	 	18	 
	 Rent
	  	 	12	 
	 RSF
	  	 	1	 
	 Security Deposit Laws
	  	 	41	 
	 Sign Specifications 
	  	 	42	 
	 Statement
	  	 	16	 
	 Subject Space
	  	 	31	 
	 Summary
	  	 	1	 
	 Superior Right Holders
	  	 	7	 
	 Tax Expenses
	  	 	14	 
	 Tenant
	  	 	1	 
	 Tenant Damage
	  	 	6	 
	 Tenant Energy Use Disclosure
	  	 	23	 
	 Tenant Signage
	  	 	42	 
	 Tenant Work Letter
	  	 	5	 
	 Tenant’s Accountant
	  	 	17	 
	 Tenant’s Agents
	  	 	18	 
	 Tenant’s Property
	  	 	27	 
	 Tenant’s Repair Obligations
	  	 	24	 
	 Tenant’s Share
	  	 	15	 
	 Transfers
	  	 	31	 
	 Transfer Notice
	  	 	31	 
	 Transfer Premium
	  	 	31	 
	 Transferee
	  	 	31	 
	 Transfers
	  	 	31	 

  

					
		 	(iv)	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]

					
	 	  	Page(s)	 
	 Triple Net
	  	 	12	 
	 Underlying Documents
	  	 	13	 
	 Warranty Period
	  	 	5	 
	 worth at the time of award
	  	 	37	 

  

					
		 	(v)	  	 [Britannia Seaport Centre]

[Bolt Biotherapeutics, Inc.]EX-10.23

 Exhibit 10.23 

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENTS, MARKED BY [***], HAS BEEN OMITTED BECAUSE BOLT BIOTHERAPEUTICS, INC. HAS DETERMINED THE
INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO BOLT BIOTHERAPEUTICS, INC. IF PUBLICLY DISCLOSED. 

MASTER SERVICES AGREEMENT 

This Master Services Agreement (together with all signed Statement(s) of Work and signed Change Orders, the “Agreement”) is
made and entered into as of June 26, 2018 (the “Effective Date”) by and between Bolt Biotherapeutics, Inc. (“Bolt”), a Delaware corporation with an office at 640 Galveston Drive, Redwood City, CA 94063, U.S.A., and
Piramal Healthcare UK Ltd (“Piramal”), a British corporation, with registered office at Whalton Road, Morpeth, Northumberland, NE613YA, UK. Bolt and Piramal hereinafter may be referred to individually as a “Party”
or collectively as the “Parties”. 
 WHEREAS, Piramal is engaged in the business of developing, manufacturing, and
supplying pharmaceutical products and/or providing pharmaceutical related services; and 
 WHEREAS, Bolt is engaged in the discovery,
development, manufacture and anticipated commercialization of pharmaceutical products. 
 NOW, THEREFORE, for good and valuable
consideration contained herein, the exchange, receipt and sufficiency of which are acknowledged, the Parties agree as follows: 

1.    Agreement Structure. From time to time, Bolt may want Piramal to provide certain Development or Manufacturing
Services (as defined below). This Agreement contains general terms and conditions under which Bolt would engage Piramal and under which Piramal would provide Services. Bolt and Piramal must complete and execute a Statement of Work (as defined below)
before any Services are provided. 
 2.    Definitions. Unless this Agreement expressly provides otherwise, the
following terms herein, whether used in the singular or plural, will have the meanings set forth below: 

2.1    “Additional Equipment” means the Equipment, if any, separately and specifically identified and
described in a Statement of Work as to be provided by Bolt or purchased or otherwise acquired by Piramal on behalf of and at Bolt’s expense. 

2.2    “Affiliate” means, with respect to a Party, any corporation, company, partnership, joint venture
and/or firm which controls, is controlled by or is under common control with such Party, for so long as such control exists. As used in this Agreement, “control” means (a) in the case of corporate entities, direct or indirect
ownership of at least fifty percent (50%) of the stock or shares having the right to vote for the election of directors, and (b) in the case of non-corporate entities, the direct or indirect power to
manage, direct or cause the direction of the management and policies of the non-corporate entity or the power to elect at least fifty percent (50%) of the members of the governing body of such non-corporate entity. 

 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENTS, MARKED BY [***], HAS BEEN OMITTED BECAUSE
BOLT BIOTHERAPEUTICS, INC. HAS DETE RMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO BOLT BIOTHERAPEUTICS, INC. IF PUBLICLY DISCLOSED. 

 

 2.3    “API/Drug Substance” means the active
pharmaceutical ingredient or any intermediate thereof, in each case identified in a Statement of Work. 

2.4    “Applicable Law” means all ordinances, rules, regulations, laws, guidelines, guidances, and
requirements of any Authority that apply to the Services and the activities contemplated under this Agreement, and any other applicable laws and regulations, as amended from time to time. 

2.5    “Authority” means any government or regulatory authority with jurisdiction over the Manufacture of
Product or use of Product in the intended country of use, including, without limitation, the FDA, PMDA, MHRA and the EMA. 

2.6    “Batch” means a specific quantity of Product that is intended to be of uniform character and
quality and is produced during the same cycle of Manufacture as defined by the applicable Batch record. 

2.7    “Batch Documentation” means the documents and other records that are produced in connection with
the Manufacture of a particular Batch and/or lot. 
 2.8    “Bolt Indemnitee” has the meaning set forth
in Section 14.1. 
 2.9    “Bolt Materials” means the materials identified in a Statement of Work
as being provided by Bolt or its designee, including the original materials, together with any derivatives, progeny, or improvements developed therefrom, and any combination of the foregoing with other substances. For clarity, Bolt Materials shall
include any and all intermediates (antibody or small molecule). 
 2.10    “Bolt Technology” means
(a) Bolt Materials, (b) Product, (c) Specifications, (d) the Technology owned by or licensed to Bolt (i) prior to the Effective Date, or (ii) after the Effective Date independently of this Agreement, and (e) the
Manufacturing Process except to the extent such process includes Piramal Technology. 
 2.11    “Certificate of
Analysis” means a document, signed by an authorized, quality assurance representative of Piramal and Piramal’s Qualified Person, describing Specifications for, and testing methods applied to, Product, and the results thereof. 

2.12    “Certificate of Compliance” means a document, signed by an authorized, quality assurance
representative of Piramal and Piramal’ s Qualified Person, attesting that a particular Batch was Manufactured in accordance with cGMP, Applicable Law, and the Specifications. 

2.13    “cGMP” means the current good manufacturing practices applicable to the Manufacture of Product
pursuant to Applicable Law, including but not limited to the Current Good Manufacturing Practice Regulations of the United States Code of Federal Regulations 21 CFR Parts 210 and 211 and the European Community Directive 2003/94/EC (Principles and
Guidelines of Good Manufacturing Practice for Medicinal Products), as well as the applicable documents developed by the International Conference on Harmonization (ICH), in effect as of the date of Manufacture of a particular Batch of Product. 

  
 2 

 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENTS, MARKED BY [***], HAS BEEN OMITTED BECAUSE
BOLT BIOTHERAPEUTICS, INC. HAS DETE RMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO BOLT BIOTHERAPEUTICS, INC. IF PUBLICLY DISCLOSED. 

 

 2.14    “Change Order” has the meaning set forth in
Section 5.2. 
 2.15    “Confidential Information” has the meaning set forth in Section 13.1.

 2.16    “Development” or “Developed” means the activities conducted by Piramal
under this Agreement to develop, modify or improve all or any part of a Manufacturing Process. 

2.17    “EMA” means the European Medicines Evaluation Agency and any successor agency having
substantially the same functions. 
 2.18    “Equipment” means any equipment or machinery, required for
the purpose of providing Services herein, used by Piramal in the Development and/or Manufacture of Product. 

2.19    “Facility” or “Facilities” means the facilities of Piramal used for the
provision of Services (as specified in the applicable Statement of Work), including facilities located at [***]. 

2.20    “FDA” means the United States Food and Drug Administration, and any successor agency having
substantially the same functions. 
 2.21    “FDCA” means the United States Federal Food, Drug and
Cosmetic Act, 21 U.S.C. §§321 et seq., as amended from time to time. 
 2.22    “force
majeure” has the meaning set forth in Section 12. 
 2.23    “Improvements” means all
Technology, discoveries and inventions, and all modifications and improvements thereto (whether or not protectable under patent, trademark, copyright or similar laws) other than Piramal Improvements that are discovered, developed or reduced to
practice by a Party, solely or jointly, in the performance of Services or through the use of Bolt’s Confidential Information and all intellectual property rights in the foregoing. 

2.24    “Manufacture” and “Manufacturing” means any steps, processes and activities
necessary to produce Product, including, without limitation, the manufacturing, processing, quality control testing, release, fill/finish, packaging, labeling or storage of Product. 

2.25    “Manufacturing Process” means any and all processes (or any step in any process) used or planned
to be used by Piramal to Manufacture Product, as evidenced in the Batch records and/or Development reports and any and all analytical methods used or planned to be used by Piramal for testing Product or incoming raw material used to Manufacture
Product (e.g. acceptance, in-process, release, Product characterization or stability testing), all of which shall be in compliance with Piramal’ s quality system. 

  
 3 

 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENTS, MARKED BY [***], HAS BEEN OMITTED BECAUSE
BOLT BIOTHERAPEUTICS, INC. HAS DETE RMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO BOLT BIOTHERAPEUTICS, INC. IF PUBLICLY DISCLOSED. 

 

 2.26    “Piramal Fault” means Piramal’s [***]. 

2.27    “Piramal Indemnitee” has the meaning set forth in Section 14.2. 

2.28    “Piramal Technology” means the Technology (a) owned by or licensed to Piramal prior to the
Effective Date, (b) owned by or licensed to Piramal after the Effective Date independently of this Agreement and without the use or disclosure of the Confidential Information of Bolt, or (c) discovered, developed or reduced to practice
solely by Piramal in the performance of Services solely to the extent necessary for the sustained or improved operation of its facilities or equipment, provided such Technology does not use or incorporate any of Bolt’s Confidential Information
and is generally applicable for manufacturing services performed by Piramal for its other customers (subsection (c), the “Piramal Improvements”). 

2.29    “Party” or “Parties” has the meaning set forth in the first paragraph of this
Agreement. 
 2.30    “Product” means any (a) API/Drug Substance, or (b) pharmaceutical
product comprised of API/Drug Substance, in each case as specified in the applicable Statement of Work. 

2.31    “Quality Agreement” means the quality agreement executed by both Parties in connection with and
prior to Services rendered pursuant to cGMP and which shall set forth quality control and quality assurance activities and responsibilities with respect to the Product. The Parties shall execute a quality agreement as soon as practical after the
execution of this Agreement, but well prior to cGMP manufacturing. 
 2.32    “Records” has the meaning
set forth in Section 5.5. 
 2.33    “Retention Period” has the meaning set forth in
Section 5.5. 
 2.34    “Services” means the Development, Manufacturing and/or other services to
be performed by or on behalf of Piramal, as described in the applicable fully executed Statement of Work or Change Order, as applicable. 

2.35    “Specifications” means a set of written criteria related to raw material acceptance, in-process testing and release testing that are provided by or approved by Bolt in writing to which Product should be considered acceptable by Bolt for the release of Product for its intended use, as such criteria
may be amended or supplemented from time to time by mutual written agreement of the Parties. 

2.36    “Statement of Work” means a written order for the performance of Services by Piramal under this
Agreement, substantially in the form attached hereto as Exhibit 1, as may be modified by a Change Order substantially in the form attached hereto as Exhibit 2, signed by duly authorized representatives from both Parties and referencing
this Agreement. 

  
 4 

 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENTS, MARKED BY [***], HAS BEEN OMITTED BECAUSE
BOLT BIOTHERAPEUTICS, INC. HAS DETE RMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO BOLT BIOTHERAPEUTICS, INC. IF PUBLICLY DISCLOSED. 

 

 2.37    “Technology” means all methods, techniques,
processes, trade secrets, copyrights, know-how, data, documentation, regulatory submissions, specifications and other intellectual property of any kind (whether or not protectable under patent, trademark,
copyright or similar laws). 
 3.    Service Performance. 

3.1    Piramal will perform the Services in strict accordance with the terms and conditions of the applicable Statement of
Work, Quality Agreement and this Agreement. Piramal will use its best efforts to provide the Facilities, supplies and staff necessary to perform the Services in accordance with the timetable(s) specified in the applicable Statement of Work. Piramal
agrees to diligently pursue the completion of each Statement of Work in a timely manner and deliver each of the deliverables in accordance with the time schedule and milestones specified therein. Time is of the essence for the performance of each
Statement of Work by Piramal. Without limiting any other obligations of Piramal set forth in this Agreement, Piramal, in performing the Services, will use that degree of experience, effort, and expertise one would expect a person skilled and
knowledgeable of the matters addressed herein to exercise and apply with respect to such matters when committed to achieving the agreed upon timelines. Piramal will perform each Statement of Work in a competent, professional, and workmanlike manner
using qualified personnel in accordance with Applicable Laws, cGMP (where applicable) and industry standards applicable to the contract development and manufacturing services industry. 

3.2    Each Party will appoint a primary “Technical Contact” having primary responsibility for day-to-day interactions with the other Party for the Services under each Statement of Work. Upon the Parties’ mutual agreement, a limited number of topic specific
“Technical Contacts” may be added with responsibility for day-to-day interactions with the other Party for specific activities for the Services under
each Statement of Work. The Technical Contacts shall be identified at the start of each Statement of Work and shall have appropriate qualifications and experience for communicating technical progress and issues related to the provision of Services
as well as an understanding of any associated impact on the timeline in the applicable Statement of Work. Piramal’s Technical Contact shall be reasonably acceptable to Bolt. The Parties will endeavor to keep the same primary Technical Contact
through the completion of each Statement of Work unless a change is requested by the other Party. Any change to a Technical Contact will be identified in writing to the other Party. Each Party will use reasonable efforts to provide the other Party
with at least [***] prior written notice of any change in that Party’s Technical Contact. Except for notices or communications required or permitted under this Agreement, which shall be subject to Section 17.3 below, all communications
between Piramal and Bolt regarding the conduct of the Services under a Statement of Work will be addressed to the Party’s relevant Technical Contact. 

  
 5 

 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENTS, MARKED BY [***], HAS BEEN OMITTED BECAUSE
BOLT BIOTHERAPEUTICS, INC. HAS DETE RMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO BOLT BIOTHERAPEUTICS, INC. IF PUBLICLY DISCLOSED. 

 

 3.3    To facilitate the relationship of the Parties and success of the
Services, Bolt may visit Piramal’s Facilities during normal business hours to observe the progress of the Services. For the purposes of this Section 3.3, Piramal shall ensure that such representatives are granted access to the Facilities;
provided that in no event shall Piramal be obligated to grant access at a time that would result in a material conflict of interest with another Piramal customer. The activities of all such representatives shall be monitored by the Technical
Contacts. Bolt acknowledges that, if any representative enters a cGMP dedicated area while activities required to be cGMP compliant are being performed, such representative must have appropriate training and qualification as required by
Piramal’s standard operating procedures. In connection with any such visits, Bolt agrees to abide by Piramal’s health and safety standard operating procedures that are required to be followed by Piramal’ s staff at the Facility, and
agrees to be responsible for the actions taken by Bolt’s visiting representatives while on Piramal’ s premises. 

3.4    Promptly after execution of this Agreement, the Parties shall establish a joint steering committee to oversee,
review and coordinate the activities of the Parties under this Agreement (the “JSC”). The JSC shall consist of [***] for each Party along with the Technical Contacts. The JSC shall meet [***] during the term of this Agreement, or as
otherwise mutually agreed by the Parties. JSC meetings may be held [***], and [***]. The JSC shall be responsible for: 
  

	 	(a)	 Overseeing the Services, facilitating the success of the Services, and facilitating a productive relationship
between the Parties; 

  

	 	(b)	 Attempting to rapidly resolve issues relating to a Statement of Work and any interactions between the Parties;

  

	 	(c)	 Reviewing reports submitted by the project managers on the progress of the Services at regular intervals as
determined by the JSC; and 

  

	 	(d)	 Reviewing any technical issues and their associated resolution submitted to the JSC by the Technical Contacts.

 3.5    The Parties will hold project team meetings [***], on a regular basis as determined by-mutual agreement of the Technical Contacts. 
 3.6    With Bolt’s prior
written consent, Piramal may subcontract the performance of certain of its obligations under this Agreement to qualified third parties, provided that (a) the third parties perform the activities in a manner consistent with this Agreement and
the applicable Statement of Work, (b) Piramal remains liable and solely responsible for the permitted subcontractor’s performance of the activities under this Agreement as if such activities were conducted by Piramal itself, and
(c) Piramal causes any such permitted subcontractor to be bound in writing by, and to comply with, all confidentiality, intellectual property, quality assurance, regulatory and other obligations and requirements of Piramal set forth in this
Agreement. Piramal will identify the need to subcontract any portion of the Services in each Statement of Work prior to the Parties’ execution of such Statement of Work. 

  
 6 

 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENTS, MARKED BY [***], HAS BEEN OMITTED BECAUSE
BOLT BIOTHERAPEUTICS, INC. HAS DETE RMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO BOLT BIOTHERAPEUTICS, INC. IF PUBLICLY DISCLOSED. 

 

 3.7    Piramal will notify Bolt in writing as soon as possible if Piramal
has reason to believe that it may be unable to perform or complete the Services or meet the timelines under any Statement of Work. 

4.    Materials and Equipment. 

4.1    Unless otherwise agreed in a Statement of Work, Piramal will procure all materials to be used by Piramal in the
performance of Services under any given Statement of Work other than the Bolt Materials indicated in such Statement of Work. Bolt or its designee(s) will provide Piramal with the Bolt Materials. Piramal agrees (a) to account for all Bolt
Materials, (b) not to provide Bolt Materials to any third party (including permitted subcontractors) without the express prior written consent of Bolt, (c) not to use Bolt Materials for any purpose other than conducting the Services under
the applicable Statement of Work, and (d) to destroy or return to Bolt all unused quantities of Bolt Materials according to Bolt’s written directions. Any pre-approved cost related to such
destruction shall be borne by Bolt. Further, Piramal agrees not to analyze, characterize, modify or reverse engineer any Bolt Materials or take any action to determine the structure or composition of any Bolt Materials unless and to the extent
explicitly required under the applicable Statement of Work. 
 4.2    Bolt will at all times retain all right, title,
and interest to and ownership of the Bolt Materials, Product and any work in process at each and every stage of the Manufacturing Process. Piramal will at all times take such measures as are required to protect the Bolt Materials, Product and any
work in process from risk of loss or damage at all stages of the Manufacturing Process. Piramal will ensure that Bolt Materials, Product and any work in process remain free and clear of any liens or encumbrances. Piramal will notify Bolt as soon as
possible if at any time it believes any Bolt Materials or Product have been damaged, lost or stolen. Piramal is responsible for the risk of loss with respect to Bolt Materials in its possession or control to the extent caused by Piramal Fault. Bolt
is otherwise responsible for the risk of loss with respect to Bolt Materials in Piramal’s possession or control. Bolt shall maintain insurance covering such Bolt Materials to the extent of Bolt’s responsibility for such risk of loss. 

4.3    Piramal acknowledges the Bolt Materials are experimental in nature and may have unknown characteristics and
therefore agrees to use prudence and reasonable care in the use, handling, storage, transportation and disposition and containment of the Bolt Materials. Piramal acknowledges that all activities conducted utilizing the Bolt Materials will be
conducted under suitable containment conditions and in accordance with Applicable Law. 
 4.4    Unless otherwise
specified in a Statement of Work, Piramal will procure all Equipment necessary to .perform the Services, except in such cases where Bolt will supply the Additional Equipment, if any. For the first Statement of Work, [***]. The cost of the

  
 7 

 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENTS, MARKED BY [***], HAS BEEN OMITTED BECAUSE
BOLT BIOTHERAPEUTICS, INC. HAS DETE RMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO BOLT BIOTHERAPEUTICS, INC. IF PUBLICLY DISCLOSED. 

 

 
Additional Equipment to be purchased by Piramal shall be paid by Bolt to Piramal, [***], or as stated in the applicable Statement of Work. Piramal shall be obliged to purchase the Additional
Equipment only after it has received the written approval and the cost for such purchase from Bolt. The Equipment will not be used by Piramal except in performance of Services under the applicable Statement of Work. Title to the Additional Equipment
will remain with Bolt and Piramal will ensure that the Additional Equipment is properly labeled and remains free and clear of any liens or encumbrances. At Bolt’s request, the Additional Equipment will be returned to Bolt, or to its designee.
Any maintenance costs for the Additional Equipment shall be the responsibility of Bolt. Piramal shall provide invoices or other relevant documents substantiating any maintenance expense incurred at the request of the Bolt. Piramal will promptly
notify Bolt if at any time it believes any Additional Equipment has been damaged, lost or stolen. If such damage or loss is due to Piramal’s negligence or willful misconduct, Piramal will be responsible for the cost of replacement. 

4.5    Piramal will seek to find competitive pricing while maintaining sufficient quality in its sourcing of materials,
consumables and equipment. The Bill of Materials for each Statement of Work will be approved by Bolt in advance of any ordering of materials for such Statement of Work by Piramal. All materials, consumables and equipment costs incurred by Piramal in
accordance with a Statement of Work will be charged at [***]. 
 5.    Development and Manufacture of Product.

 5.1    Piramal will perform all Services at the Facility, and will hold at the Facility all Equipment, Bolt Materials
and other items used in the Services. Piramal may change the location of the Facility or use any additional facility for the performance of Services by providing Bolt at least [***] prior written notice, and receiving Bolt’s prior written
consent, [***]. The Parties agree that [***]. Piramal will maintain the Facility and all Equipment required for the Manufacture of Product in a state of repair and operating ·efficiency consistent with the requirements of cGMP, the applicable
Statement of Work and Applicable Law. 
 5.2    The scope of Services under a Statement of Work may be changed only
through a written change order signed by both Parties (“Change Order”) in substantially the form attached hereto as Exhibit 2. If a change to a Statement of Work is identified by a Party, that Party will notify the other
Party as soon as is reasonably possible. Piramal will provide Bolt with a Change Order containing a description of the required modifications and their effect on the scope, fees and timelines specified in the Statement of Work within approximately
[***] of receiving or providing such notice. If the Change Order is not acceptable to Bolt, the Parties will use reasonable efforts to agree on a Change Order that is mutually acceptable. If practicable, Piramal will continue to work under the
existing Statement(s) of Work during any such negotiations but will not commence work in accordance with the Change Order until it is authorized in writing by Bolt. Should Bolt request (in writing by Bolt’s primary Technical Contact or its
Chief Business Officer) Piramal to perform additional services without there being a valid Change Order in place, Bolt shall be liable for the costs of such additional services at commercial rates consistent with the original Statement of Work. 

  
 8 

 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENTS, MARKED BY [***], HAS BEEN OMITTED BECAUSE
BOLT BIOTHERAPEUTICS, INC. HAS DETE RMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO BOLT BIOTHERAPEUTICS, INC. IF PUBLICLY DISCLOSED. 

 

 5.3    Any change or modification to the Manufacturing Process or
Specifications for any Product must be approved in writing in advance by Bolt and will be made in accordance with the provisions of the Quality Agreement. 

5.4    Piramal will take and retain, for such period and in such quantities as may be required by cGMP and the Quality
Agreement, samples of Product produced using the Manufacturing Process developed under this Agreement. 
 5.5    Piramal
will keep complete and accurate original records (or certified copies thereof), including, without limitation, reports, accounts, notes, data, and records of all information and results obtained from performance of Services (collectively, the
“Records”). All Records will be the sole property of Bolt. Upon Bolt’s written request, Piramal will promptly provide Bolt with copies of such Records. Piramal will not transfer, deliver or otherwise provide any such Records to
any third party, without the prior written approval of Bolt. While in the possession or control of Piramal, Records will be made available for inspection, examination and copying by or on behalf of Bolt. All original Records of the Development and
Manufacture of Product hereunder will be retained and archived by Piramal in accordance with the Quality Agreement for the period of time set forth therein (the “Retention Period”). Following the Retention Period, Piramal will not
destroy the Records without first giving Bolt written notice and the opportunity to further store the Records or have the records transferred to Bolt or its designee, in each case at Bolt’s expense. 

5.6    Should Bolt wish to cancel any Services, Bolt and Piramal shall meet to discuss the financial impact of the
canceled Services and any associated credits or costs that Piramal may need to refund or charge Bolt. If the canceled Services involve one or more cGMP manufacturing slots, then Bolt will reimburse Piramal [***] as set forth in the applicable
Statement of Work (but excluding the cost of any materials not yet purchased for such cGMP manufacturing and the costs included for related analytical testing) as follows: 
  

					
	 Notification Prior to Date of Manufacture
	  	Cancellation Fee Payable (% of [***]	 
	 [***]
	  	 	[***	] 

 If Piramal is able to schedule another client to utilize the cancelled cGMP slot, then Piramal will reduce the above
cancellation fee payable by Bolt by [***]. 
 6.    Product and Process Acceptance. 

6.1    Any Product to be Manufactured hereunder will be Manufactured in accordance with the Manufacturing Process approved
by Bolt and, unless otherwise stated in the applicable Statement of Work, cGMP. Each Batch of Product will be sampled and tested by Piramal against the Specifications. The quality assurance department of Piramal will review the Batch Documentation
for such Batch and will assess if the Manufacture has taken place in compliance with cGMP (if applicable) and the Manufacturing Process. 

  
 9 

 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENTS, MARKED BY [***], HAS BEEN OMITTED BECAUSE
BOLT BIOTHERAPEUTICS, INC. HAS DETE RMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO BOLT BIOTHERAPEUTICS, INC. IF PUBLICLY DISCLOSED. 

 

 6.2    If, based upon such tests, a Batch of Product conforms to the
Specifications and was Manufactured according to cGMP (if applicable) and the Manufacturing Process, then a Certificate of Compliance will be completed and approved by the quality assurance department of Piramal and Piramal’s qualified person.
Complete and accurate Batch Documentation for each Batch of Product will be delivered to Bolt. 
 6.3    If the Parties
disagree as to whether a Batch of Product conforms to the applicable Specifications, the respective Technical Contacts of the Parties will attempt to resolve any such disagreement in good faith and Bolt and Piramal will follow their respective
standard operating procedures to determine the conformity of the Batch of Product to cGMP (if applicable), the Manufacturing Process and the Specifications. Notwithstanding the foregoing, in the event the Technical Contacts are unable to resolve
such disagreement within [***], the dispute shall be submitted for determination by an independent laboratory/expert mutually selected by the Parties, the approval of the appointment of which shall not be unreasonably withheld or delayed by either
Party, and the decision of such independent laboratory/expert shall be final and binding on the Parties. The independent laboratory/expert’s fees incurred in connection with the independent laboratory/expert’s decision shall be borne
[***]. 
 6.4    If a Batch of Product fails to conform to cGMP (if applicable), the Manufacturing Process or the
Specifications due to Piramal Fault (“Defective Product”), then Piramal will, [***]: 
 (a)    Have the
Defective Product reworked by Piramal such that it conforms to cGMP (if applicable), the Manufacturing Process and the Specifications; or 

(b)    Have Piramal Manufacture a new Batch of Product that complies with cGMP (if applicable), the Manufacturing Process
and the Specifications; or 
 (c)    Return or provide (as applicable) the Defective Product for further reprocessing by
Bolt or its nominee and provide a [***] refund for [***]. 
 6.5    Where Bolt so elects, Piramal shall work diligently
and exercise professional skill and judgement to either (1) rework the Defective Product, or (2) Manufacture a new Batch of Product to replace the Defective Product as soon as reasonably practicable. Piramal’s liability for the
Manufacture or rework shall [***]. For the avoidance of doubt, payment for the applicable Batch shall not be due until successful release of the reworked or newly manufactured Batch of Product. [***]. 

6.6    Should a Batch be manufactured in accordance with cGMP and the Manufacturing Process but fail to conform to the
Specifications or is otherwise deemed un-usable for its intended purpose(s) due to quality, compliance or other issues not within Piramal’s reasonable control, then Bolt shall pay the relevant milestone
in the Statement of 

  
 10 

 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENTS, MARKED BY [***], HAS BEEN OMITTED BECAUSE
BOLT BIOTHERAPEUTICS, INC. HAS DETE RMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO BOLT BIOTHERAPEUTICS, INC. IF PUBLICLY DISCLOSED. 

 

 
Work and Piramal shall have no liability under such circumstances for the Defective Product. Piramal shall work diligently and exercise professional skill and judgement to either (1) rework
the Defective Product, or (2) Manufacture a Batch of Product to replace the Defective Product as soon as reasonably practicable, upon Bolt’s request and at Bolt’s expense. 

7.    Shipping and Delivery. 

7.1    Piramal agrees not to ship Product to Bolt or its designee until it has received a written approval to release and
ship from Bolt. Shipping will be in accordance with the instructions for shipping and packaging specified by Bolt in writing in the applicable Statement of Work or as otherwise agreed to in writing by the Parties. Piramal shall remain responsible
for all Product and shipments of Product until Product is delivered in accordance with the delivery terms in the immediately following sentence. Delivery terms are [***]. A bill of lading will be furnished to Bolt with respect to each shipment. 

7.2    Bolt will notify Piramal in writing of loss, damage, defects or
non-delivery of any part of a Product shipment [***] after receipt of such shipment by Bolt, or its designee, provided that if any loss, damage or defects are not readily evident based upon its standard
inspection procedures (a “Latent Defect”) to Bolt at the time of delivery, such notification by Bolt to Piramal will be made no later than [***] after Bolt becomes aware of such Latent Defect. 

8.    Price and Payments. 

8.1    The currency and price of Product and/or the fees for the performance of Services, including the payment schedule
therefor, will be set forth in the applicable Statement of Work. 
 8.2    Piramal will invoice Bolt according to the
milestone-based payment schedule in the applicable Statement of Work. Each invoice will include the information contained in the compensation section of the Statement of Work. Payment of undisputed invoices will be due [***] after receipt of the
invoice by the relevant Bolt contact. For undisputed invoices, if payment is not made within [***], Piramal shall notify Bolt’s primary Technical Contact and Chief Business Officer and have the right to [***]. 

8.3    Piramal will keep complete and accurate financial records of all Services performed and invoice calculations for a
period of at least [***] following the calendar year in which such costs are invoiced, and, upon the request of Bolt, will permit Bolt or its duly authorized agents to examine such records during normal business hours for the purpose of verifying
the correctness of all such calculations. If it is determined that Piramal overcharged Bolt for any amounts owed under this Agreement, Piramal shall promptly reimburse Bolt for such overcharge and if such overcharge represents more than [***]. 

8.4    Duty, sales, use or excise taxes imposed by any governmental entity that apply to the provision of Services
hereunder (other than any taxes based upon the income of Piramal) will be borne by Bolt, unless such tax results from any assignment of this 

  
 11 

 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENTS, MARKED BY [***], HAS BEEN OMITTED BECAUSE
BOLT BIOTHERAPEUTICS, INC. HAS DETE RMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO BOLT BIOTHERAPEUTICS, INC. IF PUBLICLY DISCLOSED. 

 

 
Agreement by Piramal to any Affiliate of Piramal that is domiciled or physically located outside of the United Kingdom. Piramal will assist Bolt in obtaining full credit for or any exemption from
any VAT charges and facilitate Bolt in obtaining full refund of any VAT charges that may be imposed (at no additional charge to Bolt other than any out of pocket fees for filing). 

9.    Pricing for Future Services. For the period of [***], Piramal will offer [***], and thereafter Piramal may
[***]. For purposes of this Agreement, [***]. 
 10.    Representations and Warranties. 

10.1    Piramal represents and warrants that: 

(a)    Piramal is and will remain a corporation duly organized, validly existing and in good standing under the laws of
its jurisdiction of organization. 
 (b)    The execution and delivery of this Agreement has been authorized by all
requisite corporate action. This Agreement is and will remain a valid and binding obligation of Piramal, enforceable in accordance with its terms, subject to laws of general application relating to bankruptcy, insolvency and the relief of debtors.

 (c)    Piramal is under no contractual or other obligation or restriction that is inconsistent with Piramal’s
execution or performance of this Agreement. Piramal will not enter into any agreement, either written or oral, that would conflict with Piramal’s responsibilities under this Agreement or a Statement of Work. 

(d)    The Services will be performed with requisite care, skill and diligence, in accordance with Applicable Law,
industry standards and this Agreement, and by individuals who are appropriately trained and qualified. 
 (e)    To the
best of Piramal’s knowledge, the Services and Manufacturing Process (including when used to make commercial product) will not infringe the intellectual property rights of any third party and Piramal will promptly notify Bolt in writing should
it become aware of any claims asserting such infringement. 
 (f)    The Services shall be performed as set forth in the
Statement of Work and in accordance with this Agreement, each Certificate of Analysis and Certificate of Compliance shall be accurate and complete in all material respects and all Records shall be accurate and complete in all material respects. 

(g)    At the time of delivery to Bolt, the Product Manufactured under this Agreement (i) will have been Manufactured
in accordance with cGMP (if applicable) and Applicable Law, the Manufacturing Process, and Specifications, (ii) will not be adulterated or misbranded under the FDCA or other Applicable Law, unless Bolt requests delivery to occur before the
results of product testing are available, and (iii) will be free and clear of any lien or encumbrance. 

  
 12 

 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENTS, MARKED BY [***], HAS BEEN OMITTED BECAUSE
BOLT BIOTHERAPEUTICS, INC. HAS DETE RMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO BOLT BIOTHERAPEUTICS, INC. IF PUBLICLY DISCLOSED. 

 

 (h)    Neither Piramal, its officers nor any person used
by·Piramal to perform Services (i) has been debarred, or convicted, or is subject to a pending debarment or conviction, pursuant to section 306 of the FDCA, 21 U.S.C. § 335a or (ii) has been listed by any federal or state
agencies, excluded, debarred, suspended or otherwise been made ineligible to participate in federal and/or state healthcare programs or federal procurement or non-procurement programs (as that term is defined
in 42 U.S.C. 1320a-7b(f)) or (iii) has been convicted of a criminal offense related to the provision of healthcare items or services, or is subject to any such pending action. Piramal agrees to inform
Bolt in writing promptly if Piramal or any person who is performing Services is subject to the foregoing, or if any action, suit, claim, investigation, or proceeding relating to the foregoing is pending, or to the best of Piramal’ s knowledge,
is threatened. 
 (i)    Piramal has all the necessary licenses, authorizations and approvals to perform the Services.

 (j)    Piramal’s quality system encompasses, without limitation, the proper design and validation of equipment.

 10.2    Bolt represents and warrants that: 

(a)    Bolt is and will remain a corporation duly organized, validly existing and in good standing under the laws of its
jurisdiction of organization. 
 (b)    The execution and delivery of this Agreement has been authorized by all
requisite corporate action. This Agreement is and will remain a valid and binding obligation of Bolt, enforceable in accordance with its terms, subject to laws of general application relating to bankruptcy, insolvency and the relief of debtors. 

(c)    Bolt is under no contractual or other obligation or restriction that is inconsistent with Bolt’s execution or
performance of this Agreement. Bolt will not enter into any agreement, either written or oral, that would conflict with Bolt’s responsibilities under this Agreement or a Statement of Work. 

(d)    To the best of Bolt’s knowledge, the use of Bolt Technology as contemplated in the Services will not infringe
the intellectual property rights of any third party and Bolt will promptly notify Piramal in writing should it become aware of any claims asserting such infringement. 

10.3    EXCEPT AS EXPRESSLY SET FORTH IN THIS AGREEMENT, NEITHER PARTY MAKES ANY REPRESENTATIONS OR EXTENDS ANY WARRANTIES
OF ANY KIND, EITHER EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NONINFRINGEMENT. 

10.4    Limitation of Liability. NEITHER PARTY SHALL BE LIABLE TO THE OTHER FOR EXEMPLARY, PUNITIVE, SPECIAL,
INDIRECT, INCIDENTAL OR 

  
 13 

 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENTS, MARKED BY [***], HAS BEEN OMITTED BECAUSE
BOLT BIOTHERAPEUTICS, INC. HAS DETE RMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO BOLT BIOTHERAPEUTICS, INC. IF PUBLICLY DISCLOSED. 

 

 
CONSEQUENTIAL DAMAGES (INCLUDING LOST PROFITS), WHETHER IN CONTRACT, WARRANTY, NEGLIGENCE, TORT, STRICT LIABILITY OR OTHERWISE. NOTWITHSTANDING THE FOREGOING, PIRAMAL’S LIABILITY UNDER THIS
AGREEMENT WITH RESPECT TO [***] SHALL IN NO CASE EXCEED [***]. NOTWITHSTANDING ANYTHING CONTAINED IN THIS AGREEMENT TO THE CONTRARY, THE LIMITATIONS ON DAMAGES AND LIABILITY SET FORTH IN THIS SECTION 9.4 WILL NOT APPLY TO [***]. 

11.    Compliance With Government Regulations. 

11.1    Piramal agrees to comply with all Applicable Law in performing Services. Piramal shall promptly notify Bolt in
writing of any non-compliance with Applicable Law. Piramal will be responsible for obtaining, at its expense, any Facility or other licenses or permits, and any regulatory and government approvals necessary
for the performance of Services. At Bolt’s written request, Piramal will provide Bolt with copies of all such approvals and submissions to Authorities, Bolt will have the right to use and reference any and all information contained in such
approvals or submissions in connection with the development, regulatory approval and/or commercialization of Product and Piramal will execute and deliver such documents and instruments as reasonably necessary to implement such rights of use and
reference. 
 11.2    Bolt will be responsible for obtaining, at its expense, all regulatory and governmental approvals
and permits necessary for Bolt’s use of any Product Developed and/or Manufactured hereunder. Piramal will be responsible for promptly providing Bolt with all supporting data and information relating to the Development and/or Manufacture of
Product necessary for obtaining such approvals. The format, content and cost of provision of such data and information for submission by Bolt to a regulatory agency will be borne by Bolt. 

11.3    Piramal will permit Bolt or its representatives to be present on site during any visit or inspection by any
Authority of the Facility (to the extent it relates to any Product or to the Manufacturing Process). Piramal will give as much advance notice as possible to Bolt of any such visit or inspection. Piramal will provide to Bolt a copy of any report or
other written communication received from any Authority within [***] after receipt thereof, and will consult with and obtain approval from, Bolt before responding to each such communication. Piramal will provide Bolt with a copy of its final
responses within [***] after submission thereof. 
 12.    Term and Termination. 

12.1    This Agreement will take effect as of the Effective Date and, unless earlier terminated pursuant to this Section,
will remain in effect for five years (5) years. Thereafter, this Agreement will automatically renew for successive one (1) year terms unless either Party notifies the other Party in writing not later than six (6) months in advance of
expiration of the original term or any additional renewed term of its intention to terminate this Agreement; provided, however that any such non-renewal will not affect any valid Statement of Work until the
expiration or termination of such Statement of Work. 

  
 14 

 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENTS, MARKED BY [***], HAS BEEN OMITTED BECAUSE
BOLT BIOTHERAPEUTICS, INC. HAS DETE RMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO BOLT BIOTHERAPEUTICS, INC. IF PUBLICLY DISCLOSED. 

 

 12.2    Bolt may terminate this Agreement or any Statement of Work upon
[***] prior written notice to Piramal. Either Party may terminate this Agreement upon thirty (30) days’ prior written if there has been a material breach of this Agreement and this breach is not cured during the notice period. 

12.3    Upon termination or expiration of this Agreement or any Statement(s) of Work, neither Piramal nor Bolt shall have
any further obligations under this Agreement or such Statement(s) of Work, except that with respect to each terminating or expiring Statement(s) of Work: 

(a)    In the case of early termination, Piramal will terminate all Services in progress for the affected Statement(s) of
Work, including subcontracted Services (if any), in an orderly manner as soon as practical and in accordance with a schedule agreed to by Bolt, unless Bolt specifies in the notice of termination that Services in progress should be completed; and

 (b)    Piramal will deliver to Bolt all Bolt Materials, Equipment, Product, retained samples (except for samples
Piramal is requited to retain pursuant to Applicable Law), Records, data, reports and other property, information and/or know-how in recorded form that was provided by Bolt, or developed in the performance of
the Services, that are owned by or licensed to Bolt; and 
 (c)    In the case of early termination, Bolt (i) will
purchase from Piramal any existing inventories of Product conforming to the Specifications and Manufactured in accordance with cGMP (if applicable) and the Manufacturing Process, at the price for such Product set forth in the applicable Statement of
Work, and (ii) may either (x) purchase any Product in process held by Piramal as of the date of the termination, at a price [***], or (y) direct Piramal to dispose of such material at Bolt’s cost; and 

(d)    In the case of early termination, within [***] after the termination of any Statement(s) of Work, Piramal will
provide to Bolt a written itemized statement of all work performed by Piramal in connection with the terminated Statement(s) of Work, an itemized breakdown of the costs associated with that work, and a final invoice for such Statement(s) of Work. If
Bolt has paid to Piramal in advance more than the amount in a final invoice, then Piramal agrees to refund the amount of overpayment to Bolt, or to credit the excess payment toward any other existing or future Statement(s) of Work, at the election
of Bolt; and 
 (e)    Each Party will promptly return the other Party’s Confidential Information; and 

(f)    Upon the expiration of this Agreement or its earlier termination, upon Bolt’s request, Piramal will use its
commercially reasonable efforts ·to assist Bolt in the transfer of 

  
 15 

 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENTS, MARKED BY [***], HAS BEEN OMITTED BECAUSE
BOLT BIOTHERAPEUTICS, INC. HAS DETE RMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO BOLT BIOTHERAPEUTICS, INC. IF PUBLICLY DISCLOSED. 

 

 
relevant manufacturing technology and information to another manufacturing site; Bolt will pay Piramal for its reasonable costs (to be mutually agreed upon) incurred in connection with such
transfer, unless such termination is by Bolt for Piramal’s breach pursuant. to Section 11.2, in which event such transfer costs shall be borne by Piramal; and 

(g)    Any rights and obligations of the Parties that by their terms survive termination or expiration of this Agreement
or of any Statement(s) of Work, including, without limitation, the Record retention (Section 5.5), representations and warranties and limitation of liability (Section 9), confidentiality (Section 13), indemnification (Section 14), intellectual
property rights (Section 16) and miscellaneous (Section 17) provisions of this Agreement, will survive termination or expiration. 

13.    Force Majeure. 

Except as otherwise expressly set forth in this Agreement, neither Party will have breached this Agreement for failure or delay in fulfilling or performing any
term of this Agreement when such failure or delay is caused by or results from causes beyond the reasonable control of the affected Party, including, without limitation, fire, floods, embargoes, shortages, epidemics, quarantines, war, acts of war
(whether war be declared or not), insurrections, riots, civil commotion, strikes, acts of God or acts, omissions, or delays in acting, by any governmental authority (“force majeure”). The Party affected by any event of force
majeure will promptly notify the other Party, explaining the nature, details and expected duration thereof and shall remain responsible for performing any activities affected by such force majeure under a Statements of Work within such timelines as
mutually agreed between the Parties. Such Party will also notify the other Party from time to time as to when the affected Party reasonably expects to resume performance in whole or in part of its obligations hereunder, and to notify the other Party
of the cessation of any such event. A Party affected by an event of force majeure will use all reasonable efforts to remedy, remove, or mitigate such event and the effects thereof with all reasonable dispatch. If a Party anticipates that an
event of force majeure may occur, such Party will notify the other Party of the nature, details and expected duration thereof. Upon termination of the event of force majeure, the performance of any suspended obligation or duty will
promptly recommence. Notwithstanding the foregoing, if a force majeure event is expected to prevent a Party’s performance under this Agreement for an aggregate of [***] or more, the other Party may terminate this Agreement upon written
notice to the non-performing Party. 
 14.    Confidentiality. 

14.1    “Confidential Information” means any scientific, technical, trade or business information which is
disclosed by or on behalf of one Party (“disclosing Party”) to the other Party (“receiving Party”). Confidential Information does not include information that the receiving Party can demonstrate (a) is in
possession of the receiving Party at the time of disclosure, as reasonably demonstrated by written records and without obligation of confidentiality, (b) is or later becomes part of the public domain through no fault of the receiving Party in
breach of this Agreement, (c) is received by the receiving Party from a 

  
 16 

 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENTS, MARKED BY [***], HAS BEEN OMITTED BECAUSE
BOLT BIOTHERAPEUTICS, INC. HAS DETE RMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO BOLT BIOTHERAPEUTICS, INC. IF PUBLICLY DISCLOSED. 

 

 
third party without an obligation of confidentiality to the disclosing Party, or (d) is developed independently by or on behalf of the receiving Party as reasonably demonstrated by written
records and without use of, reference to, or reliance upon the disclosing Party’s Confidential Information. The disclosing Party will, to the extent practical, use reasonable efforts to label or identify as confidential, at the time of
disclosure, all such Confidential Information that is disclosed in writing or other tangible form, provided that, in the absence of such labeling or identification, Confidential Information will include all information otherwise reasonably expected
to be treated in a confidential manner under the circumstances of disclosure under this Agreement or by the nature of the information itself. Confidential Information of Piramal includes, but is not limited to, Piramal Technology, whether or not
labeled confidential. Confidential Information of Bolt includes, but is not limited to, any information or documentation developed for Bolt by Piramal under any Statement(s) of Work, Records, Improvements and Bolt Technology, whether or not labeled
confidential. 
 14.2    Each receiving Party agrees (a) to keep confidential the Confidential Information of the
disclosing Party and the terms of this Agreement, (b) not to disclose the disclosing Party’s Confidential Information to any third party without the prior written consent of such disclosing Party, and (c) to use such Confidential
Information only as reasonably necessary to fulfill its obligations or in the reasonable exercise of rights granted to it hereunder (the “Authorized Purpose”). A receiving Party, however, may disclose (i) Confidential
Information of the disclosing Party to its Affiliates, and to its and their directors, employees, consultants, and agents in each case for the Authorized Purpose and who are bound in writing by the obligations of confidentiality and restriction on
use not less stringent than as set forth in this Agreement, (ii) Improvements to the extent reasonably necessary to exploit its rights and perform its obligations under Section 16 of this Agreement, and (iii) Confidential Information
of the disclosing Party to the extent such disclosure is required to comply with Applicable Law or to defend or prosecute litigation; provided, however, that in the case of (iii) only, the receiving Party provides prompt prior
written notice of such disclosure to the disclosing Party and takes reasonable and lawful actions to avoid or minimize the degree of such disclosure. Furthermore, Bolt may disclose Confidential Information of Piramal relating to the Development
and/or Manufacture of Product to entities with whom Bolt has (or may have) a marketing and/or development collaboration and who have a specific need to know such Confidential Information and who are bound in writing by obligations of confidentiality
and restrictions on use not less stringent than as set forth in this Agreement. Notwithstanding anything to the contrary in this Agreement, Bolt may disclose the existence and terms of this Agreement to actual and potential investors, acquirers,
licensees and collaborators on a reasonable need to know basis under circumstances that reasonably ensure the confidentiality thereof. Notwithstanding anything to the contrary in this Agreement, Piramal will not disclose or transfer Bolt’s
Confidential Information (including Bolt Technology) to any facility, personnel or Affiliate of Piramal located outside of the United States, Canada or the United Kingdom unless expressly authorized by Bolt in writing, not to be unreasonably
withheld or delayed. 

  
 17 

 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENTS, MARKED BY [***], HAS BEEN OMITTED BECAUSE
BOLT BIOTHERAPEUTICS, INC. HAS DETE RMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO BOLT BIOTHERAPEUTICS, INC. IF PUBLICLY DISCLOSED. 

 

 14.3    Except to the extent required by Applicable Law, neither Party
will make any public statements or releases concerning this Agreement or the transactions contemplated by this Agreement without obtaining the prior written consent of the other Party. 

15.    Indemnification. 

15.1    Piramal will indemnify and hold harmless Bolt, its Affiliates and their respective officers, directors, employees
and agents (each a “Bolt Indemnitee”) from and against any and all losses, damages, liabilities or expenses (including reasonable attorneys’ fees and other costs of defense) (collectively, “Losses”) in
connection with any and all actions, suits, claims or demands that may be brought or instituted against any Bolt Indemnitee by any third party based on, arising out of, or resulting from, any (a) breach by Piramal of its representations,
warranties or covenants hereunder, or (b) negligent act or omission or the willful misconduct of any Piramal Indemnitees (as defined in Section 14.2 below) in performing obligations under this Agreement. As a condition of this
indemnification obligation, Bolt must promptly notify Piramal in writing of a covered claim, must tender to Piramal (and/or its insurer) full authority to defend or settle the claim, and must reasonably cooperate with the defense. Notwithstanding
the foregoing, Piramal will not, without Bolt’s prior written consent, agree to settle any claim on such terms or conditions as would impair Bolt’s ability or right to Manufacture, market, sell or otherwise use or exploit Product or
otherwise impose any condition or obligation on Bolt, or as would impair Piramal’s ability, right or obligation to perform its obligations hereunder. 

15.2    Bolt will indemnify and hold harmless Piramal, its Affiliates and their respective officers, directors, employees
and agents (each a “Piramal Indemnitee”) from and against any and all Losses in connection with any and all actions, suits, claims or demands that may be brought or instituted against any Piramal Indemnitee by any third party based
on, or arising out of, or resulting from (a) the use of the Product after delivery by Piramal to Bolt or its designee, except to the extent that such damages are within the scope of the indemnification obligation of Piramal under
Section 14.1, (b) breach by Bolt of its representations, warranties or covenants hereunder, or (c) any negligent act or omission or the willful misconduct of any Bolt Indemnitees in performing obligations under this Agreement. As a
condition of this indemnification obligation, Piramal must promptly notify Bolt in writing of a covered claim, must tender to Bolt (and/or its insurer) full authority to defend or settle the claim, and must reasonably cooperate with the defense.

 16.    Insurance. 

16.1    Piramal will secure and maintain in full force and effect throughout the term of this Agreement insurance with
coverage and minimum policy limits set forth as follows: 
 [***] 

16.2    As specified in 4.2, and without limiting Piramal’s responsibilities under this Agreement, Bolt shall insure
all Bolt Materials or any Product containing Bolt Materials whilst on the premises of any Piramal Facility, be they in the form of raw materials, work in process or finished goods. 

  
 18 

 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENTS, MARKED BY [***], HAS BEEN OMITTED BECAUSE
BOLT BIOTHERAPEUTICS, INC. HAS DETE RMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO BOLT BIOTHERAPEUTICS, INC. IF PUBLICLY DISCLOSED. 

 

 16.3    Piramal will comply, at Bolt’s expense, with reasonable
requests for information made by Bolt’s insurance provider representative(s), including permitting such representative(s) to inspect the Facility during operational hours and upon reasonable notice to Piramal. In regard to such inspections, the
representative(s) will adhere to such guidelines and policies pertaining to safety and non-disclosure as Piramal may reasonably require. Upon request, Piramal shall deliver copies of its Certificates of
Insurance. 
 17.    Intellectual Property Rights. 

17.1    Bolt Technology. As between the Parties, all rights to and interests in Bolt Technology will remain the
exclusive property of Bolt. Piramal agrees that its rights to Bolt Technology are for the limited purpose of providing Services during the term of this Agreement. 

17.2    Improvements. Piramal agrees that all Improvements will [***]. 

17.3    Exclusivity. During the term of this Agreement and [***], Piramal and its Affiliates shall not (and shall
not grant rights to any third party to) develop or manufacture any pharmaceutical product that is [***], in each case without Bolt’s prior written approval, not to be unreasonably withheld or delayed. 

17.4    Patents on [***]. Bolt will have the exclusive right and option, but not the obligation, to prepare, file,
prosecute, maintain, enforce and defend at its sole expense, any patent applications and/or patents that claim and/or cover [***]. 

17.5    Piramal Technology. All rights and title in all Piramal Technology shall vest solely with Piramal and Bolt
shall not have any ownership claim on any such Piramal Technology used by Piramal in the provision of Services hereunder. Piramal hereby grants Bolt a worldwide, non-exclusive, royalty-free, limited,
irrevocable license (with the right to grant and authorize the further grant of sublicenses) under any portion of Piramal Technology that is necessary or useful for the research, development, manufacture (included to have manufactured), sale
(including to have sold), commercialization or other exploitation of the Products and deliverables covered under this Agreement. 

18.    Miscellaneous. 

18.1    Assignment. This Agreement may not be assigned or otherwise transferred by either Party without the prior
written consent of the other Party; provided, however, that either Party may, without such consent, but with notice to the other Party, assign this Agreement, in whole or in part, (a) in connection with the transfer or sale of all
or substantially all of the assets of such Party or the line of business or Product to which this Agreement relates, (b) to the successor entity or acquirer in the event of the merger, consolidation or change of control of such Party, or
(c) to any Affiliate of the assigning Party. Any purported assignment in violation of the preceding sentence will be void. Any permitted assignee will assume the rights and obligations of its assignor under this Agreement. 

  
 19 

 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENTS, MARKED BY [***], HAS BEEN OMITTED BECAUSE
BOLT BIOTHERAPEUTICS, INC. HAS DETE RMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO BOLT BIOTHERAPEUTICS, INC. IF PUBLICLY DISCLOSED. 

 

 18.2    Severability. If any provision of this Agreement becomes
or is declared by a court of competent jurisdiction to be illegal, unenforceable or void, this Agreement will continue in full force and effect without said provision. If any provision of this Agreement is held to be excessively broad, it will be
reformed and construed by limiting and reducing it so as to be enforceable to the maximum extent permitted by law. The Parties will use their reasonable efforts to replace the invalid, illegal or unenforceable provision(s) with valid, legal and
enforceable provision(s), which, insofar as practical, implement the intent of the Parties. The foregoing will not apply to provisions relating to price and payment hereunder. 

18.3    Notices. All notices or other communications which are required or permitted hereunder will be made in
writing and delivered personally, sent by nationally-recognized overnight courier or sent by registered or certified mail, postage prepaid, return receipt requested, addressed as follows: 

 

			
	If to Piramal Grangemouth, to:	  	 If to Bolt, to:

		
	 Piramal Healthcare UK Ltd
 Whalton Road

Morpeth
 Northumberland

United Kingdom
 NE61 3YA

 
 Attention: [***]

Telecopier No: [***]
  

If to Piramal Lexington, to:
  

Coldstream Laboratories, Inc.
 1500 Bull Lea Road, Suite 250

Lexington, KY 40511
 USA

 
 Attention: [***]
	  	 Bolt biotherapeutics, Inc

640 Galveston drive

Redwood City, CA 94063

U.S.A.

    
  

Attention: [***]

with CC: [***]

 or to such other address as the Party to whom notice is to be given may have furnished to the other Party in writing. Any such
communication will be deemed to have been given (a) when delivered, if personally delivered, (b) [***], if sent by nationally-recognized overnight courier for next business day delivery, or (c) [***] after mailing if sent via registered or
certified mail. 

  
 20 

 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENTS, MARKED BY [***], HAS BEEN OMITTED BECAUSE
BOLT BIOTHERAPEUTICS, INC. HAS DETE RMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO BOLT BIOTHERAPEUTICS, INC. IF PUBLICLY DISCLOSED. 

 

 18.4    Choice of Law and Disputes. This Agreement will in all
events and for all purposes be governed by, and construed in accordance with, the laws of the State of New York, U.S.A. without regard to any choice of law principle that would dictate the application of the law of another jurisdiction. Any disputes
arising out this Agreement shall be submitted before the exclusive jurisdiction of the federal and state courts located in New York, New York. 

18.5    Entire Agreement; Amendment. This Agreement along with the Exhibits constitutes the entire agreement of the
Parties with regard to its subject matter, and supersedes all previous written or oral representations, agreements and understandings between Bolt and Piramal. This Agreement, including any Statement of Work or purchase order issued hereunder, may
only be changed by a writing signed by authorized representatives of both Parties. 
 18.6    Conflicts. If there
is any conflict, discrepancy, or inconsistency between the terms of this Agreement and any Statement(s) of Work, purchase order, Quality Agreement or other form used by the Parties, the terms of this Agreement will control. 

18.7    Headings; Construction. The Section headings are intended for convenience of reference only and are not
intended to be a part of or to affect the meaning or interpretation of this Agreement. Both Parties have participated equally in the formation of this Agreement and the language of this Agreement will not be presumptively construed against either
Party. 
 18.8    No Partnership or Employment Relationship. The Parties are independent contractors and this
Agreement does not create a partnership or employment relationship between Bolt and Piramal. 
 18.9    Waiver.
The waiver by either Party hereto of any right hereunder or the failure to perform or of a breach by the other Party will not be deemed a waiver of any other right hereunder or of any other breach or failure by said other Party whether of a similar
nature or otherwise. 
 18.10    Counterparts. This Agreement may be executed in multiple counterparts, each of
which will be deemed an original, but all of which together will constitute one and the same instrument. Signatures to this Agreement delivered by electronic transmission (e.g., portable document format (PDF)) shall be deemed to be binding as
original signatures. 
 (The remainder of this page is intentionally left blank. The signature page follows.) 

  
 21 

 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENTS, MARKED BY [***], HAS BEEN OMITTED BECAUSE
BOLT BIOTHERAPEUTICS, INC. HAS DETERMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO BOLT BIOTHERAPEUTICS, INC. IF PUBLICLY DISCLOSED. 

IN WITNESS WHEREOF, the Parties hereto have caused this Agreement to be executed by their duly authorized representatives as of the Effective
Date. 
 BOLT BIOTHERAPEUTICS, INC 
  

			
	By:	 	 /s/ Grant Yonehiro

	Name:	 	Grant Yonehiro
	Title:	 	Chief Business Officer
		
	Date:	 	June 26 2018
	
	PRIMAL HEALTHCARE UK LTD
		
	By:	 	 /s/ Stuart Needleman

	Name:	 	Stuart Needleman
	Title:	 	Chief Commercial Officer
		
	Date:	 	June 27, 2018

 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENTS, MARKED BY [***], HAS BEEN OMITTED BECAUSE
BOLT BIOTHERAPEUTICS, INC. HAS DETERMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO BOLT BIOTHERAPEUTICS, INC. IF PUBLICLY DISCLOSED. 

EXHIBIT 1- STATEMENT OF WORK 

APPENDIX #1 - SOW FCXXXX 

For the GMT Manufacture and Testing of XXXXX 

THIS STATEMENT OF WORK is by and between Bolt Biotherapeutics, Inc. (“Bolt”) and Piramal Healthcare UK Ltd (Piramal), and upon execution will
be governed by the terms and conditions of the Master Services Agreement between Bolt and Piramal dated XXXX (the “Agreement”). Capitalized terms in this Statement of Work will have the same meaning as set forth in the Agreement.

 All terms and conditions of the Agreement will apply to this Statement of Work. In the event of any conflict between this Statement of Work and the
Agreement, the terms and conditions of the Agreement will prevail. 
 STATEMENT OF WORK AGREED TO AND ACCEPTED BY: 

BOLT BIOTHERAPEUTICS, INC. 
  

			
	By:	 	             

	Name:	 	
	Title:	 	
	
	PIRAMAL HEALTHCARE UK LTD
		
	By:	 	  

	Name:	 	
	Title:	 	

 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENTS, MARKED BY [***], HAS BEEN OMITTED BECAUSE
BOLT BIOTHERAPEUTICS, INC. HAS DETERMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO BOLT BIOTHERAPEUTICS, INC. IF PUBLICLY DISCLOSED. 

EXHIBIT 2 - PROJECT CHANGE ORDER FORM 

THIS CHANGE ORDER to Statement of Work xxxx is by and between Bolt Biotherapeutics, Inc. (“Bolt”) and Piramal Healthcare UK Ltd
(“Piramal”), and upon execution will be governed by the terms and conditions of the Master Services Agreement between Bolt and Piramal dated XX:XX (the “Agreement”). Capitalized terms in this Change Order will have
the same meaning as set forth in the Agreement. 
 All terms and conditions of the Agreement will apply to this Change Order. In the event of any conflict
between this Change Order and the Agreement, the terms and conditions of the Agreement will prevail. 
  

							
	Project Name:	  	 	  	Change Order #:	  	#1    
	Statement of Work #:	  	 	  	Supplier Contact:	  	                    
	Supplier:	  	Piramal Healthcare UK Ltd	  	Requestor Name:	  	 
	Request Date:	  	 

 Bolt has requested the following additional task(s) or changes in the scope of the xxxx Statement of Work between
Piramal Healthcare UK Ltd and Bolt as dated above. 
 General Description of change to project: 

 

	
	    

 Provide a description of changes to each line item below 

 

	
	    

 Costs associated with this Change Order: 

Acceptance: The above services and estimated costs from this Change Order are hereby accepted and shall be made a part of the above-referenced Statement
of Work. All work is to be performed under the same terms and conditions as specified in the original Statement of Work unless otherwise stipulated herein. 

 

			
	BOLT BIOTHERAPEUTICS, INC.

			
		
	By:	 	  

		
	Name:	 	  

		
	Title:	 	  

		
	Date:	 	  

 

			
	PIRAMAL HEAL TH CARE UK LTD

			
		
	By:	 	  

		
	Name:	 	  

		
	Title:	 	  

		
	Date:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00319-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00319-of-00352.parquet"}]]